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Abstract 
Joshua D. Waetzig, Ph.D. 
Department of Chemistry, April 2008 
The University of Kansas 
 The utilization of phosphate tethers in synthesis is the focus of the dissertation 
research described herein.  Specifically, cross metathesis of various olefin partners 
with a phosphate tether has been demonstrated.  These studies established the Type 
III olefin reactivity of the exocyclic olefin of the triply allylic bicyclic phosphate 
tether.  Cross metathesis between the bicyclic phosphate and complex olefin partners 
allowed for rapid assembly of advanced polyol subunits.  Understanding the reactivity 
of the bicyclic phosphate allowed for the application of this methodology toward the 
synthesis of a natural product.  The target chosen was dolabelide C, a 24-membered 
macrolactone possessing cytotoxicity against HeLa-S3 cervical cancer cells.  
Retrosynthetic analysis of dolabelide C revealed two subunits that could be accessed 
by the developed bicyclic phosphate tether methodologies.  In the synthesis of the C1-
C14 subunit of dolabelide C the bicyclic phosphate tether mediates a selective cross 
metathesis with the terminal exocyclic olefin, differentiates the endocyclic and 
exocyclic olefins for selective hydrogenation, and serves as a leaving grouping for a 
regioselective palladium(0)-catalyzed hydride opening.  Upon removal of the 
phosphate tether, the C1-C14 subunit of dolabelide C was completed in six 
subsequent steps.  Studies toward the C15-C30 subunit of dolabelide C also utilized 
the bicyclic phosphate tether methodology.  Three routes toward this subunit were 
 iv 
realized, each took advantage of the latent leaving group ability of the phosphate 
tether to set the C23 stereocenter.  These sequences supplied the C15-C30 of 
dolabelide C which was then prepared for pairing with the C1-C14 subunit.  Final 
coupling of the C1-C14 and C15-C30 subunits of dolabelide C was accomplished and 
five more steps were successfully achieved, culminating in a macrocyclic ring-closing 
metathesis to completed the total synthesis of dolabelide C.  The total synthesis of 
dolabelide C using our temporary phosphate tether methods was achieved in 24 steps 
(longest linear sequence from acetylacetone) and 54 total steps.  The overall yield for 
this synthesis was 0.73% with an average yield per chemical step being 81.5%. 
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Chapter 1 
Temporary Tethers in Total Synthesis 
 2 
1.1 Introduction 
 The art of total synthesis requires careful retrosynthetic analysis and planning 
for the desired natural product to be achieved in a rapid and efficient manner.  During 
the course of a synthesis, problems are often encountered where intermolecular 
reactions provide low reactivity or selectivity and thus necessitate the development of 
new methods to achieve the desired transformation.  One way to circumvent the 
problems of intermolecular reactions is to install a temporary tether to change the 
transformation from an intermolecular reaction to one that is intramolecular.  
The inherent advantages of intramolecular reactions as compared to 
intermolecular reactions are numerous.  Intramolecular reactions often benefit from 
the reactive functionalities being in close proximity, which may lower the entropy of 
the overall reaction.  Also, with the reactive centers being attached, milder reactions 
conditions can be used, decreasing the amount of unwanted side products.  
Temporary tethers have been shown to regiocontrol over transformations such as the 
Diels-Alder, Pauson-Khand, as well as olefin metathesis reactions. 
When designing a temporary tether, several factors should be considered. 
First, temporary tethers must be easily installed and covalently attached to the two 
reacting species.  A good tether should be long enough to allow the transformation to 
occur, but not so long as to lose all the advantages tethers provide.  Tethers should 
also provide some level of pre-organization within the structure that may increase 
reactive and selectivity.  Finally, once the transformation has been achieved, removal 
of the tether must also be facile as not to destroy the newly formed molecular 
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structure.  Additionally some temporary tethers, when not immediately removed, can 
also control the regio- and diastereoselectivity in subsequent reactions and participate 
in further functionalization during their removal. 
Ley and Cox reviewed the use of temporary tethers in synthesis in 2000, 
where they discussed various uses of temporary tethers in synthetic methods as well 
as in total synthesis.1  This review will focus on temporary tethers that have been used 
in total synthesis or are being applied in total synthetic pathways since that 
publication and cover additional total synthetic efforts not covered by the previous 
review.  All tethers described herein form covalent bonds with the reacting substrates 
and are isolable, or have the possibility of being isolated, once the reaction is 
achieved.  Transition metal tethers reacting through closed transition states will not be 
discussed.  The focus of this review will be on the installation, functionalization, and 
removal of temporary tethers with a brief explanation of the advantages that these 
temporary tethers provide over standard synthetic pathways.  
1.2 Silicon Tethers  
Temporary silicon tethers are the most widely used tethers in total synthesis.  
They are extremely attractive due to their facile installment and protecting group 
attributes upon installation.  Also, a number of simple cleavage pathways such as 
protodesilylation, oxidation, and cross-coupling pathways are available with a silicon 
tether.  This section will discuss temporary silicon tethers used in cycloadditions, 
olefin metathesis, and radical mediated processes.  
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1.2.1 Temporary Silicon Tethers: Cycloadditions 
Temporary silicon tethers utilized for cycloadditions provide enhanced levels 
of stereo- and regiocontrol, as well as increased reaction rates.  Denmark and 
coworkers used a silicon tether mediated cycloaddition strategy in the synthesis of  
(-)-detoxinine (1.10) (Scheme 1).2  The key step in the synthesis of this target was a 
tandem [4+2]/[3+2] cycloaddition reaction that is orchestrated by a heteroatom tether.  
The proper tether choice required that (i) its removal reveal two hydroxy moieties; (ii) 
two atoms must link the fragments to allow for proper diastereocontrol of the 
intramolecular cycloadditions; (iii) the tether must tolerate a nitroalkane 
cycloaddition reaction.  Silicon was an ideal choice because of its ability to undergo 
the Tamao-Fleming oxidation for removal and the possibility for enhanced 
diastereoselectivity due to the nature of the two-atom tether provided by silicon.   
Assembly of the cycloaddition precursor began with the addition of potassium 
nitroacetaldehyde (1.2) to the E-configured chlorosilane (1.1) to yield vinyl silane 
1.3.  Silane 1.3 was immediately subjected to the conditions for cycloaddition without 
further purification.  Addition of chiral vinyl ether 1.4 and Lewis acid 1.5 provided a 
60% yield of the tandem [4+2]/[3+2] cycloaddition product 1.7.  This reaction first 
underwent the [4+2] cycloaddition to generate a zwitterionic species (1.6) that reacted 
with the silicon-tethered dipolarophile in a subsequent [3+2] cycloaddition.  The 
silicon tether was maintained for four steps, when a Tamao-Fleming oxidation 
cleaved the silicon tether to provide lactam 1.9 in 86% yield.  Final acid hydrolysis of 
the lactam generated (-)-detoxinine (1.10) in 90% yield.  This total synthesis 
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showcases how a temporary silicon tether can provide excellent diastereocontrol for a 
[3+2] cycloaddition and then be removed to reveal two hydroxy stereocenters en 
route to the total synthesis of (-)-detoxinine.   
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 Martin and coworker have taken advantage of the regiocontrol that silicon-
tethered cycloadditions provide in their synthesis of vineomycinone B2 methyl ester 
(Scheme 2).3  The key to the synthesis of vineomycinone B2 methyl ester was 
employing a previously developed silicon-tethered benzyne/furan Diels-Alder 
reaction4 that would provide regiocontrol and construct the carbohydrate framework 
of the natural product in a single step.  Assembly of the silicon tether began with a 
Mitsunobu reaction between primary alcohol 1.12 and phenol 1.11 providing Diels-
Alder precursor 1.13 in 85% yield.  Dropwise addition of nBuLi allowed for benzyne 
formation and subsequent biscycloaddition5 to occur in 85% yield affording a mixture 
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of diastereomers (1.14).  It was found that both silicon tethers could be efficiently 
removed using modified Rickborn conditions (KOH in DMF/H2O).
6  This crude 
mixture was then subjected to ethanolic HCl that resulted in the regioselective bis-
ring-opening followed by air oxidation to provide a 34% yield of quinone 1.15 over 
two steps.  Only three more steps were needed to complete the total synthesis of 
vineomycinone B2 methyl ester.  Overall, Martin’s synthesis of vineomycinone B2 
methyl ester was the first application using silicon tethers to control regioselectivity 
in a Diels-Alder reaction of substituted benzynes and furans.  The successful use of 
this reaction displayed the ability of temporary silicon tethers to facilitate challenging 
transformations and rapidly assemble complex targets that might not be possible by 
intermolecular processes. 
Scheme 2 
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Shea and coworkers utilized a silicon tether in their efforts toward the 
synthesis of (+)-aldosterone (Scheme 3).7  The synthetic route envisioned for this 
target was centered on a chiral silicon-tethered type II intramolecular Diels-Alder 
reaction.  A one pot, three component coupling between 1.16, 1.17, and Ph2SiCl2 
afforded chiral cycloaddition precursor 1.18.  This intermediate was heated to 200 ºC 
in a sealed tube to provide a 78% yield of cyclized 1.19 as a 2.7:1 mixture of 
diastereomers.  This single reaction set the C8, C10, C13, and C14 stereocenters and 
validated the use of the proposed Diels-Alder cycloaddition for the enantioselective 
synthesis of (+)-aldosterone.  Facile removal of the tether was achieved with K2CO3 
in methanol and silica gel separation of the diastereomers provided a 44% yield of 
1.20.  The route described is currently being employed to complete the  
Scheme 3 
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 8 
enantioselective total synthesis of (+)-aldosterone.  Given the complexity of this 
tethered Diels-Alder reaction, it is difficult to imagine a simpler intermolecular 
reaction that could arrive at the same substrate.  This demonstrates how a silicon 
tether can be used to couple major subunits of natural products and allow 
stereochemically complex transformations to be achieved. 
Other heteroatom and carbon tethers have been used to mediate cycloadditions 
in total synthesis; yet finding a suitable tether to achieve the desired transformation 
can be its own challenge.  In their total synthesis of (+)-aloperine, Overman and 
coworkers proposed three disposable tethers for an intramolecular Diels-Alder 
reaction.8  Investigations began with sulfonyl- and carbonyl-tethered systems due to 
the electron-withdrawing nature of these groups that were proposed to facilitate the 
cycloaddition reaction (Scheme 4).  Reaction of the sulfonamide-tethered Diels-Alder 
precursor (1.21) provided a 3.4:1 dr of the cyclized adduct (1.22) in favor of the 
desired product.  Attempts to remove the sulfonamide tether with various reducing 
conditions were unsuccessful and led to examination of a carbonyl tether.  The 
carbonyl-tethered Diels-Alder precursor 1.23 was cyclized and afforded the 
tetracyclic core (1.24) at 0 ºC as an inseparable mixture of diastereomers.  Attempts 
to remove this tether led to more elaborate synthetic sequences.9 
Scheme 4 
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For their final investigation into the tethered Diels-Alder reaction, a silicon tether was 
attempted. Overman was able to achieve the direct addition of amine 1.25 to silyl 
triflate 1.26 to provide 1.27 (Scheme 5).  Upon cyclization, a 5:1 mixture of 
diastereomers favoring the product with the desired stereochemistry (1.28) was 
obtained.  Interestingly, when this reaction was tried intermolecularly with amine 
1.25 and the phenylsilane derivative, no reaction was observed, even when the 
reaction was heated at 165 ºC.  Due to the instability of the silicon tether, silane 1.28 
was immediately subjected to HF, cleaving the Si—N bond.  After concentrating the 
reaction and adding mesitylene, the reaction was heated to allow for intramolecular 
lactamization providing lactam 1.29.  It was found that lactam 1.29 was also unstable 
to water work-up and thus was taken on directly using the Tamao-Fleming10 
oxidation to furnish alcohol 1.30 in 63% yield.  Removal of the alcohol and tosyl 
deprotection then provided (+)-aloperine (1.31).  Overall, Overman has shown that a 
variety of disposable tethers allow for the desired cycloaddition to be achieved, yet 
not all tethers provide the same results.  The tethered systems shown by Overman 
each gave different diastereoselectivities for the Diels-Alder cyclization and required 
different conditions for their removal.  The silicon-tethered route was chosen because 
of its facile removal making it the most viable tether for their total synthesis of (+)-
aloperine. 
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Further, Malacria and coworkers have tested the differences between carbon- 
and silicon-based tethering strategies in their synthesis of the polycyclic taxane ring 
system.11  The approach Malacria envisioned for entry into the taxane ring system 
was the implementation of a known [4+2] cycloaddition12 followed by a colbalt-
mediated [2+2+2] cyclization that had been developed in his laboratories.13  Initial 
efforts were focused on using an intermolecular Diels-Alder reaction to synthesize the 
A ring and a subsequent [2+2+2] cyclization to construct the B, C and D rings 
(Scheme 6).  The Diels-Alder cyclization occurred in 68% yield (1.34) but the 
Scheme 6 
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cyclotrimerization using cobalt and light did not afford the desired compound (1.35).  
However, when the carbonyl was converted to the dimethoxy ketal, the [2+2+2] 
cyclization did provide tetracyclic 1.35, albeit in only 15-20% yield. 
Switching to an alkyl-tethered approach, compound 1.36 was initially 
subjected to cyclotrimerization conditions forming the C, D and E rings although in 
only 18% yield (Scheme 7).  This cycloadduct then underwent the Diels-Alder 
reaction to generate taxane skeleton 1.38 in 95% yield.  
Scheme 7 
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Given the limited success with the carbon-based tether, silicon tethers were 
tested to facilitate both of the proposed reactions (Scheme 8).  Construction of silicon 
tether 1.41 was achieved by the addition of alcohol 1.39 to chlorodiisopropylsilane; 
this species was then converted to a bromosilane using NBS, and final addition of 
alcohol 1.40 generated silane 1.41 in 68% yield.  Cyclization of triyne 1.41 was 
promoted by a cobalt catalyst and light and removal of the silicon tether with TBAF 
then afforded benzocyclobutene 1.42 in 88% over two steps.  Benzocyclobutene 1.42 
was taken forward in six steps to access the taxane skeleton, in which the [4+2] 
cycloaddition constructed the A ring in the last step. 
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Scheme 8 
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Overall, Malacria has studied various tethers to probe for the best temporary 
connection and reaction parameters to achieve their desired cyclizations.  Although 
the initial efforts were plagued by side reactions and low yields for the desired 
transformation, the temporary silicon strategy was successful in providing a high 
yielding pathway for the taxane skeleton to be accessed. 
The intermolecular Pauson-Khand reaction forms a useful cyclopentenone 
building block, but the reaction is known to have problems with low regioselectivities 
and yields, limiting its use in synthesis.  Intramolecular reactions have shown to be 
more effective, thus a tethered process has the potential to alleviate these problems.  
Brummond and coworkers pursued a silicon-tethered allenic [2+2+1],14 Pauson-
Khand-type reaction, to rapidly access the cyclopentanone core of prostaglandins and 
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address the inherent regiochemical issues in their synthesis of 15-deoxy-!12,14-
prostaglandin J2 (Scheme 9).
15  Construction of the silicon tether began by converting 
iodide 1.43 into the lithiate followed by addition of diphenyldichlorosilane.  This 
chlorosilane intermediate was then subjected to ethynylmagnesium bromide to couple 
the alkyne and allene moieties through silicon providing silane 1.44 in 75% yield over 
three steps.16  Then a molybdenum-mediated Pauson-Khand reaction of 1.44 afforded 
a 1:2 mixture of E-1.45 and Z-1.45 cyclopentenones in 38% yield.17  Despite the low 
yield, the undesired Z-1.45 isomer could be readily converted to E-1.45 by addition of 
propanedithiol and boron trifluoride to yield only E-1.45.18  Reduction of the 
cyclopentenone was achieved using DIBAL-H and then followed by immediate 
removal of the silicon tether with benzyltrimethylammonium fluoride to yield 
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silanol 1.46.  This compound was not purified, but directly subjected to Tamao-
Fleming oxidation conditions to provide diol 1.47 in 21% yield over three steps.  
Three more steps were needed to complete the first total synthesis of 15-deoxy-!12,14-
prostaglandin J2 (1.48).  This route displays the utility of a silicon tether to rapidly 
couple the reacting centers and further functionalize the molecule upon removal of 
the tether by Tamao-Fleming oxidation.  Although the reaction was still low yielding, 
the restraint the silicon tether imposed to set the regioselectivity for the Pauson-
Khand reaction was vital to the total synthesis of 15-deoxy-!12,14-prostaglandin J2. 
1.2.2 Temporary Silicon Tethers: Olefin Metathesis 
Over the past decade new olefin metathesis catalysts have emerged that 
possess increased activity and functional group tolerance.  These catalysts have had a 
profound impact on tethering strategies toward natural product targets. Ring-closing 
metathesis (RCM) has mainly been employed due to the cooperative effects of both 
metathesis and tethers.  Again, silicon-tethered RCM is the most commonly used 
tether in natural product synthesis and described below are the routes which utilizing 
RCM and a silicon tether.  
In the synthesis of (-)-mucocin, P. Andrew Evans and coworker reported a 
new approach toward 1,4-diols utilizing a temporary silicon tether and RCM (Scheme 
10).19  Their strategy rapidly assembles the silicon tether by coupling allylic alcohols 
1.49 and 1.50 with silicon provide silane 1.51 in 74% yield. The metathesis of trans-
1, 4-diols is known to be an unfavorable process, as shown in a transition state model 
proposed in early silicon tether metathesis work by Evans.20  This model reveals that 
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formation of the trans-diol requires one of the allylic R substituents to be placed in an 
unfavorable pseudo-axial position that imposes increased steric demands on the 
forming ring as the R becomes larger.  The desired RCM in the synthesis of (-)-
mucocin (1.53) required almost two equivalents of the Grubbs II catalyst to obtain 
1.52 in 83% yield.  This illustrates that hindered systems, such as this case, may 
require large amounts of the ruthenium catalyst.  Silicon tether removal was achieved 
with HF and subsequent diimide reduction provided (-)-mucocin (1.53) in 91% and 
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95% yields, respectively.  The temporary silicon tether in this total synthesis displays 
the ability of tethers to rapidly couple advanced subunits of natural products.  Once 
the two olefins are coupled to silicon, RCM provides direct reaction between the 
olefins, as opposed to CM of these substrates that would lead to both product and 
homodimerization of these advanced subunits.  This report was also the first 
application of a complex temporary silicon tether RCM as a cross-coupling reaction 
in total synthesis. 
Evans and Murthy were also able to access C2-symmetric 1,4-diols using a 
silicon tether/RCM approach. These symmetric 1,4-diols21 are utilized as asymmetric 
catalysts,22 chiral auxiliaries,23 and as precursors in target-directed synthesis.24  Evans 
demonstrated the silicon-tethered/RCM in the total synthesis of D-altritol (Scheme 
11).25  Addition of chiral allylic alcohol 1.54 to diphenyldichlorosilane with 2,6-
lutidine afforded bisalkoxysilane 1.55 in 87% yield.  1.55 was then treated with 8 mol 
% Grubbs I catalyst with an additional 2.5 mol % of catalyst added after 20 h.  A 91% 
yield of silaketal 1.56 was obtained after 32 h.  The long reaction times may have 
been necessary due to the increased sterics of the allylic substituents used in this 
tethered process.26  This also displays the difference between the sterics of a 
symmetric and unsymmetric 1,4-diol.  Following dihydroxylation of the olefin, the 
silicon tether was removed with TBAF.  The entire molecule was peracetylated, to aid 
in isolation, providing 1.57 in 75% yield.  Finally, addition of catalytic sodium 
methoxide afforded D-altritol 1.58 in 88% yield.  The silicon-tethered RCM 
methodology was the highlight in the rapid synthesis of D-altritol obtaining excellent 
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yields for the tethered processes of coupling, metathesis, and removal.  This 
methodology can be applied to a wide range of chiral allylic alcohols and can be used 
in either target directed synthesis or applied toward other useful intermediates.   
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In a related example, Hoye and coworkers were able to combine different 
modes of metathesis and mixed silicon tethers in their synthesis of (+)-gigantecin 
(Scheme 12).27  This synthesis involved the construction of mixed silaketal 1.61 that 
was obtained by sequential addition of alcohols 1.60 and 1.59 to 
diphenyldichlorosilane.28  With silicon tether 1.61 in hand, initial experiments were 
conducted on triene 1.61 with Hoveyda-Grubbs second generation catalyst29 to allow 
for the seven-membered RCM to occur with subsequent CM of 1.62 at the terminal 
olefin.  When this reaction was run and the tether was removed the mass spectrum 
and the initial 1H NMR suggested that (+)-gigantecin had indeed been synthesized.  
Upon closer inspection of the 1H NMR spectrum and comparison with the known 
spectrum, noticeable differences were discovered and the melting point of the final 
product differed from the reported melting point of the natural product.  These 
differences were validated when the product of the reaction was shown to have 
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initially undergone an RCM between the terminal olefin and the distal allylic siloxane 
olefin and then a CM involving the proximal siloxane olefin and terminal olefin 1.62 
to yield 1.63a.  To overcome this problem, a site-directed metathesis strategy was 
adopted in which CM partner 1.62 and Grubbs II catalyst were initially added and 
then mixed silaketal 1.61 was added over 9 h by syringe pump.  This allowed initial 
CM between the two Type I terminal olefins followed by a slower RCM of the Type 
II siloxane olefins.30  The properly metathesized product (1.63) was obtained in 63% 
yield when these conditions were used.  Diimide reduction and subsequent Scheme 
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global deprotection provided (+)-gigantecin 1.64 in good yield over the two steps.  
This silicon tether strategy allowed for the rapid coupling of the two major subunits 
of (+)-gigantecin and demonstrated the control of metathesis initiation, setup by the 
silicon tether to access the proper carbon framework of (+)-gigantecin. 
Mulzer and Gaich took advantage of silicon-tethered metathesis and the 
inherent Z-olefin geometry formation of RCM in the total synthesis of epothilones B 
and D (Scheme 13).31 In a one-pot process, alcohol 1.6532 was rapidly coupled with 
Si(Me)2Cl2 and subsequent addition of alcohol 1.68 provided disiloxane 1.69 in 84% 
yield.  1.69 was subjected to RCM with 15 mol % of Grubbs II catalyst or Hoveyda-
Grubbs II catalyst being added by syringe pump to generate the olefin-containing 
nine-membered ring 1.70 in 98% yield (Z:E = 5:1).28  The silicon tether was then 
removed with TBAF to provide the Z-configured 1.71 in 84% yield.  This diol was 
further functionalized to a common intermediate in their previous total synthesis of 
epothilones B and D.33 The incorporation of an ester linkage instead of using silicon 
as a tether led only to the CM product in 19% yield.  The silicon-tethered process was 
reasoned to be atomically larger and have more distorted bonds allowing for the RCM  
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to be achieved due to the decreased ring strain.34  This shows how heteroatom tethers 
facilitate transformations that their carbon or carbonyl counterparts are unable to 
achieve. 
Disruptive steric interactions during RCM have been shown to be prevalent in 
silicon-tethered reactions and Van de Weghe and coworkers were able to support 
these findings in their total synthesis of attenol A (Scheme 14).35 Van de Weghe was 
interested in using silicon to tether two different allylic alcohols and then utilize 
metathesis to join the two moieties, which they had shown to be a viable process in 
previous work.34b Coupling of the subunits to silicon was achieved by first adding 
1.72 and subsequently adding 1.73 to yield bis-siloxane 1.74.  Subjection of 1.74 to 
metathesis using Schrock’s molybdenum catalyst led to partial conversion of cyclized 
product 1.75.  NOE experiments confirmed the stereochemistry of metathesis product 
1.75 and showed that only two of the diastereomers were reactive in the metathesis. 
In this experiment, the catalyst resolved the diastereomeric allylic alcohol connected 
to silicon from a 1:1 diastereomeric mixture to a 7:3 mixture of starting material 1.74. 
This observation contrasts previous cases where stereochemistry of the substrates did 
not dictate the outcome of the RCM.34b TFA removal of the silicon tether provided 
1.76 in 22% yield over two steps.  Ten additional steps were required to complete the 
total synthesis of attenol A.  This example demonstrates the limitations associated 
with the steric demands of the catalyst and those interactions during ring formation.  
Further studies into sterically hindered RCM are needed to fully understand this 
synthetic problem.  This establishes that successful tethered RCM methods must 
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account for the steric environment about the reactive olefins for the transformation to 
be successful.36   
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Silicon-tethered RCM can be used to easily access the Z-olefin geometry that 
may not be as simple to obtain by other methods.  Miller and coworkers employed 
this feature of silicon-tethered RCM in their total synthesis of (+)-streptazoline 
(Scheme 15).37  Previous syntheses of (+)-streptazoline (1.81) by Kozikowski,38 
Overman,39 and Miller40 all utilized a late-stage Wittig olefination to introduce the 
ethylidene side chain, which provided a 2:1 E:Z mixture (in favor of the incorrect 
isomer) of geometric isomers.  Miller proposed that, in combination with a 
heteroatom-tether, the RCM could avoid the stereochemical problem by preferentially 
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cyclizing to the Z-geometry providing a more efficient route to (+)-streptazoline.  
Silicon was chosen as the tether and was reacted with alcohol 1.77 using 
commercially available allylchlorodimethylsilane.  Subjection of diene 1.78 to 
Grubbs II generation catalyst allowed for RCM to afford 1.79 quantitatively.  Other 
RCM studies with bis-alkyloxysilanes (Me2Si(OR1)(OR2), Ph2Si(OR1)(OR2), 
iPr2Si(OR1)(OR2)) gave no RCM product, yielding only dimers of the starting 
material.  A less ordered seven-membered transition state was proposed to cause the 
dimerization, while the six-membered ring was hypothesized to form a tighter 
transition state, allowing the RCM to proceed.  Protodesilation of silane 1.79 afforded 
alcohol 1.80 in 50% yield and final deprotection/cyclization provided (+)-
streptazoline in 76% yield.  This silicon tether strategy allowed for exclusive 
formation of the Z-ethylidene side chain in excellent yield and was easily removed to 
access (+)-streptazoline far surpassing other routes.  The differential reactivity 
between the alkylsilane and the bis- alkyloxysilane provides further evidence that the 
sterics and electronics of reacting olefins play important roles in the success of RCM. 
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Barrett and coworker demonstrated the utility of RCM to define olefin 
geometry in their synthesis of D,L-glucosylceramide (Scheme 16).41  Key to this 
synthesis was the installation of a trans-disubstituted double bond that is not easily 
achieved with high selectivity using conventional methods.  To overcome this 
inherent selectivity problem, Barrett envisioned the use of olefin metathesis to 
provide the requisite E-olefin found in D,L-glucosylceramide.  Initial studies focused 
on cross-metathesis to install the side chain employing either Grubbs I or Schrock’s 
catalysts.  All attempts to achieve the desired cross-metathesis product were 
unsuccessful and an alternative route was needed.  RCM using silicon to append the 
olefins was then attempted; as Barrett42 and others26 have shown such silicon-tethered 
processes to be successful.  The silicon tether was constructed by generating a silicon 
triflate in situ with silver triflate and silyl chloride 1.82 followed by the addition of 
alcohol 1.83 to afford silane 1.84 in 79% yield.  RCM using 25 mol % Schrock’s 
catalyst provided the ring-closed product (1.85) in 70% yield.  1.85 was treated with 
phenyl lithium to open the silicon tether and generate silane 1.86 in good yield.43  A 
Mitsunobu reaction was used to invert the stereochemistry of the alcohol and install 
the azide.  Subsequent TBAF deprotection removed all protecting groups, including 
the remaining portion of the silicon tether and upon acetylation, 1.87 was afforded in 
80% yield.  This species was then taken on to complete the synthesis of D,L-
glucosylceramide.  Barrett’s use of the silicon-tethered RCM overcame the problem 
of the trans-disubstituted double bond in D,L-glucosylceramide, while showing the 
advantages a silicon-tethered RCM has over the intermolecular CM reaction. 
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Enyne RCM (EYRCM) is another type of metathesis reaction that has been 
exploited in synthetic routes toward natural products.  Initial ring-closure for EYRCM 
begins with reaction at the terminal olefin to yield the terminal ruthenium alkylidiene, 
which is then poised to react with other olefins to generate a 1,3-diene. EYRCM can 
be used to form bicyclic compounds in a single synthetic operation.  Tartrolon B has a 
characteristic 1,3-diene motif that Lee and coworkers envisioned to be quickly 
assembled by a silicon-tethered enyne-metathesis strategy (Scheme 17).44  To this 
end, alcohol 1.89 was coupled with silyl ether 1.90 to generate 1.91 in 58% yield.  
This system was designed to control the initiation site of metathesis45 by allowing the 
terminal olefin to react first with the ruthenium catalyst followed by subsequent ring-
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closures, by way of the alkyne, to provide the 7,8-ring system.  As designed, this 
metathesis reaction afforded bicyclosilaketal 1.92 in 89% yield using 8 mol % Grubbs 
II catalyst and then the silicon tether was removed with TBAF to afford 1.93 in 60% 
yield.  The diene system of tartrolon B would be difficult to access by other methods 
as standard CM does not favor the formation of Z-olefins and CM of conjugated 
dienes has also proven to be difficult.  This silicon tether approach rapidly coupled 
the major subunits contained within tartrolon B and effectively mediated dienyne 
metathesis to efficiently construct the requisite E/Z-1,3-diene found in tartrolon B. 
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Movassaghi and coworkers showed the continued utility of silicon tethers and 
EYRCM in their syntheses of both (-)-acylfulvene and (-)-irofulven (Scheme 18).46  
In their retrosynthetic analysis of the proposed natural products, they envisioned 
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silicon-mediated EYRCM would not only assemble the AB rings of (-)-acylfulvene 
and (-)-irofulven but also set the stage for another RCM to complete the total 
synthesis.  Successful construction of bis-siloxane 1.94 set the stage for the proposed 
tethered EYRCM.  Subjection of 1.94 to 15 mol % Grubbs II catalyst at 90 ºC 
allowed for the formation of the silicon-tethered intermediate 1.95 as observed by 1H 
NMR spectroscopy.  This reaction was presumed to be initiate metathesis at the 
mono-substituted terminal olefin and sequentially reacted through the alkyne and 1,1-
disubstituted olefin to complete the silicon-tethered bicycle (1.95).  This intermediate 
was directly converted to triol 1.96 by the addition of TBAF.  Earlier attempts to 
isolate the ring-closed product without the oxygen spacer using allyldimethylsilane, 
were unsuccessful as the compound decomposed on silica, alumina or when exposed 
to air.  The chosen silyloxy route alleviated the need for isolation of the tethered 
intermediate due to the facile nature of silicon removal.  Three and four subsequent 
steps were needed to complete the total syntheses of both (-)-acylfulvene and  
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(-)-irofulven, respectively.  This route toward (-)-acylfulvene and (-)-irofulven 
showcases how a tethered EYRCM can access 1,3-diene motifs and how different 
silicon tethers can affect isolation and removal of the tether. 
1.2.3 Temporary Silicon Tethers: Radical Processes 
Controlling the regio- and stereoselectivity of intermolecular radical processes 
is often inefficient.  Tethered radical reactions allow for the intramolecular radical 
cyclization to be more efficient and often times highly regio- and stereoselective.47  
Applications of tethered radical cyclizations in total synthesis have been rarely used 
over the past decade, but Matsuda and coworkers were able capitalize on a temporary 
silicon tether radical acceptor in their synthesis of 4’!-C-vinylthymidine (Scheme 
19).48  Thymidine derivative 1.99 was prepared and reacted with 
chlorodiphenylvinylsilane to provide 1.100.  Homolytic cleavage of the Se—C bond 
was achieved with h" and (Bu3Sn)2 to allow for the 5-exo-trig cyclization to occur.  
The bicyclic silicon-tethered species was unstable to chromatographic conditions, 
which necessitated the addition of TBAF to remove the silicon tether and generate 
1.101 in 61% yield.  The silicon tether used here is an efficient radical acceptor and  
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allowed for rapid installation of a vinyl group followed by fluoride elimination to 
synthesize 4’!-C-vinylthymidine.49 
1.3 Boron Tethers  
Boron tethers are rarely used in natural product synthesis likely due to 
silicon’s ease of manipulation relative to boron.  Despite this fact, Batey and 
coworkers have employed a boron-tethered Diels-Alder approach to access 
cyclohexendiol systems that constructs a common intermediate toward the synthesis 
of ent-!1-tetrahydrocannabinol (THC) (Scheme 20).50  The boron tether was 
assembled by an initial hydroboration of enyne 1.102 followed by an oxidation to 
provide diene boronate 1.103.  Addition of an alcohol allowed for transesterification 
and a Diels-Alder reaction then occurred to generate boronate 1.104.  The boron 
tether was easily removed with Me3N(O) to afford diol 1.105 in 81% yield over the 3 
steps.  1.105 was used in the total synthesis of ent-!1-tetrahdrocannabinol (THC).51  
Interestingly, changing to O—B—O tethers is not applicable in these cyclization 
reactions unlike the C—B—O tethers used in this study.52  Overall, this boron- 
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tethered methodology readily assembles the diene and dienophile necessary for the 
cycloaddition.  Accessing the dienes utilized in this study may not be as easy with the 
silicon tether methodology and demonstrates the utility of boron tethers for these 
transformations. 
1.4 Carbonyl-Based Tethers 
1.4.1 Ketal Tethers 
Ketal tethers offer some unique features that distinguish them from their 
silicon counterparts.  The bond lengths of the C—O and Si—O bonds are 1.43Å and 
1.64Å, respectively, which provides ketal tethers an increased reactivity due to 
proximity for Diels-Alder reactions.  An inherant problem with shorter C—O bonds 
and their higher reactivity profile is that the more compact transition state also 
increases the sterics of the exo addition pathways and can reduce the selectivity of the 
tethered reactions.53  Ketal tethers, like their silicon counterparts, are also used as a 
common protecting group in synthesis and thus act in a dual role when they are used 
in tethering strategies.  These known features impact the following examples and can 
be used in planning other transformations with temporary ketal tethers.   
In 2001, Burke and coworkers showcased metathesis on a ketal tether in their 
synthesis of 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) (Scheme 21).54  
The ketal tether was constructed by refluxing C2-symmetric diol 1.107 with alkyl 
bromide 1.106 to afford ketal 1.108 in 90% yield.  Displacement of the bromine was 
achieved with o-NO2PhSeCN and oxidative elimination of this species provided 
terminal olefin and metathesis precursor 1.109.  Efforts to make this ketal directly 
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from the corresponding unsaturated ketone led to double bond isomerization to the 
!,"-unsaturated ketone.  Treatment with Grubbs I catalyst allowed for RCM to 
desymmeterize the C2-symmetric diol and form bicyclic ketal tether 1.110.  After 
three steps, the ketal tether was released with H2SO4 and MeOH to provide methyl 
glycoside 1.112 that was subjected to RuCl3•H2O to afford the carboxylic acid and 
subsequent methylation provided 1.113 (KDN) in 84% yield.  Burke displays how a 
ketal tether can be a tool for desymmeterization by RCM, with further 
functionalization while the ketal tether is still in place to provide the necessary 
constraints for selective transformations to be achieved.  Intermolecular CM 
pathways for this desymmeterization would most likely provide a mixture of starting 
material, CM on both olefins of 1.107, and the desired product, which highlights the 
utility of this ketal-tethered RCM.  
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In 2004, Burke and coworkers then explored expanding the scope of their 
ketal tethers to include C2-symmetric 1,3-diols for their synthesis of the C1-C16 
subunit of bryostatin (Scheme 22).55  The ketal tether was constructed by addition of 
CSA to a refluxing solution of diol 1.114 and vinylogous carbonate 1.115 to generate 
ketal 1.116 in 87% yield.  Interestingly, when the equivalent !-keto ester was used, 
no reaction was observed.  The quaternary center adjacent to the carbonyl was 
believed to impede the ketal formation.  Triene 1.116 underwent RCM with 2 mol % 
Grubbs I catalyst to provide bicyclic ketal 1.117 in excellent yield.  This tether was 
taken forward ten more steps to yield 1.118.  At this point, CSA and MeOH were 
added to release of the six-membered ring of the ketal tether to generate 1.119 and 
complete the targeted subunit of bryostatin.  Overall, the ketalization/RCM strategy 
mediates the desymmeterization of a diol, provides steric and conformational 
constraints for selective functionalization, and serves as a protecting group in their 
synthesis of the C1-C16 subunit of bryostatin.   
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Hsung and coworkers have developed unconventional routes toward 
spiroketals by developing ketal-tethered reactions such as intramolecular Diels-
Alder56 and RCM57 approaches to this important substructure (Scheme 23).  To 
display the utility of their methodology they synthesized the C11-C23 subunit of 
spirastrellolide A, a potent protein phosphatase 2A inhibitor.58  Formation of a mixed 
ketal was the first challenge in the implementation of a successful ketal-tethered 
RCM.  Initial additions of simple alcohols into hemiketal 1.120, activated with 
various Lewis acids, revealed competing pathways in ketal formation. 1,2- and 1,4-
additions, as well as elimination byproducts (1.122), were observed upon subjection 
to acids such as CSA, PPTS, TMSOTf, K-10 clay, and BF3•OEt2.  Finally, treatment 
with Tf2NH
59 at -78 ºC led to exclusive formation of 1.123 as a single diastereomer.  
RCM of 1.123 proceeded smoothly to give unsaturated spiroketal 1.124 in 50% yield 
over the two steps.  This route towards the C11-C23 subunit of spirastrellolide A 
highlights the synthetic utility of forming mixed ketal systems and promoting a 
unique spirocyclization by a ketal-tethered RCM.  This spirocycle has been most 
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commonly formed by additions of a diol into a ketone, yet this example shows the 
ease of setting the Z-olefin geometry and forming the spirocycle by a tethered 
intramolecular RCM. 
1.4.2 Ester Tethers 
A variety of transformations have been mediated by temporary ester tethers to 
afford increased levels of regioselectivity for the desired reactions. Clarke and 
Cridland utilized an ester-tethered Diels-Alder strategy in their studies toward the 
synthesis of hexacyclinic acid (Scheme 24).60  Ester tethers have been problematic in 
Diels-Alder reactions due to the harsh reaction conditions and an unfavorable 
equilibrium for the reactive s-cis diene conformer.  Despite their dependence on chain 
length and problems with polymerization,61 Clarke and Cridland found an efficient 
use of an ester tether.  First, the ester tether was constructed by a Mitsunobu 
esterification between alcohol 1.125 and propiolic acid that proceeded in 86% yield.  
Refluxing ester 1.126 in toluene allowed the intramolecular [4+2] cycloaddition to 
occur in 80% yield.  A copper-mediated vinyl conjugate addition on 1.127 was 
achieved with complete selectivity to provide !-unsaturated lactone 1.129.62  At this 
point the relative stereochemistry was conformed by 1H NMR coupling constants and 
gradient NOE experiments.  Reduction of the ester tether with DIBAL-H and 
subsequent formation of the dithiolane provided 1.130 in good yields.  Efforts toward 
completing hexacyclinic acid are currently in progress. This report of a 
stereocontrolled ester-tethered Diels-Alder reaction showcases the controlled 
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construction of the desired tethered moiety, the conformation and electronic bias an 
ester tether can provide, and the ease at which an ester tether can be removed. 
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Tethering strategies have been employed as a tool for macrocyclization. Ley 
and coworkers, in their total synthesis of (-)-rapamycin, showcased a transannular 
catechol-templated Dieckmann-like reaction for the formation of the macrocycle 
contained within (-)-rapamycin (Scheme 25).63  Synthesis of the tether began with a 
DCC-coupling between carboxylic acid 1.131 and catechol, followed by the 
intramolecular alkylative ring closure with K2CO3 to provide 1.132 in 71% overall 
yield.  Subsequent ring contraction with LiHMDS constructed the necessary C9-C10 
bond in 78% yield.  The success of this reaction was due to the Dieckmann-like 
condensation that proceeds through a six-membered transition state and not through a 
larger macrocycle, allowing for a successful ring-contracting pathway.  This same 
tethering strategy was also successfully employed by Ley in the synthesis of 
antascomcin B.64 Allyloxycarbonyl (Alloc) deprotection with palladium provided 
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1.133 and set the stage for tether removal.  Using PhI(OAc)2, the catechol tether was 
cleaved from the molecule allowing for the final oxidation and global deprotection to 
yield (-)-rapamycin 1.134.  This catechol tether strategy provided an efficient route 
for macrocyclization by a simple six-membered ring contraction.  This elegant 
pathway to the formidable core contained within (-)-rapamycin provides one synthetic 
answer to problems associated with cyclization of large ring systems. 
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Piva and Faure, in the synthesis of both (-)-italicene and (-)-isoitalicene, 
applied a chiral, temporary ester-tethering strategy to mediate an intramolecular [2+2] 
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photocycloaddition (Scheme 26).65  (S)-lactic acid was a chiral tether66 between the 
requisite alcohol and the known oxoacid.67  1.135 was subjected to 366 nm light in 
CH2Cl2 to generate cycloadducts 1.136 in 81% yield with complete regioselectivity 
and excellent diastereoselectivity (97:3).  The ester tether was opened by NaOMe and 
heat followed by slightly acidic conditions to provide lactone 1.137.  1.137 is a 
synthetic intermediate en route toward both (-)-italicene and (-)-isoitalicene, which 
are currently being completed in the Piva laboratories.  This temporary ester tether 
demonstrates the ability of a chiral ester tether to couple major subunits of natural 
products though photochemical reactions and control the regio-, enantio-, and 
diastereoselectivity of a desired intramolecular transformation.  
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1.5 Sulfur Tethers 
 Sulfur tethers have been used in synthesis due to their ease in preparation and 
high reactivity toward cycloaddition reactions.  Mascareñas and coworkers utilized a 
sulfide tether and a homochiral p-tolylsulfinyl group to provide a regio- and 
 37 
diastereoselective thermal [5+2] intramolecular pyrone-alkene cycloaddition in a 
concise total synthesis of (+)-nemorensic acid (Scheme 27).  Intramolecular [5+2] 
cycloadditions have been difficult to achieve intermolecularly, providing either poor 
selectivity or no reaction.  Mascareñas envisioned that a sulfide-mediated [5+2] 
cycloaddition where the sulfur could be easily removed would provide a pathway to 
(+)-nemorensic acid.  The formation of thioether 1.140 was achieved by addition of a 
thiol to mesylate 1.139 with subsequent addition of bromide 1.138 to yield the PMB-
protected thiol ether.  This thioether was taken on, without purification, to remove the 
PMB protecting group with TFA and reprotected with TBS to generate 1.140.  1.140 
was then heated in a sealed tube at 160 ºC for 12 h to provide the cycloadduct in 82% 
yield and 93:7 diastereoselectivity.  Treatment of this thioether with Raney nickel 
allowed for desulfenation of the entire compound and yielded ketone 1.141.  TBS-
removal and oxidative cleavage of the seven-membered carbocycle provided (+)-
nemorensic acid.  Earlier studies had shown that tethered olefins, without the vinyl 
sulfinyl group, did react but required higher temperatures and longer reaction times.  
The increased rate of this reaction is attributed to the electron-withdrawing nature of 
the vinyl sulfinyl, which promotes the thermal [5+2] intramolecular cycloaddition.  
Interestingly, carbon-tethered analogues of this reaction have increased reaction rates 
and provide the product in similar yields and selectivities.  The sulfide tether was 
ideal for its ease of installation and ability to mediate difficult [5+2] cycloaddition as 
well as its ability to be removed from the molecule in a traceless manner, which 
cannot be as readily achieved for the carbon-based counterparts.  
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 Sulfone tethers have been used by Cossy and coworkers in their in total 
synthesis of (±)-mycothiazole (Scheme 28).68  Previously, the Cossy groups had 
demonstrated that homoallylic alcohols and allylsulfonyl chloride could be readily 
coupled and undergo RCM to give various sulfone precursors.69  These sulfones were 
then elaborated with sequential deprotonation/alkylation pathways.  Removal of the 
sulfone-tether was achieved by addition of a carbenoid ICH2MgCl
70 to alkylate the 
sulfone and subsequent !-hydride elimination resulted in loss of sulfur dioxide and 
removal of the tether.  To test this strategy in total synthesis, alcohol 1.142 was 
coupled with allylsulfonyl chloride and the crude product was subjected to Grubbs II 
catalyst to generate cyclic unsaturated sulfone 1.144 in 70% yield.  1.144 was then 
monoalkylated with iodide 1.14571 to give 1.146.  The sulfone tether was then 
removed by "-deprotonation followed by addition of carbenoid ICH2MgCl to provide 
1.147 in 60% yield.  Following this, just four more steps were needed to complete the 
total synthesis of (±)-mycothiazole.  In retrospect, the sulfone tether was used to set 
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the Z-olefin geometry through metathesis, couple the major subunits of the molecule, 
and was then eliminated to afford the necessary terminal olefin. Cossy has provided 
an excellent example of temporary tethers, not only to couple subunits of a molecule 
but also reveal new functionality as they are removed.    
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1.6 Summary 
 This review demonstrates the utility of temporary tethers in the total synthesis 
of natural products over the past decade.  The cornerstone of these reactions that has 
allowed them to gain prominence and overcome synthetic problems is their ability to 
convert a difficult intermolecular reaction to an intramolecular transformation.  Other 
benefits of tethers continue to be showcased by their ability to control the regio-, 
enantio-, and diastereoselectivities of reactions, act as protecting group, provide steric 
constraint after being installed, and reveal new and different functionality upon their 
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removal.  As new methods are reported, even more elaborate and imaginative uses of 
these temporary connections will be demonstrated and tethering strategies will 
continue to be a simplifying tactic in total synthesis.    
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Cross Metathesis in Synthesis: Applications to Phosphate Tethers 
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2.1 Introduction 
Over the past decade, olefin metathesis has revolutionized transition metal 
mediated C—C bond formation to become one of the most powerful synthetic tools 
available in organic synthesis.  The advent of new, well-defined metathesis catalysts, 
possessing immense functional-group compatibility, has permitted the rapid, mild, 
and selective construction of rings via ring-closing metathesis (RCM).
1a
 Additionally, 
polymers can be synthesized by ring-opening metathesis polymerization (ROMP),
1b
 
and cross metathesis (CM) can rapidly functionalize olefins.
1c
 Compared to its 
metathesis counterparts, CM is relatively underrepresented owing to a lack of 
predictability of olefinic reaction partners as well as poorly defined stereochemical 
outcome of the ensuing product.  Ongoing development in the field of CM has lead to 
a greater understanding of viable olefin partners for selective CM and has provided 
opportunities for stereoselective synthesis of interesting targets.   
Identifying the differential reactivity of olefins is a synthetic challenge 
encountered when utilizing CM chemistry.
2
  Effective synthetic routes may be altered 
to allow for the most precious substrate to undergo a CM in which its only operative 
pathway is productive CM and not deleterious homodimerization.  The current 
methodology and total synthetic efforts highlighted herein showcase the successful 
use of selective CM.  
2.1.1 Examples of Selective Cross Metathesis 
For selective CM to occur, a suitable catalyst must be chosen that accounts for 
the steric and electronic nature of the reacting olefin partners. Common catalysts used 
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for these CM are Grubbs first (2.1)
3a,b
 and second (2.2)
3c
 generation catalysts in 
addition to Hoveyda-Grubbs catalyst (2.3)
3d
 (Figure 1). In 2003, Grubbs and 
coworkers put forth a general model for selectivity in olefin cross metathesis 
reactions.
2
 Olefins were categorized by their relative rates of homodimerization 
correlating to the metathesis catalyst being used for CM.  The classes ranged from 
Type I olefins, which were characterized by rapid, reversible homodimerization to 
Type IV olefins, which were classified as spectators to CM.  The pairing of different 
olefin types allows for varying product ratios to be attained; reacting two Type I 
olefins yields a statistical mixture of CM product to homodimers of each olefin.  In 
contrast, a reaction between a Type I and a Type III olefin generates a selective, high 
yielding CM.  Therefore olefin partners possessing disparate reactivity are optimal for 
CM to proceed selectively and efficiently. 
O
Ru
iPr
NNMes Mes
Cl
Cl
PCy3
Ru
PCy3
Cl
Cl
PCy3
Ru
NNMes Mes
Cl
Cl
Ph
Ph
2.1 2.2 2.3  
Figure 1. Structure of the metathesis catalysts. 
Building on the established model for olefin CM, further research is 
expanding the array of olefin partners and leading to a greater understanding of their 
reactivity.  An example of this development was the construction of functionalized 
dienes utilizing CM.  This area has not been studied as in depth due to the chemo- and 
stereoselectivity issues encountered in the CM of conjugated systems.  To overcome 
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these issues, Grubbs and coworkers adjusted the electronics and sterics of conjugated 
dienes to deactivate just one of the double bonds.
4,5
 Placing electron-withdrawing 
groups on the !-carbon of the diene sufficiently reduced the electron density of the  
!,"-unsaturated double bond such that efficient CM was achieved to yield conjugated 
dienes 2.6 and 2.9 (Table 1, entries 1 and 2).  Steric differentiation of conjugated 
double bonds was also accomplished using 3-methyl-1,3-pentadiene (2.11) to shield 
one of the olefins to allow for the vinyl boronate (2.10) to react with the sterically 
unencumbered olefin yielding boronate 2.12.  Again, steric deactivation of one olefin 
was accomplished by placing substituents at the 2-position of butadiene (2.14) 
permitting CM at the more reactive olefin providing diene 2.15.  This method further 
illustrates the importance of disparate olefin reactivity in CM, which Grubbs was able 
to employ via steric and electronic demands in diene systems to enable 
chemoselective construction of functionalized conjugated dienes. 
Table 1. CM with Functionalized Dienes. 
entry olefin yield (%)
E/Z ratio
conjugated 
diene
product
1
2
4
3
OAcAcO
Br
Br
Br
Br
Me
Me
O
OEt
O
OEt
AcO
Me
Me
Me
Me
B
O
O
B
O
O
OBzBzO
nhexyl nhexyl
OBz
2.4 Br Br
70 
7.5:1
60 
20:1
80 
>99:1
73 
>99:1
2.45 2.6
2.7 2.8 2.9
2.10 2.11 2.12
2.13 2.14 2.15  
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Hoveyda and coworkers investigated CM reactivity patterns in their efforts to 
synthesize unsaturated amino alcohols.
6
  The authors proposed using Type III and 
Type I cyanide olefin partners and reacting these with various unsaturated alcohols.  
Subsequent reduction of the CM products rapidly produced the corresponding amino 
alcohols.  When submitting acrylonitrile
7
 (2.17a), a Type III olefin, to CM conditions 
with pent-4-en-1-ol (2.16), a Type I olefin, the reaction proceeded with catalysts 2.2 
and 2.3 to yield the desired products (Table 2). This reaction was presumed to be 
selective because electron deficient 2.17a exhibits a slow rate of homodimerization, 
which allows for selective CM.  Additional reactions of allyl cyanide
8
 (2.17b) and 
homoallyl cyanide (2.17c) with 2.16 revealed that these proposed Type I CM partners 
did undergo selective CM reactions at optimal reaction concentrations.  This may be 
due to decreased reactivity of olefins 2.17b and 2.17c as a result of the inductively 
withdrawing nature of the cyanide group.  As illustrated in Table 2 (entries 4-10), 
adjustment of the reaction concentration with respect to the catalyst allows for 
products 2.18b and 2.18c to be formed in good yields and E/Z selectivities. 
Hoveyda’s examples of CM between 2.17b and 2.17c with Type I olefins emphasizes 
that considerations for these reactions must not only focus on the number of 
equivalents of olefin used, but also rely on proper choice of catalyst with regard to 
reaction concentration, thus affording the most efficient CM. 
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Table 2.  CM patterns of various unsaturated cyanides.  
entry
Ru 
complex
yield (%),
E/Z ratio
reaction
concentration (M)
product
HO
3
CN
y
cat. 2.1, 2.2, or 2.3 (5 mol %)
CH2Cl2, reflux
y
HO
2.16 2.17a (y=0)
2.17b (y=1)
2.17c (y=2)
2.18a (y=0)
2.18b (y=1)
2.18c (y=2)
1 2.2 0.5 2.18a 35, 1:2
2 2.3 0.07 2.18a 74, 1:2.5
3 2.3 0.24 2.18a 60, 1:2
4 2.1 1.2 2.18b  2, 3.5:1
5 2.2 0.05 2.18b 38, 6:1
6 2.2 0.5 2.18b 81, 6:1
7 2.3 0.05 2.18b 72, 2:1
8 2.3 0.5 2.18b 65, 6:1
9 2.2 0.5 2.18c 72, 5:1
10 2.3 0.05 2.18c 48, 4:1
1 equiv. 2 equiv.
CN
 
A new approach in the CM of less reactive olefin partners was shown in the 
synthesis of enynes and related structures as disclosed by Hansen and Lee.
9
  Critical 
to this process was the generation of alkynyl Ru-alkylidene 2.22 to understand its 
reactivity toward both alkenes and alkynes (Scheme 1).
10
  Initial attempts employed 
catalyst 2.2 and terminal enyne 2.19. Surprisingly, a 34% yield of predominately the 
Z-isomer of 2.24 was obtained despite the electron-deficient nature of 2.19 with a 
Type I olefin partner 2.23.  Due to the low reactivity of the enyne olefin partner an 
alternate delivery system was required.  Synthesis of compound 2.21 and treatment 
with catalyst 2.2 revealed that metathesis was initiated at the terminal allyl of the 
conjugated enyne system and subsequently generates alkynyl alkylidiene 2.22.  
Further, CM with 2.23 yields 2.24 in better yield albeit with slightly lower selectivity 
for the Z-isomer.  Generating of the Ru-alkylidene complex on a previously 
unreactive olefin metathesis converts a low yielding process into a viable synthetic 
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route for relay construction of these enyne systems.  Implementation of this novel 
catalyst delivery and subsequent CM displays an approach that may be applied to 
other challenging systems.  
Scheme 1. 
Ph
O
A: 5-10 mol % cat. 2.2, rt, 18h, 2 equiv. 2.23
RuLn
BnO
Ph
O
OBnBnOB: 5-10 mol % cat. 2.2, rt, 6h, 2 equiv. 2.23
O
Ph
O
RuLn
Ph
O
OBn
63% E:Z = 1:4
34% E:Z = 1:7
A
B
2.19 2.20
2.21 2.22
2.24
2.23
Ph
O
OBn
2.24
 
2.1.2 Cross Metathesis in Total Synthesis 
Establishing effective CM models and expanding methodologies surrounding 
reactive olefin partners is allowing CM to gain greater prominence in total synthetic 
efforts. Vital to developing successful synthetic CM pathways is the appropriate 
design of olefin partners possessing differential reactivity.  This is optimal when the 
precious component displays either Type I reactivity patterns, where 
homodimerization is not a deleterious pathway, or Type III reactivity when the 
homodimerization pathway is non-operative.
2
 Utilizing these techniques allows for 
the implementation of selective CM in total synthetic routes. 
The total synthesis of (-)-mucocin illustrates the use of disparate olefin 
reactivity for a selective CM in a key step of the synthesis.
11
 Exploiting asymmetric 
glycolate Aldol additions and RCM methods, Crimmins efficiently constructed CM 
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precursors 2.25 and 2.26 (Scheme 2).  Modifying 2.25 to bear a MOM group allowed 
for differential reactivity between the otherwise similar allylic alcohols in the CM.  
Mixing a 1:1 ratio of 2.25 and 2.26 with catalyst 2.3 yields the desired cross-coupled 
product 2.27 in 68% (6:1 E/Z).  Changing the protecting group on allyl alcohol 2.25 
to a TES-group rendered the olefin unreactive, but reacting this system with catalyst 
2.2 under the same conditions yielded 58% of the desired product.
12
 Overall, the 
synthesis of (-)-mucocin displays a selective CM without use of excess ratios of either 
substrate, ideal for natural product synthesis. 
Scheme 2 
O
MOMO
H
TIPS
H
OC10H21
H H
BnO
OH
10 mol % cat. 2.3
CH2Cl2, 17h, reflux
O
H H
OC10H21
H H
BnO
OH
MOMO
68% yield, 6:1 E/Z
TIPS
2.25
2.26
2.27
 
Conversely, when both olefins possess Type I reactivity, an excess of one CM 
partner is necessary to achieve the heterocoupled product.  In the total synthesis of 
(+)-rolliniastatin 1 and (+)-rollimembrin by Lee and coworkers, a pivotal CM 
between fragment 2.28 and compound 2.29 or 2.30 coupled large fragments of these 
molecules (Scheme 3).
13
  Using four equivalents of 2.29 and 20 mol % catalyst 2.1, 
CM product 2.31 was achieved for the synthesis of (+)-rolliniastatin 1 in 79% yield.  
Again, four equivalents of 2.30 were used to obtain 2.32 in 74% yield, a precursor of 
(+)-rollimembrin, using only 10 mol % catalyst 2.2.  When using just one equivalent 
of 2.30, a 46% yield of 2.32 was obtained along with 28% yield of the homodimer of 
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2.30.  This synthesis displays that CM between two olefins of similar reactivity 
requires an excess of one olefin to achieve the desired product in good yield.  If one 
of the CM partners is easily synthesized, as in this case, this does not present a 
problem in obtaining the CM product.  Lee has shown in his syntheses of (+)-
rolliniastatin 1 and (+)-rollimembrin the power of CM to rapidly access a variety of 
natural product targets. 
Scheme 3.  
TBSO O
SPh
O
HO
O
O
TBSO C10H21
HO
O
O
TBSO C10H21
TBSO
O
SPh
O
20 mol % 
cat. 2.1
10 mol % 
cat. 2.2
4 equiv. 2.29
4 equiv. 2.30 m=7, 79% of 2.31
m=5, 74% of 2.32
(+)-rolliniastatin 1
(+)-rollimembrin
3 steps
3 steps
2.28
X
x= 7, 2.29
x= 5, 2.30
X
 
The total synthesis of both (±)-pinnaic acid and (±)-halichlorine was 
accomplished by CM methodology with terminal olefin 2.33 to achieve advanced 
subunits en route to the natural product targets (Scheme 4).
14
 Martin and coworkers 
showcased a selective CM between 2.34, sterically and electronically biased,
4
 and 
electron rich 2.33 to obtain intermediate 2.35.  Similarly, Type I olefin 2.33 was 
reacted with Type II olefin crotonaldehyde to achieve 2.36 in 89% yield with 
excellent E:Z selectivity.  When using a more common CM partner acrolein, 30-35% 
yields were consistently obtained with a large amount of unreacted 2.33, displaying 
that the stability, electronics, or sterics of acrolein are not ideal for this C—C bond 
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construction.  This methodology highlights the utility of CM in natural product 
synthesis where a common subunit may be functionalized by CM to quickly obtain 
advanced intermediates required for the synthesis of multiple targets. 
Scheme 4 
BocHN
H
Me
TBDPSO
Me
EtO2C
Me
BocHN
H
Me
TBDPSO
R
R=
EtO2C
Me
OHCR=
10:1 E:Z
2.35
20:1 E:Z, 
89% yield of 2.36
1 equiv. 2.34
10 mol % 
cat. 2.2,
10 mol % 
cat. 2.2,
5 equiv. 
crotonaldehyde
3 steps Formal synthesis
of (±)-pinnaic acid
4 steps
Formal synthesis
of (±)-halichlorine
2.34
2.33
 
O’Doherty and coworker in their synthesis of cryptocarya triacetate, 
cryptocaryolone, and cryptocarylolone diacetate showcase a simple and effective use 
of CM.
15
 Their route to these natural products hinged on a CM between homoallylic 
alcohol 2.37, a Type I olefin, and 2 equiv. of Type II CM partner ethyl acrylate 
(Scheme 5).  Previously, a three-step protection/oxidative cleavage/Wittig reaction 
protocol was used to obtain 2.40 from 2.37, yet the envisioned CM would provide the 
desired product in a single step.  Selective cross coupling occurred between 2.37 and 
ethyl acrylate with catalyst 2.2 in 96% yield after 24 hours with a E:Z ratio of 20:1.  
Exposure of 2.39 to benzaldehyde and a catalytic amount of tBuOK installed the final 
stereocenter of cryptocarya triacetate in 55% yield.  This procedure showed how CM 
could react two olefins without the need for additional functionalization to achieve a 
shorter and more facile route to tetraol 2.40 by CM. 
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Scheme 5. 
O O
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OEt
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Kozmin and coworkers synthesized advanced intermediates by CM in their 
route toward bistramide A (Scheme 6).
16
 A tandem ring opening/CM sequence 
between cyclopropene 2.42 and alkene 2.41 yields 2.43 upon acidic deprotection of 
the ketal in 63% yield with 2:3 E:Z selectivity.  Using two equivalents of dienone 52, 
a Type II olefin, and 1 equiv. of compound 2.44, a Type I olefin, afforded the desired 
product (2.45) in 68% yield.  Subsequent hydrogenation of 2.45 allowed for the 
formation of a single spiroketal fragment found in bistramide A. Sequential selective 
Scheme 6 
Me
OBn
NR2
NR2= N
O
O
O O
Me Me
1.5 equiv.
10 mol  %
cat. 2.2
1.
Benzene, 60 ºC
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CM revealed by Kozmin demonstrates the power of this methodology to construct 
complex targets. 
The application of CM in the final stages of the enantioselective synthesis of 
apoptolidinone by Crimmins and coworkers showcases a regio- and stereoselective 
use of CM methodology (Scheme 7).
17
 Construction of 2.46 and 2.47 set the stage for 
the key CM between the Type II and Type III olefins, respectively.  Relying on the 
unreactive nature of the trisubstituted and conjugated olefins in 2.46, and the 
terminally biased reactivity of the diene in 2.47, the proposed CM was expected to be 
selective for the terminal olefins of each molecule. With two equivalents of 2.46 and 
10 mol % catalyst 2.2, a 63% yield of 2.48 in 95:5 E:Z selectivity was achieved along 
with 31% yield recovered 2.47.  Both the recovered starting material and 
homocoupled 2.46 could be recycled in this process.  When compound 2.46 was 
protected as a TBS ether instead of the free alcohol the CM proceeded in poor yields 
(~20%) which is most likely attributed to the additional steric congestion imposed on 
the Type II olefin partner, rendering it less reactive with a Type III olefin partner. 
Scheme 7. 
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This synthesis validates that a well-designed CM can be utilized, even in the 
presences of numerous olefins, in synthesis. 
2.2 Results and Discussion 
2.2.1 Cross Metathesis with Temporary Phosphate Tethers 
Exploiting temporary tethers
18
 as a tactic to join complex synthetic building 
blocks has emerged as a versatile approach to rapidly access biologically relevant 
targets.  As previously discussed, the use of temporary tethers in synthesis has 
centered largely on silicon.
18
  We have reported the use of phosphinamide, 
phosphonamide, phosphonamidate,
19
 and phosphate tethers (P-tethers),
20
 each 
possessing a number of salient features that can be exploited in synthesis.  In 
particular, we have demonstrated that phosphate tethers not only provide orthogonal 
protective attributes, but also multifaceted activation of the corresponding phosphate 
ester appendages by providing innate leaving group ability within the tether.  
Employing a phosphate tether, we constructed the unique P-chiral 
bicyclo[4.3.1]phosphate triester 2.53 (Scheme 8) and demonstrated its utility in a 
myriad of regio-, chemo- and stereoselective transformations.
20
  In light of this 
advancement, we then reported an extension of the phosphate tether methodology in 
which additional functionalization via highly selective cross metathesis (CM) of 2.53 
allows for the facile assembly of a diverse array of complex polyol subunits. 
Bearing in mind the features of CM, we set out to explore the scope and utility 
of CM reactions between the terminal olefin of 2.53 and other olefinic partners.  
Construction of P-chiral bicyclic[4.3.1]-phosphate triester 2.53 began with coupling 
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of C2-symmetric diene 1,3-diol 2.49
21
 and phosphoryl trichloride producing the 
pseudo-C2-symmetric compound 2.50 possessing interchangeable, homotopic Cl and 
P=O groups. Concurrent addition of lithium allyloxide 2.51 into phosphoryl 
monochloride 2.50 yields phosphate triene 2.52.  Ring-closing metathesis (RCM) 
using Grubbs second-generation catalyst 2.2
3c
 afforded desired phosphate 2.53 in 
good yield.  
Scheme 8  
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This project was started by screening metathesis catalysts 2.1, 2.2, and 2.3 for 
viability in CM between 2.53 and suitable olefinic partners (Table 3).  Reaction of 
phosphate 2.53 with methyl vinyl ketone under refluxing CH2Cl2 was employed as a 
standard system for preliminary proof-of-concept experiments.  Various catalyst 
loadings and reaction concentrations produced disappointingly low conversions,  
< 5% and 26%, when using both Grubbs first and second generation catalysts 2.1
3
 
and 2.2, respectively.  We next studied use of Hoveyda-Grubbs second-generation 
catalyst 2.3,
22
 which Blechert and coworkers employed in successful CM with 
electron-deficient systems.
23
  Using Blechert’s conditions, we produced a selective 
CM between 2.53 and methyl vinyl ketone yielding 2.54 (75%) with excellent olefin 
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selectivity (E:Z = 44:1).  Increasing the concentration to 0.1 M (relative to the 
substrate) provided similar yields but E:Z ratio decreased to 15:1. 
Table 3. CM studies with bicyclic phosphate 2.53. 
O
Ru
iPr
NNMes Mes
Cl
Cl
PCy3
Ru
PCy3
Cl
Cl
PCy3
Ru
NNMes Mes
Cl
Cl
Ph
Ph
entry 10% catalyst % yield
CM
partner
O
Me
O
Me
O
Me
conc./ solvent
1
2
0.05 M/ CH2Cl2
0.05 M/ CH2Cl2
0.05 M/ CH2Cl2
<5a
25a
75b
0.1 M/ CH2Cl2 71
b,c
4
5
O
P
O O
O
2.53
O
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O O
O
2.1
2.2
2.3
0.1 M/ CH2Cl2 26
a3
3 equiv CM
Partner
     a Yields determined by 31P NMR. b Yields determined by isolated,
purified products. c Used 4.0 equiv of MVK.
2.54
O
Me
  
With this result in hand, other CM partners were studied.  Beginning with 
Type I olefins (Table 4), CM of 2.53 with allyl alcohol and TBS-protected allyl 
alcohol proceeded smoothly with excellent yield and selectivity (86% and 87% 
yields, >99:1 E:Z selectivity) using 10 mol % of Hoveyda-Grubbs catalyst 2.3 in 
refluxing CH2Cl2 over a 3-6 hour period.  When the CM partner was switched to a 
Boc-protected allyl amine, the yield of the corresponding protected amino phosphate 
triester 2.57 decreased, but selectivity was maintained (>99:1).  Coupling allyloxy 
dimethoxyphosphate with bicyclic phosphate 2.53 produced 2.58 in good yield, albeit 
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with low E:Z  selectivity (2:1). Again, when 2.1 and 2.2 were used in these CM 
reactions with Type I olefin partners, yields were considerably lower. 
Table 4. CM with Type I olefins. 
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69
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Given the success of Type I olefins, we next turned toward screening CM 
reactions between Type II olefin coupling partners and 2.53 (Table 5).  With electron 
deficient Type II olefins, 4-5 equivalents of the CM partner were needed to obtain the 
highest yields.  Optimized conditions were found to occur with 10-12 mol % 
Hoveyda-Grubbs catalyst 2.3.  Having achieved CM with methyl vinyl ketone, other 
electron deficient olefins were employed.  Treatment of 2.53 with methyl acrylate 
occurred in good yield and selectivity (78% yield, E:Z = 8:1) (Table 5, entry 1).  
Interestingly, when tbutyl acrylate was used the yield dropped to 60% and the E:Z 
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ratio decreased to 5:1 (Table 5, entry 2).  When acrolein was used, CM proceeded 
smoothly to afford 16 in good yield and with excellent selectivity (Table 5, entry 3). 
Table 5. CM with Type II olefins. 
O
P
O O
O
X
Type II
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O
P
O O
O
X
O
H
entry product % yield
4
1
3
CM
partner
E:Z
O
MeO
O
P
O O
O
HO
BnO
O
P
O O
O
O
MeO
O
P
O O
O
O
H
72
78
78
8:1
>99:1
>99:1
2.60
2.62
2.63
HO
BnO
2.59
O
P
O O
O
O
tBuO
2.61
O
tBuO
2 60 5:1
2.53
 
Use of more elaborate coupling partners provides an attractive extension of 
this chemistry.  Thus, treatment of 5 with readily prepared (R)-1-(benzyloxy)but-3-
en-2-ol 2.59
24
 (Table 5, entry 4) gave phosphate 2.63 in 72% yield and E:Z = 99:1.  
Furthermore, convenient removal of the tether in 2.63 was realized with LiAlH4
25
 
affording the advanced polyol subunit 2.64 in 70% yield (Scheme 9).  Overall, 
stereochemically rich 2.64 is readily derived from 2.49 in a concise five-step 
sequence. 
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To fill out the reactivity profile of 2.53, Type III olefins were surveyed as CM 
partners.  After treating with methyl methacrylate for 12 h, 2.53 was unreacted and 
could be cleanly recovered (Table 6, entry 1).  Using isobutylene afforded only trace 
amounts of product even when the reaction was run neat (Table 6, entries 2 and 3).  
CM between bicyclic phosphate 2.53 and electron deficient acrylonitrile
6
 also yielded 
no product (Table 6, entry 4).  Attempted homo-dimerization of bicyclic phosphate 
2.53, produced no observable product after 24 h under the aforementioned CM   
Table 6. CM with Type III olefins. 
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conditions (Scheme 10).  This result, when taken with the data compiled in Table III, 
suggests the external olefin of phosphate 2.53 possess Type III character. 
Scheme 10  
O
P
O O
O
10 mol % H-G cat.
0.05 M CH2Cl2
No Homodimerization
24h2.53  
To display the utility of this CM methodology, we were able to construct 
complex polyketide fragment 2.70 (Scheme 11) possessing a key stereotriad found in 
a number of natural products,
26
 including dolabelides A and B.
27
  We envisioned that 
a selective hydrogenation would be possible at the external olefin of phosphate 2.53 if 
we imposed additional steric constraints by incorporation of a geminal dimethyl 
group in 2.67.  Thus, utilizing the lithium alkoxide of 2-methylbut-3-en-2-ol as a 
coupling partner with diol 2.49 and POCl3, provided a phosphate triene that 
undergoes smooth RCM to afford 2.66.  CM of phosphate 2.66 with homoallyl 
alcohol using Hoveyda-Grubbs catalyst 2.3 generated functionalized phosphate 2.67.  
Subjection of 2.67 to 10 mol % of Grubbs catalyst 2.2, in the presence of 0.5 
equivalents of triethylamine
28
 at 300 psi H2, achieved selective hydrogenation of the 
external olefin in good yield. PMB-protection of alcohol 2.68 using a PMB-imidate 
produced 2.69 in 94% yield.  Final diversification of this substrate using a highly 
regio- and diastereoselective methyl cuprate addition,
20 
followed by phosphate 
removal, produced the differentiated polyol fragment 2.70 as the sole product in 65% 
yield over three steps. 
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This study demonstrated the utility of CM in bicyclic phosphates 2.53 and 
2.66 with application to rapid assembly of advanced polyol subunits.  Moreover, we 
have determined a Type III olefinic character with respect to CM for the exocyclic 
olefin in both 2.53 and 2.66.  This empirical observation illustrates deficiencies in our 
knowledge of cross metathesis in complex molecules and suggests that additional 
studies are necessary to fully understand these systems.  
2.3 Summary 
Advances in CM methodology have led to a greater understanding and 
increased application of CM in synthetic pathways.  Despite being underrepresented 
in the field of metathesis, CM is becoming an indispensable tool for organic 
chemistry and complex natural product synthesis. 
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Chapter 3 
Phosphate Tethers in Synthesis: 
Total Synthesis of Dolabelide C 
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3.1 Introduction 
3.1.1 Overview of the Dolabelide Family 
In 1995, the isolation and structural characterization of two new 22-membered 
macrolides, dolabelides A and B,
1
 from the sea hare Dolabella auricularia was 
reported.  Isolation of dolabelides C and D (3.1),
2
 24-membered macrolides, was 
achieved shortly after from the same source in 1997.  Cytotoxicity studies of 
dolabelides A-D revealed activity of these macrolactones against cervical cancer 
HeLa-S3 cells with IC50 values of 6.3, 1.3, 1.9, and 1.5 µg/mL, respectively.  
Although the mechanism of action of these compounds remains unknown, synthetic 
studies toward various subunits of dolabelide have recently been reported
3
 with 
Leighton and coworkers completing the only total synthesis of dolabelide D in 2006.
4
  
3.1.2 Leighton’s Synthesis of Dolabelide D
 
Leighton’s synthesis of dolabelide D (3.1) began with disconnections at the 
lactone between C1-C23 and at the C14-C15 olefin (Scheme 1).  The two subunits of 
dolabelide D generated by this analysis were C1-C14 3.2 and C15-C30 3.7.  
Carboxylic 3.2 and alcohol 3.7 were coupled by a Yamaguchi esterification with a 
subsequent RCM to afford the trisubstituted C14/C15 olefin and complete the 
macrocycle.  The C1-C14 (3.2) subunit was constructed by an asymmetric anti-Aldol
5
 
reaction to make the C9/C10 C—C bond by reacting ketone 3.3 and aldehyde 3.4.  
Subsequent reduction of the C9 ketone with L-selectride set the requisite 
stereochemistry for the formation of C1-C14 subunit 3.2.  Ketone 3.3 was achieved 
by Wacker oxidation of a terminal olefin, which was preceded by an asymmetric 
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allylation of aldehyde 3.5 using Leighton’s strained silacycle technology.
6
  Aldehyde 
3.4 was generated by a hydroformylation of diene 3.6 in the presence of 2,2-
methoxypropane to afford the requisite acetal, which was subjected to a 
hydroboration
7
-oxidation-oxidation-deprotection sequence to provide aldehyde 3.4.  
Diene 3.5 was obtained using an asymmetric crotylation reagent, developed by 
Leighton, and methacrolien.
8
  
The C15-C30 subunit of dolabelide D, 3.7, was initially disconnected between 
the C19-C20 bond, which was achieved by an asymmetric Aldol addition
9
 of ketone 
3.8 with aldehyde 3.9 followed by an Evan’s anti reduction of the C21 ketone.
10
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Assembly of ketone 3.8 was achieved by Wacker oxidation of a terminal olefin, 
which was preceded by a tandem rhodium-catalyzed silylformylation-crotylsilylation 
of silyl ether 3.10
11
 and a Brook-type rearrangement
12
 of the vinyl silane.  This 
sequence installed the C24-C25 trisubstituted olefin and set the C22 and C23 
stereocenters.  Leighton utilized their catalytic asymmetric alcoholysis methodology 
for construction of silyl ether 3.10 from homopropargylic alcohol 3.11 and tbutyl-cis-
crotylsilane.
13
  Overall, Leighton’s synthesis of dolabelide D showcased his strained 
silacycle methodologies to rapidly assemble this complex natural product in 17 steps 
(longest linear sequence) from methacrolien. 
3.2 Results and Discussion 
3.2.1 Phosphate Tether Approach to Dolabelide C. 
The cornerstone for our synthetic approach to dolabelide C (3.12) employs our 
recent studies that have revealed a functionally active phosphate tether
14
 within the P-
chiral bicyclic phosphate 3.17 (Scheme 2).
15
  These studies revealed selective 
cleavage through displacement reactions at carbon (SN2, SN2’) and phosphorus, 
ultimately affording multi-positional activation, which extends throughout the 
bicyclic framework.  Using this tether approach it was envisioned that access to 
advanced polyol synthons could be attained, providing the impetus for this total 
synthesis.
11 
3.2.2 Retrosynthetic Analysis of the C1-C14 Subunit of Dolabelide C 
Common features among the dolabelide family are eleven-stereogenic centers, 
eight of which bear oxygen, and two E-configured trisubstituted olefins.  Other 
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attributes possessed by this family of macrolactones include 1,3-anti-diol fragments 
found at C7/C9 and C19/C21, along with an accompanying 1,3-syn-diol at C9/C11 
and polypropionate fragments at C1/C4 and C22/23.  The endgame strategy for ring 
closure was planned to hinge on a key RCM of the C14/C15 trisubstituted olefin 
following precedent set by Leighton and coworkers.
4a
 Preceding this 
macrocyclization is a simple esterification connecting the C1 carboxylic acid and C23 
alcohol, thus coupling the C1-C14 (3.12) and C15-C30 subunits of dolabelide C.  
Retrosynthetic analysis shows that assembly of the C1-C14 (3.12) portion can be 
achieved via a Grignard addition into C11 aldehyde 3.14, which is accessed by 
regioselective hydride opening of the advanced phosphate intermediate 3.15.  
Regioselective CM between bicyclic phosphate (R,R)- 3.17 and terminal olefin 3.16 
Scheme 2 
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generates the C5-C6 alkene and brings together five of the six stereocenters found 
within the C1-C14 subunit of dolabelide.  Bicyclic phosphate tether (R,R)- 3.17 is 
readily constructed from the proper enantiomeric, C2-symmetric 1,3-anti-diol, (R,R)-
3.18 via a P-tether-mediated diastereotopic differentiation using RCM. 
3.2.3 Synthesis of the C1-C14 Subunit of Dolabelide C 
Our synthesis of the C1-C14 subunit of dolableide C began with the 
construction of CM partner 3.22 (Scheme 3).  Terminal olefin 3.22 was achieved 
through initial reduction of TBS-protected Roche ester 3.19, followed by subsequent 
Swern oxidation of the alcohol providing the necessary aldehyde 3.20.
16
  Reaction of 
the formed aldehyde with the Z-crotyl (-)-Ipc-borane generated enantiopure 
homoallylic alcohol 3.21 in 80% yield.
17
  PMB-protection of alcohol 3.21 was 
achieved using p-methoxybenzyl bromide and sodium hydride to afford 3.22 in 95% 
yield.
18
  
Scheme 3 
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A key component of the proposed synthesis of dolabelide C was the selective 
CM between bicyclic phosphate (R,R)-3.17
11a
 and synthesized homoallylic alcohol 
3.22.  Previous studies of CM with bicyclic phosphate (R,R)- 3.17
19
 had shown that 
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the exocyclic olefin possessed Type III olefin behavior, implying that no detrimental 
homodimerization pathways would be operative.
19,20
 Other protected derivatives of 
3.22 (TBDPS (3.23)
21a
 and PMP acetal (3.24)
21b
) were synthesized to determine the 
most viable substrate to undergo the necessary CM reaction.  Using TBDPS as a 
protecting group (3.23) gave low reactivity and low yields during CM (Table 1, 
Entries 1-3).  CM was then attempted between (R,R)- 3.17 and 3.22 under the 
conditions previously reported (6 mol % Hoveyda-Grubbs cat., DCM, 45 ºC),
19
 but 
incomplete consumption of the starting phosphate was observed after six hours (Entry 
4).  Optimizing the reaction conditions with various solvents revealed that use of 
toluene (90 ºC), with the same catalyst loading, gave essentially the same results 
(Table 1, Entry 5).  However, an improved yield of 60% was obtained (Table 1, Entry 
6) when 12 mol % catalyst was added to the CM reaction.  Switching to DCE (90 ºC), 
and adding only 6 mol % Hoveyda-Grubbs catalyst, gave the optimum results with 
3.22 providing 72% yield of CM product 3.25 after two hours.  When removing the 
silyl protecting group altogether, 3.24 furnished similar results to 3.22 .  It should be 
noted that in all cases excess 3.22, 3.23, and 3.24, Type II CM partners, could be 
recovered in near quantitative yield and recycled in future CM events.  This 
differential reactivity pattern of protected alcohol substrates demonstrates that both 
proximal and distal steric interactions play vital roles in the success of selective CM 
reactions.
22
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Table 1. CM Studies with (R,R)-3.17. 
Me
OP1
Me
OP2
O
P
O O
O H-G cat
O
P
O O
O
MeMe
OP2 OP1
O O
PMP
CM
partner
Me
PMBO
Me
OTBS
Me
PMBO
Me
OTBDPS
2 equiv. CM
partner
 H-G cat. solvent temp. (ºC) yield (%)
6 mol % Toluene 60 N.A.
6 mol % Toluene 90 28
12 mol % Toluene 90 31
6 mol % 50 42
6 mol % Toluene 90 45
12 mol % Toluene 90 60
CH2Cl2
6 mol % DCE 90 72
6 mol % 50 32
6 mol % Toluene 90 63
6 mol % DCE 90 73
CH2Cl2
MeMe
(R,R)-3.17
3.23
3.22
3.24
3.25
entry
1
2
3
4
5
6
7
8
9
10
 
Having identified optimal CM conditions, 3.22 was chosen over 3.24 owing to 
the facile removal of the silyl protecting group in the late stages of the synthesis.  The 
CM between (R,R)-3.17 and 3.22 provided phosphate 3.26 in 72% yield on multigram 
scale (Scheme 3).  Regioselective hydrogenation of the exocyclic C5-C6 olefin in the 
presence of the C10-C11 internal olefin was paramount to allow for subsequent 
regioselective opening of the bicyclic system.  Upon investigating several 
hydrogenation conditions, (Wilkinson’s catalyst, Crabtree’s catalyst, Pd/C) it was 
found that an in situ generated diimide reduction under mild conditions (o-
nitrobenzenesulfonyl-hydrazine,
23
 Et3N, DCM) provided the necessary regioselective 
hydrogenated phosphate 3.27 with near complete selectivity for the exocyclic olefin.  
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Other diimide conditions (tosylhydrazine, NaOAc, H2O, DCE, 90 ºC) gave drastically 
lower yields, likely due to the bicyclic phosphate’s instability under basic medium.   
With phosphate 3.27 in hand, efforts were directed to making further use of 
the tether in a potential regioselective olefin transposition to the desired terminal 
olefin.  Initial attempts focused on the use of allylic hydride addition employing 
various reagents (Stryker’s reagent, CuCN•LiCl/PhSiH3, CeCl3•7H2O/NaBH4).  To 
our dismay, however, all conditions probed provided unreacted starting material or 
total decomposition of the reaction mixture.  Various palladium-catalyzed formate 
reductions were then investigated for generation of the requisite terminal olefin.
24
  
Employing 1.5 equivalents of formic acid and 5 mol % palladium acetate at 40 ºC in 
DCE selectively opened phosphate 3.27 to provide the desired terminal olefin. 
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Methylation of the phosphate acid intermediate showed that a highly regioselective 
process was operative (37:1 ratio of regioisomers as evident by 
31
P NMR analysis).  
Purification provided phosphate 3.30 in 87% yield.  The remarkable regioselectivity 
reveals another feature of the phosphate tether, whereby orthogonal orbital 
alignment
11
 within 3.27 allows for selective Pd(0)-catalyzed allylic phosphate 
ionization at C12 over C9. 
Installation of the C11-C14 fragment began with cleavage of the phosphate 
3.30 using LiAlH4, which generated a diol (3.31) that was subsequently protected as 
the acetonide (PPTS, 2,2-methoxypropane, DCM) to yield 3.32 in 96% (Scheme 4).  
Ozonolysis (O3, pyridine, DCM:MeOH 1:1, Me2S) of the terminal olefin produced 
the intended aldehyde (3.33), which was subjected to the Grignard generated from 1-
iodo-3-methyl-3-butene
25
 affording 3.34 in 95% yield.  Dess-Martin periodinane 
(DMP, NaHCO3, DCM) oxidation of the free alcohol in 3.34 generated the requisite 
ketone (3.35) in 90% yield.  Attempts to selectively reduce the acetonide protected 
ketone, using an assortment of reducing agents, resulted in a 1:1 mixture at C11.
26
  
This problem seemed likely to be circumvented by deprotection of the acetonide and 
subsequent syn reduction taking advantage of the C9 free alcohol for chelation.  
Removal of the acetonide was achieved by the addition of CeCl3•7H2O and water,
27
 
which efficiently cleaved the acetonide protecting group without loss of the primary 
TBS group and provided diol 3.36 in 86% yield. 
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To complete the synthesis of the C1-C14 subunit of dolabelide, a 1,3-syn 
reduction at the C11 position was needed.  Attempts with DIBAL and LiAlH4/LiI
28
 
did not provide the desired 1,3-syn selectivity, obtaining only 1:1 and 1.6:1 mixtures, 
respectively (Table 2).  However, utilizing different chelating groups did allow for the 
selective 1,3-syn reduction to be achieved.  The addition of ZnCl2 and NaBH4 
provided a 3.2:1 syn:anti ratio, while Et3B/NaBH4 afforded a 5.3:1 syn:anti mixture in 
71% yield.
29
  Lastly, ketone 3.36 was reduced using Et2BOMe and NaBH4 to afford 
triol 3.37 in 60% yield (95%, based on recovered starting material) with excellent 
diastereoselectivity (dr = >20:1)
30
 completing the desired C1-C14 subunit of 
dolabelide.  
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Table 2. Synthesis of C1-C14 Subunit of dolabelide C (3.37).  
3.37
C1-C14 subunit of 
Dolabelide C
OHOH
Me
PMBO
Me
OTBS
OH
Me
79 1
11
OHOH
Me
PMBO
Me
OTBS
O
Me
79 1
11
Conditions  Yield (%)
d.r. 
C9/C11-syn : C9/C11-anti
1:1
20:1
 75
60
DIBAL-H, -78 ºC
Et3B, NaBH4, THF, MeOH -78 ºC
ZnCl2, NaBH4
64 3.2:1
LiAlH4, LiI 90 1.6:1
4:182Et2BOMe, NaBH4, THF, MeOH -78 ºC
Hydride
Reduction
3.36
 
The completion of the stereoselective reduction marked the successful 
synthesis of the C1-C14 subunit of dolabelides A-D using phosphate tether 
methodology has been achieved.  Overall, the phosphate tether serves a multifaceted 
role by (i) mediating the initial desymmeterization event leading to (R,R)-3.17, (ii) 
providing a selective Type III CM to couple two major complex fragments in the C1-
C14 subunit of dolabelides, (iii) differentiating olefin reactivity within the bicyclic 
system 3.26 allowing for a selective hydrogenation, and finally (iv) serving as an 
excellent leaving group in a regioselective Pd(0)-catalyzed formate reduction.  The 
route outlined above takes advantage of orthogonal protecting and leaving group 
properties innate to phosphate esters.  
3.2.4 Retrosynthetic Analysis of the C15-C30 Subunit of Dolabelide C. 
Several synthetic studies
3
 have recently been reported for the dolabelide 
family, including the aforementioned total synthesis of dolabelide D by Leighton and 
coworkers in 2006.
4
 Among these efforts, two reports toward the C15-C30 fragment 
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have been presented, with Leighton and coworkers publishing the only complete C15-
C30 fragment bearing the requisite stereochemistry.
3d
   
As previously mentioned, retrosynthetic analysis reveals a logical 
disconnection at C1-C14 and C15-C30 (3.38, Scheme 5) for the entire family of 
dolabelides.  Convergent assembly of the C15-C30 subunit by the C23-C24 bond is 
envisioned to occur through a coupling of metallated 3.39 with aldehyde 3.40.  A 
regio- and diastereoselective cuprate addition into a functionalized bicyclic phosphate 
(by terminal olefin oxidation or CM/hydrogenation) was expected to provide the 
requisite stereotriad found in the C19-C22 subunit of dolabelide.  The 1,3-anti diol 
moiety contained within subunit 3.38 (C19 and C21) can be derived from phosphate 
triester building block (S,S)- 3.17,
15,19
 assembled via phosphate tether mediated 
desymmeterization of C2-symmetric anti-diol (S,S)- 3.18.   
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3.2.5 Synthesis of the C15-C30 Subunit of Dolabelide C. 
Initial efforts toward the construction of the C15-C30 subunit of dolabelide 
began with the enantiomeric bicyclic phosphate (S,S)-3.17 of that used for the C1-
C14 subunit (Scheme 6).  Chemoselective hydroboration of the exocyclic olefin of 
(S,S)-3.17, followed by a perborate oxidation protocol developed by Burke and 
coworkers
31
 that was optimized for bicyclic phosphate 3.17.  The yields obtained for 
these reactions were highly dependent on the amount of oxidant, equivalents of H2O, 
and reaction time.  Subsequent PMB ether formation using p-methoxybenzyl 
trichloroacetimidate produced 3.41 in good yields and highlights the stability of 
bicyclic phosphate (S,S)-3.17 under acidic conditions.  A regio- and diastereoselective 
cuprate addition
15
 to 3.41 (CuCN•2LiCl, ZnMe2, THF, -30 ºC to rt) generated the 
SN2’ displaced phosphate acid exclusively (dr = >95:5).  Subsequent methylation 
(TMSCHN2 and MeOH) afforded cyclic phosphate ester 3.42 in excellent yield 
(87%).   The unique orbital alignment within bicyclic phosphate 3.41, in synergy with 
its concave nature, dictates the high selectivity in this SN2’ cuprate reaction.
32
   
The remaining steps to aldehyde 3.45 were non-problematic and involved an 
initial reductive cleavage of the monocyclic phosphate ester with LiAlH4 in Et2O to 
provide diol 3.43 as a single diastereomer in excellent yield (96%).  Near quantitative 
acetonide formation and subsequent ozonolysis afforded 3.45a in good yield.  
Alternatively, diol 3.43 was also selectively mono-TIPS protected (TIPSCl, 
imidazole, rt)
33
 followed by a MOM protection (3.44b) and ozonolysis to produce 
3.45b in good yield over three steps. 
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3.15
O
P
O
O
O
O
P
O
O
O
OPMB
PMBO
OH
Me
OH
3.41
TIPSO
Me
OMOMTIPSO OP
1
Me
O
H
PMBO
19 2119 21
PMBO 3.44b
O3, pyridine,
1. 9-BBN, then H2O
10 eq. NaBO3•4H2O, 
80 %
2. PPTS, DCM, 
p-OMeC6H4OCH2OC=NH(CCl3),
89 %
i. CuCN2•2LiCl
Me2Zn, THF
single diastereomer
PMBO
O
Me
O
P
O OMe
ii. TMSCHN2 MeOH, 87 %;
LiAlH4, Et2O, 
single diastereomer  
96 %
1. TIPSCl, imidazole, 
DMAP, DCM, 86 %;
2. MOMCl, iPr2NEt, 
DCE, 50 ºC, 91 %
1:1 MeOH:DCM, 
-78 ºC to RT, 75 %
3.43P1 = P2 = CMe2, 3.45a
P1 = MOM, P2 = TIPS, 3.45b
2,2-DMP
PPTS, 98 % 3.44a
3.42
 
Construction of the C24-C30 vinyl iodide fragment 3.48 was achieved in two 
steps from known 3.46 (Scheme 7).
3d
 Alkyne 3.46 was produced from commercially 
available R-(-)-epichlorohydrin, employing a Yamaguchi protocol for oxirane 
alkynylation.
34
  Subsequent zirconocene-promoted carboalumination, utilizing Wipf’s 
water-accelerated procedure
35
 and iodine quench, provided trisubstituted vinyl iodide 
3.47 in 61% yield.  MOM protection ultimately afforded 3.48 in >95% yield. 
Scheme 7 
I
OHOHH
I
OMOM
3.46 3.47
3.48
Cp2ZrHCl, AlMe3, 
H2O; then I2
THF, 61%
MOMCl, iPr2NEt,
DCE, 50 ºC, >95%.
 
With 3.45a/3.45b and vinyl iodide 3.48 in hand, methods for the construction 
of both the C23-C24 C—C bond and installation of the C23 stereochemistry were 
investigated (Table 3).  To this end, reaction of acetonide-protected 3.45a with 
lithiate 3.48 (tBuLi, -78 ºC to rt) or the vinyl Grignard of 3.48 (tBuLi, -78 ºC, 
MgBr2•Et2O) provided Felkin 22,23-syn selectivity for the undesired C21-C23 1,3-
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anti product 3.49a in modest diastereoselectivity (2-4:1 dr).  Selectivity for the 
undesired C23 carbinol was the highest when employing an Oshima protocol
36
 using 
vinyl magnesiate formation in the presence of MgBr2•Et2O, where selectivities of 
~8:1 were observed in favor of 1,3-anti-3.49a.
37
 To circumvent this selectivity issue 
we employed a reagent controlled asymmetric addition using Oppolzer’s zinc 
vinylate-lithium alkoxy N-methylephedrine complex
38
 recently described by 
Marshall
39
 and coworkers for vinylate
 
additions with chiral aldehydes.  Under these 
conditions, 3.49b was formed in an 11:1 ratio of diastereomers favoring the desired 
C21-C23-syn product in moderate yield. 
Table 3. Additions to aldehyde 3.45. 
OP1
Me
OP2 OH Me
nPr
OP1
H
OP1
Me
OP2 O
H
Me
nPr
OMOM
I
+3.45
3.48
3.49a P1 = P2 = C(Me)2
3.49b P1 = TIPS, P2 = MOM
OPMB
3.45a P1 = P2 = C(Me)2
3.45b P1 = TIPS, P2 = MOM
Conditions Yield
dr
1,3-syn : 1,3-anti
tBuLi, -78 ºC
tBuLi, MgBr2•Et2O, -78 ºC
sBuLi, iPrMgCl; MgBr2•Et2O, -78 ºC
1:2
1:4
1:6-8
78%
68%
78%
1,3 selectivity
tBuLi, -78 ºC 1:170%
tBuLi, ZnBr2; nBuLi, (R,S)-NME 11:155%
conditions
PMBO
22
23
 
Despite this success, difficulties in reaction reproducibility (also recently 
noted by Marshall)
40
 and low product yields prompted the investigation of an 
alternative oxidation/hydride reduction sequence for the formation of the requisite 
1,3-syn diol within 3.49b (Scheme 8).  Thus, Dess-Martin periodinane oxidation of 
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the C23 epimers of 3.49b, followed by reduction of the resulting ketone (3.50) using 
Suzuki’s 1,3-syn selective, chelation-controlled reduction conditions (LiAlH4, LiI)
28
 
afforded a 4.3:1 mixture of diastereomers the desired 1,3-syn diol (3.49b) in 90% 
yield.
41
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With 3.49b in place, only the installation of the C14-C15 terminal olefin was 
needed to complete the C15-C30 subunit of dolabelide C.  Following MOM-
protection of the C23 alcohol (3.51), DDQ removal of the PMB ether proceeded in 
good yield to afford alcohol 3.52 (Scheme 9).  Tosylation of the primary alcohol 
provided 3.53 in 90% yield.  Treatment of 3.53 with an allyl Grignard in the presence 
of stoichiometric CuI led to the formation of allylated product 3.54 in 89% yield.  
Overall, this sequence represents a 12-step synthesis to 3.54 from 3.17, bearing the 
requisite stereochemistry for the C15-C30 subunit of dolabelide C. 
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An alternative approach to the C15-C30 side chain was investigated to show the 
flexibility of our phosphate tether as well as our previously established cross 
metathesis methodology (Scheme 10).
19
 
 
As anticipated, 3.17 underwent CM with 
3.55 in the presence of 6 mol % H-G catalyst
42
 in DCE (90 ºC) providing E-
configured 3.56 in 82% yield (>95:5, E:Z).
19
 Selective reduction of the external olefin 
was achieved with onitrobenzenesulfonylhydrazine,
23
 which provided 3.57 in (>95:5) 
regioselectivity and 75% yield.
43
  Regio- and diastereoselective methyl cuprate 
addition into 3.57, under the aforementioned conditions, and subsequent phosphate 
cleavage afforded diol 3.59 in good yield. Aldehyde 3.61 was rapidly accessed using 
a three-step TIPS-MOM-ozonolysis sequence (Scheme 10).  Lithiate addition into 
aldehyde 3.61 produced 3.48 as a 1:1 mixture of C23 epimers in 70% yield.  
Subsequent employment of the aforementioned Suzuki oxidation/reduction conditions 
(LiAlH4/LiI) afforded the desired diastereomer of 3.63 in 92% yield (dr = 4.5:1 at 
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C23).
28
  Substrate 3.63 was MOM-protected and the PMB-ether removed using DDQ 
to produce primary alcohol 3.64.  Iodination of the C14 primary alcohol occurred in 
83% yield, followed by facile E2 elimination of the primary iodide in the presence of 
tBuOK (THF, 30 min, rt) afforded 3.54, in 92% yield.  Due to the success, and 
convenience of the alternative elimination approach to the C15 olefin, we are 
currently investigating selective vinylate addition with 3.48 for stereocontrolled 
formation of C23 within 3.62. 
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The C15-C30 subunit 3.54 bearing three MOM-protecting groups proved to 
be problematic when attempting to remove these groups.  To our dismay, all 
conditions tested for cleavage of these groups in the presence of the more labile TIPS-
protecting groups provided unreacted starting material or total decomposition of the 
substrate.  The difficulty in removing these protecting groups prompted a reevaluation 
of protecting groups to access a suitable C15-C30 subunit of dolabelide.   
We embarked on a route that utilized the CM/diimide reduction sequence to 
obtain diol 3.59.  Acetonide protection of diol 3.59 with PPTS and 2,2-
dimethoxypropane provided acetonide 3.65 in 96% yield (Scheme 11).  The terminal 
olefin was then converted into a primary alcohol (3.66) by a dihydroxylation/ 
oxidation/reduction sequence, which occurred in good yields.  TBS-protection of 
alcohol 3.66 proceeded in 86% yield and was followed by removal of the PMB-ether 
with DDQ to provide the corresponding primary alcohol 3.67.  Iodination of alcohol 
3.67 allowed for the formation of the primary iodide that was immediately taken onto 
the next reaction without further purification.  Elimination was achieved with tBuOK 
to afford terminal olefin 3.68 in excellent yield over the two step sequence.  TBAF 
removal of the TBS protecting group and Swern oxidation provided aldehyde 3.69 
necessary for the addition of the C24-C30 fragment.  Vinyl iodide 3.70 was converted 
to the lithiate with 2 equivalents of tBuLi followed by the addition of aldehyde 3.69 
to afford a 1:1 mixture of C23 epimers of alcohol 3.71 in 70% yield. The two 
diastereoisomers of 3.71 were easily separated by column chromatography allowing 
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for the isolation of the correct stereoisomer of alcohol 3.71 that was taken forward to 
couple with the C1-C14 subunit of dolabelide C. 
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The low diastereoselectivity prompted us to find a reaction that provided 
increased diastereoselectivity of alcohol 3.71.  Therefore 3.71 was oxidized to ketone 
3.72 and subjected to various reducing conditions to obtain a reaction that favored the 
desired isomer of alcohol 3.71 (Scheme 12).  Initial reduction utilizing Mori’s 
condition (LiAlH4, LiI)
28
 generated only a 1:1 mixture diastereomers.  Other 
reductants such as DIBAL-H and NaBH4 provided the undesired isomer in a greater 
then 1:1 diastereomeric ratio.  Further, it was tested whether removal of the silyl 
group prior to the reduction of ketone 3.73 could be beneficial.  To this end, 
deprotection of ketone 3.72 with TBAF and acetylation with acetic anhydride 
occurred in good yield to afford acetate 3.73.  Upon subjection of acetate 3.73 to 
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Luche’s conditions
44
 with CeCl3 and NaBH4 we were disappointed at the observation 
of a 10:1 mixture of isomers in favor of undesired alcohol 3.74.  Currently, studies are 
being directed toward reducing ketone 3.72 using a CBS-reduction to provide the 
desired diastereomer of alcohol 3.71 as the major product of the reaction.  Overall, 
this alternative route to 3.71 is a 13-step synthesis from phosphate 3.17, and provides 
a route with protecting groups that allow for coupling of the C15-C30 subunit with 
the C1-C14 subunit of dolabelide C.  
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To date, we have successfully completed the synthesis of the C15-C30 subunit 
of dolabelides A-D using different strategies that all rely on the temporary phosphate 
tether methodologies developed in our laboratories.  These pathways make use of the 
orthogonal protecting- and leaving group properties innate to phosphate esters and 
showcase the utility of phosphate tethers in synthesis.   
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3.2.6 Endgame: Total Synthesis of Dolabelide C. 
With both subunits of dolabelide C successfully synthesized, we began studies 
toward the completion of dolabelide C.  This process began with the complete 
acetylation of triol 3.37 to install the proper acetylation pattern for C1-C14 subunit of 
dolabelide C (Scheme 13).  This was accomplished by adding acetic anhydride and 
pyridine to triol 3.37 that afforded triacetyl 3.75 in excellent yield.  Deprotection of 
the TBS protecting group was then achieved with TBAF to provide alcohol 3.76 in 
93% yield.  It was found that Swern oxidation of alcohol 3.76 generated the desired 
aldehyde that was prone to epimerization and was taken on without purification.  
Further oxidation of the aldehyde provided carboxylic acid 3.77 in 81% yield over the 
two-step sequence.  Carboxylic acid 3.77 was the properly acetylated C1-C14 subunit 
of dolabelide C for coupling with the C15-C30 subunit.   
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 Previous studies on the coupling the C1-C14 and C15-C30 subunits of 
dolabelide B and D used Yamaguchi’s esterification conditions to join these 
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subunits.
13,45
 Other esterification protocols were attempted [(PhO)2P(O)Cl, DCC, and 
Mukaiyama reagent] with only starting material recovered and no observation of the 
desired coupled product.
45
  In the course of these studies it was demonstrated that 
Yamaguchi conditions at 0 ºC caused epimerization at the C2 position of carboxylic 
acid 3.2 when using extended reaction times.
45
  Knowing this, and having sufficient 
quantities of 3.71, we investigated a Mitsunobu reaction to invert the C23 carbinol 
and join the two subunits (Scheme 14).  Unfortunately, this reaction provided no 
coupled product but observation of the reaction mixture by 
1
H NMR spectroscopy 
demonstrated that elimination by-products of the C15-C30 subunit were formed.  This 
could be attributed to the steric congestion about the C23 carbinol position of 3.71 
and activation of triphenylphosphine causing elimination to be more favorable than 
SN2 displacement. 
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 The final coupling of the C1-C14 carboxylic acid, 3.77, and the C15-C30 
alcohol, 3.71, was achieved using the Yamaguchi conditions as previously describe 
by Leighton and coworkers (Scheme 15).
4
  The addition of 2,4,6-trichlorobenzoyl 
chloride, DMAP, Et3N, and DMAP at -78 ºC for 21 hours avoided epimerization at 
C2 and afforded the desired coupled 3.78 in 73% yield.  With the C1-C14 subunit 
coupled with the C23 alcohol, deprotection of the C27 TES protecting group was 
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achieved with TBAF in 93% yield.  This alcohol was then acetylated to afford 3.79 in 
96% yield.  The final two protecting groups were removed with the addition of PPTS 
in MeOH and DDQ to provide metathesis precursor 3.80 in excellent yield over two 
steps.  Efforts to close the ring were attempted prior to PMB ether removal and 
provided the RCM product as observed by high resolution mass spectrometry.  
Unfortunately, observation of the reaction by TLC poor reaction conversion and 
further investigations focused on the RCM of deprotected triol 3.80.  Addition of 
Grubbs II catalyst to triol 3.80 afforded dolabelide C (3.12) in a 60%  
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yield as a 1:1 mixture of E:Z isomers.  These isomers were sparingly separable by 
column chromatography and were able to isolated as a 4:1 E:Z mixture for 
spectroscopic identification of dolabelide C.  The total synthesis of dolabelide C 
using our temporary phosphate tether methods was achieved in 24 steps (longest 
linear sequence from acetylacetone) and 54 total steps.  The overall yield for this 
synthesis was 0.73% with an average yield per chemical step being 81.5%. 
3.3 Summary 
In conclusion, we have successfully completed the total synthesis of 
dolabelide C.  The synthesis used a temporary phosphate tether methodology 
developed in our laboratories, which includes selective CM with the exocyclic olefin, 
regioselective olefin hydrogenation, regioselective Pd(0)-catalyzed opening of the 
bicyclic phosphate, a selective terminal olefin oxidation, and a highly regio- and 
diastereoselective cuprate addition.  Collectively, these methods allowed for the first 
total synthesis using temporary phosphate tethers for the construction of dolabelide C.  
Ongoing efforts will continue to expand and develop new temporary phosphate tether 
methodologies to allow for the synthesis of new bioactive natural products.  
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Chapter 4 
Experimental Data: Chapters 2 and 3 
 105 
4.1 General Experimental Methods 
All air and moisture sensitive reactions were carried out in flame- or oven-
dried glassware under argon atmosphere using standard gastight syringes, cannulas, 
and septa.  Stirring was achieved with oven-dried magnetic stir bars.   Et2O, toluene, 
THF and CH2Cl2 were purified by passage through the Solv-Tek purification system 
employing activated Al2O3 (Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518-1520).  Et3N was purified by passage over basic 
alumina and stored over KOH.  nButyl Lithium (2.5M in THF) was purchased from 
Aldrich and titrated prior to use.  Grubbs first and second-generation, as well as the 
Hoveyda-Grubbs olefin metathesis catalysts, were acquired from Materia and used 
without further purification.  Glycidol ether was acquired from Daiso Co., Ltd., Fine 
Chemical Department and used without further purification. Flash column 
chromatography was performed with Sorbent Technologies (30930M-25, Silica Gel 
60A, 40-63 um).  Thin layer chromatography was performed on silica gel 60F254 
plates (EM-5717, Merck).  Deuterated solvents were purchased from Cambridge 
Isotope laboratories.  
1
H, 
13
C and 
31
P NMR spectra were recorded on a Bruker DRX-
400 spectrometer operating at 400 MHz, 100 MHz, and 162 MHz respectively; or a 
Bruker Advance operating at 500 MHz and 125 MHz respectively.  High-resolution 
mass spectrometry (HRMS) and FAB spectra were obtained on a VG Instrument 
ZAB double-focusing mass spectrometer. 
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4.2 Experimental Data: Chapter 2 
General Procedure for Cross Metathesis of Type I Olefins: A flask or pressure 
tube containing 2.53 (20 mg, 0.099 mmol) was charged with CH2Cl2 (2 mL) that had 
been degassed 15 minutes with argon. The Type I olefin partner (1.1 equiv. relative to 
compound 2.53) followed by Hoveyda-Grubbs II catalyst (2.3) (6.2 mg, 0.009 mmol) 
were added and the reaction mixture was refluxed for 3-6 h. Upon completion 
(monitored by TLC) the reaction was cooled to rt and concentrated under reduced 
pressure.  
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(2E)-Propen-1-ol, 3-[(1R, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]: 2.55  
O
P
O O
O
HO
 
Purification via flash chromatography (9:1 EtOAc/MeOH) supplied 19 mg (86% 
yield) of 2.55 as a viscous oil.  
[!]D -78.8 (c = 0.60, CH2Cl2);  
IR (neat) 3402, 2923, 2358, 1286, 1064, 973 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.92-6.03 (m, 2H), 5.72 (ddd, JHH = 15.5, 3.8, 1.5 Hz, 
1H), 5.55 (ddd, JHH = 11.8, 3.6, 2.7 Hz, 1H), 5.10-5.19 (m, 1H), 5.01 (dd, JHH = 11.8, 
5.6 Hz, 1H), 4.91-4.98 (m, 1H), 4.38 (ddd, J = 27.8, 14.8, 6.7 Hz, 1H), 4.14 (d, JHH = 
4.3 Hz, 2H), 2.20 (ddd, JHH = 18.3, 12.2, 6.2 Hz, 1H), 1.73 (d, JHH = 14.7 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) " 133.6, 130.1, 128.5, 127.2 (d, JCP = 10.3 Hz), 77.6, 
76.4 (d, JCP = 6.1 Hz), 63.5 (d, JCP = 6.4 Hz), 62.5, 35.6 (d, JCP = 5.7 Hz); 
31
P NMR 
(162 MHz, CDCl3) " -2.70; Exact Mass: calculate for C9H13O5P (M+Na)
+
 255.0398; 
found 255.0403 (ESI) 
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(1R, 6R, 8R)- 2,9,10-Trioxa-1-phosphabicyclo[4.3.1]dec-4-ene, 8-[(1E)-3-[[(1,1-
dimethylethyl)dimethylsilyl]oxy]-1-propenyl]-, 1-oxide: 2.56 
O
P
O O
O
TBSO
 
Purification via flash chromatography (1:1 Hexane/EtOAc) supplied 29 mg (87% 
yield) of 2.56 as a oil.  
[!]D -44.2 (c = 0.24, CH2Cl2);  
IR (neat) 2954, 2927, 2856, 2348, 1299, 1068 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.98 (dddd, JHH = 12.0, 6.6, 2.8, 2.8 Hz, 1H), 5.88 
(dddd, JHH = 15.5, 8.2, 4.1, 1.6 Hz, 1H), 5.67-5.71 (m, 1H), 5.63 (ddd, JHH = 11.8, 3.8, 
2.8 Hz, 1H), 5.18-5.25 (m, 1H), 5.00 (dd, JHH = 11.5, 5.4 Hz, 1H), 4.95 (m, 1H), 4.37 
(ddd, J = 27.7, 14.8, 6.7 Hz, 1H), 4.13 (t, JHH = 1.9 Hz, 2H), 2.19 (ddd, JHH = 18.2, 
12.1, 6.2 Hz, 1H), 1.70-1.74 (m, 1H), 0.84 (s, 9H), 0.00 (s, 6H);  
13
C NMR (125 MHz, CDCl3) " 133.1, 129.7, 128.4, 125.8 (d, JCP = 10.0 Hz), 76.0 (d, 
JCP = 6.3 Hz), 63.0 (d, JCP = 6.4 Hz), 62.5, 35.3 (d, JCP = 6.3 Hz), 25.9, 18.4, -5.31, -
5.29;  
31
P NMR (162 MHz, CDCl3) " -2.75;  
HRMS Exact Mass: calculate for C15H27O5PSi (M+Na)
+
 369.1263; found 369.1263 
(ESI) 
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Carbamic acid, [(2E)-3-[(1R, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-2-propenyl]-, 1,1-dimethylethyl ester: 2.57 
O
P
O O
O
BocNH
 
Purification via flash chromatography (1:1 Hexane/EtOAc) supplied 22 mg (69% 
yield) of 2.57 as a oil.  
[!]D -49.4 (c = 0.16, CH2Cl2);  
IR (neat) 3330, 2962, 2358, 1712, 1515, 1292 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.98-6.02 (m, 1H), 5.81 (app dt, JHH = 15.3, 5.3 Hz, 
1H), 5.59 (dd, JHH = 15.5, 5.1 Hz, 1H), 5.53 (app dt, JHH = 10.9, 3.2 Hz, 1H), 5.13 
(app d, J = 24.5 Hz, 1H), 4.90-5.01 (m, 2H), 4.40 (ddd, J = 28.8, 14.8, 6.7 Hz, 1H), 
3.71 (s, 2H), 2.17 (ddd, JHH = 18.41, 12.32, 6.26 Hz, 1H), 1.71 (d, JHH = 14.53, 1H) 
1.46 (s, 9H);  
13
C NMR (125 MHz, CDCl3) " 155.7, 130.9, 129.6, 128.2, 127.9 (d, JCP = 9.6 Hz), 
76.9, 75.8 (d, JCP = 6.1 Hz), 63.0 (d, JCP = 6.3 Hz), 41.6, 35.1 (d, JCP = 6.0 Hz), 29.7, 
28.4;  
31
P NMR (162 MHz, CDCl3) " -2.96;  
HRMS Exact Mass: calculate for C14H22NO6P (M+H)
+
 332.1263; found 332.1277 
(ESI) 
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Phosphoric acid, dimethyl (2E)-3-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-2-propenyl ester: 2.58 
O
P
O O
O
O
P
O
MeO
MeO
 
Purification via flash chromatography (9:1 EtOAc/MeOH) supplied 27 mg (80% 
yield) of 2.58 as a oil.  
[!]D -48.3 (c = 0.48, CH2Cl2);  
IR (neat) 2956, 2358, 1296 1037, 955 cm
-1
;   
1
H NMR (500 MHz, CDCl3) trans isomer " 5.98-6.03 (m, 1H), 5.94 (app dt, JHH = 
15.5, 5.3 Hz, 1H), 5.78 (dd, JHH = 15.5, 3.5 Hz, 1H), 5.55 (app dt, JHH = 11.8, 3.7 Hz, 
1H), 5.15 (d, JHH = 24.3 Hz, 1H), 5.00-5.06 (m, 1H), 4.91-4.99 (m, 1H), 4.51 (dd, J = 
7.8, 4.7 Hz, 2H), 4.33 (ddd, J = 27.7, 14.8, 6.7 Hz, 1H), 3.73 (s, 3H), 3.71 (s, 3H), 
2.17 (app ddd, JHH = 18.3, 12.4, 6.1 Hz, 1H), 1.75 (app d, JHH = 14.2 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) trans isomer " 130.0 (d, JCP = 10.3 Hz), 129.5, 128.3, 
127.4 (d, JCP = 6.6 Hz), 77.0, 76.9, 75.1 (d, JCP = 6.0 Hz), 66.5 (d, JCP = 5.2 Hz), 54.5, 
54.4, 35.0 (d, JCP = 5.8 Hz);  
31
P NMR (162 MHz, CDCl3) trans isomer " 2.66, -3.04; cis isomer " 2.74, 2.89; 
HRMS Exact Mass: calculate for C11H18O8P2 (M+Na)
+
 363.0375; found 363.0386 
(ESI)  
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General Procedure for Cross Metathesis of Type II Olefins: A flask or pressure 
tube containing 2.53 (20 mg, 0.099 mmol) was charged with CH2Cl2
 
(2 mL) that had 
been degassed 15 minutes with argon. The Type II olefin partner (4-5 equiv. relative 
to compound 2.53) followed by Hoveyda-Grubbs II catalyst (2.3) (6.2 mg, 0.009 
mmol) were added and the reaction mixture was refluxed for 3-6 h. Upon completion 
(monitored by TLC) the reaction was cooled to rt and concentrated under reduced 
pressure.  
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(3E)-Buten-2-one, 4-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]: 2.54 
O
P
O O
O
Me
O
 
Purification via flash chromatography (9:1 EtOAc/MeOH) supplied 18 mg (75% 
yield) of 2.54 as an oil.  
[!]D -56.7 (c = 0.33, CH2Cl2);  
IR (neat) 2958, 2362, 1701, 1677, 1275, 973 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 6.61 (app dt, JHH = 20.3, 3.5 Hz, 1H), 6.50 (dd, JHH = 
15.7, 1.7 Hz, 1H), 6.12 (ddd, JHH = 11.9, 3.8, 2.8 Hz, 1H), 5.57 (dddd, JHH = 11.8, 6.6, 
2.8, 2.4 Hz, 1H), 5.20-5.24 (m, 1H), 5.14-5.19 (m, 1H), 4.94-5.00 (m, 1H), 4.35 (ddd, 
J = 28.0, 14.9, 6.7 Hz, 1H), 2.22 (s, 3H), 2.13-2.23 (m, 1H), 1.82 (app dd, JHH = 14.6, 
1.5 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) " 197.2, 140.4 (d, JCP = 10.4 Hz), 129.9, 129.2, 128.7, 
76.9 (d, JCP = 5.7 Hz), 74.2 (d, JCP = 5.9 Hz), 63.2 (d, JCP = 6.3 Hz), 34.5 (d, JCP = 6.0 
Hz), 28.67;  
31
P NMR (162 MHz, CDCl3) " -3.39;  
HRMS Exact Mass: calculate for C10H13O5P (M+Na)
+
 267.0398; found 267.0409 
(ESI)  
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(2E)-Propenoic acid, 3-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-, methyl ester: 2.60 
O
P
O O
O
OMe
O
 
Purification via flash chromatography (1:2 Hexane/EtOAc) supplied 20 mg (78% 
yield) of 2.60 as a oil.  
[!]D -42.8 (c = 0.40, CH2Cl2);  
IR (neat) 2954, 2852, 1724, 1300, 973 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 6.87 (app dt, JHH = 15.6, 3.7 Hz, 1H), 6.27 (dd, JHH = 
15.5, 1.9 Hz, 1H), 6.12 (dddd, JHH = 11.9, 6.6, 2.8, 2.4 Hz, 1H), 5.66 (ddd, JHH = 11.9, 
3.8, 2.7 Hz, 1H), 5.28-5.32 (m, 1H), 5.22-5.28 (m, 1H), 5.03-5.09 (m, 1H), 4.44 (ddd, 
J = 27.9, 14.8, 6.7 Hz, 1H), 3.79 (s, 3H), 2.25 (ddd, JHH = 18.4, 12.3, 6.2 Hz, 1H), 
1.90 (app dd, JHH = 14.7, 1.3 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) " 166.2, 142.6 (d, JCP = 10.3 Hz), 129.2, 128.7, 122.1, 
76.8, 74.1 (d, JCP = 5.8 Hz), 52.0, 34.4 (d, JCP = 5.9 Hz) 29.7;  
31
P NMR (162 MHz, CDCl3) " -3.36;  
HRMS Exact Mass: calculate for C10H13O6P (M+H)
+
 261.0528; found 261.0533 
(ESI) 
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(2Z)-Propenoic acid, 3-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-, 1,1-dimethylethyl ester: 2.61 
O
P
O O
O
OtBuO
 
Purification via flash chromatography (1.5:1 Hexane/EtOAc) supplied 3 mg of the 
minor cis-2.61 isomer of methyl acrylate derived bicyclic phosphate as a oil. The 
trans isomer was inseparable from starting material (5:1 E/Z).  
[!]D -65.5 (c = 0.20, CH2Cl2);  
IR (neat) 3010, 2923, 1710, 1301, 1242, 1159, 973 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 6.21 (dd, JHH = 11.7, 6.7 Hz, 1H), 6.04-4.14 (m, 2H), 
5.77 (dd, JHH = 11.7, 1.1 Hz, 1H), 5.72 (ddd, JHH = 11.9, 3.9, 2.7 Hz, 1H), 5.16-5.27 
(m, 1H), 4.98-5.08 (m, 1H), 4.44 (ddd, J = 28.0, 14.6, 6.7 Hz, 1H), 2.14-2.24 (m, 1H), 
2.06 (ddd, JHH = 14.4, 3.9, 2.4 Hz, 1H), 1.48 (s, 9H);  
13
C NMR (100 MHz, CDCl3) " 164.5, 144.5 (d, JCP = 12.5 Hz), 129.8, 128.0, 122.7, 
81.2, 74.3 (d, JCP = 5.0 Hz), 63.1, 33.4 (d, JCP = 6.3 Hz) 29.7, 28.1;  
31
P NMR (162 MHz, CDCl3) " -3.33 trans, -3.29 cis;  
HRMS Exact Mass: calculate for C13H19O6P (M+Na)
+
 325.0817; found 325.0825 
(ESI) 
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(2E)-Propenal, 3-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-
4-en-8-yl]: 2.62 
O
P
O O
O
H
O
 
Purification via flash chromatography (9:1 EtOAc/MeOH) supplied 18 mg (78% 
yield) of 2.62 as a oil.  
[!]D -34.4 (c = 0.45, CH2Cl2);  
IR (neat) 3150, 2930, 1698, 1300, 975 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 9.93 (d, JHH = 7.4 Hz, 1H), 6.76 (ddd, JHH = 15.7, 3.9, 
3.1 Hz, 1H), 6.47 (ddd, JHH = 16.3, 7.4, 1.6 Hz, 1H), 6.12-6.18 (m, 1H), 5.68 (ddd, 
JHH = 11.9, 3.9, 2.7 Hz, 1H), 5.36 (ddd, J = 12.3, 3.8, 1.8 Hz, 1H), 5.26-5.33 (m, 1H), 
5.04-5.11 (m, 1H), 4.46 (ddd, J = 28.0, 14.9, 6.7 Hz, 1H), 2.33 (ddd, JHH = 18.4, 12.2, 
2.1 Hz, 1H), 1.95 (ddd, JHH = 14.5, 3.4, 2.1 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) " 192.1, 149.8 (d, JCP = 10.8 Hz), 132.1, 129.1, 128.9, 
76.7, 74.0 (d, JCP = 5.7 Hz), 63.2 (d, JCP = 6.3 Hz), 34.2 (d, JCP = 6.0 Hz);  
31
P NMR (162 MHz, CDCl3) " -3.65;  
HRMS Exact Mass: calculate for C9H11O5P (M+H)
+
 231.0422; found 231.0447 (ESI)  
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(2R, 3E)-Buten-2-ol, 4-[(1S, 6R, 8R)-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-1-(phenylmethoxy): 2.63 
O
P
O O
O
HO
BnO
 
Purification via flash chromatography (1:2 Hexane/EtOAc) supplied 25 mg (72% 
yield) of 2.63 as a oil.  
[!]D -45.0 (c = 0.60, CH2Cl2);  
IR (neat) 3404, 2923, 2854, 1272, 1114 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 7.22-7.33 (m, 5H), 5.94-6.01 (m, 1H), 5.75-5.85 (m, 
2H), 5.53 (ddd, JHH = 11.9, 3.8, 2.6 Hz, 1H), 5.13 (app d, J = 24.5 Hz, 1H), 4.91-5.02 
(m, 2H), 4.50 (s, 2H),  4.33 (m, 1H), 4.31 (ddd, J = 27.8, 14.8, 6.7 Hz, 1H), 3.48 (dd, 
JHH = 9.6, 3.3 Hz, 1H), 3.27 (dd, JHH = 9.6, 8.0 Hz, 1H), 2.47 (s, 1H), 2.16 (ddd, JHH = 
18.2, 12.1, 6.2 Hz, 1H), 1.72 (dd, JHH = 14.7, 1.2 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) " 137.6, 131.6, 129.6, 128.5, 128.3 (d, JCP = 10.1 Hz), 
128.2, 128.0, 127.9, 77.0, 75.6 (d, JCP = 6.1 Hz), 73.7, 73.5, 70.2, 63.0 (d, JCP = 6.3 
Hz), 35.2 (d, JCP = 5.7 Hz);  
31
P NMR (162 MHz, CDCl3) " -2.88  
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(2Z,4R,6R,7E,9R)-10-(benzyloxy)deca-2,7-diene-1,4,6,9-tetraol: 2.64 
HO
OH OH
OH
OBn
 
2.63 (0.033 g, 0.090 mmol) was taken up in THF (2.0 mL) and lowered to 0 ºC. 
LiAlH4
 
(17 mg, 0.45 mmol) was slowly added. Upon complete addition of LiAlH4, 
the reaction was warmed to rt and stirred for one hour. The reaction was quenched 
under non-aqueous conditions (0.017 mL H2O slowly, 0.017 mL 15% NaOH slowly, 
and 0.051 mL H2O). Salts were filtered and washed (5x with ether) and reaction was 
concentrated.  The concentrated reaction mixture was purified by flash 
chromatography (9:1 EtOAc) to supply 23 mg of 2.64 (70% yield) as an oil.  
[!]D -24.28 (c = 0.034, CH2Cl2);  
IR (neat) 3404, 2923, 2856, 1452, 1272, 1110 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 7.29-7.39 (m, 5H), 5.85 (dd, JHH = 15.3, 5.2 Hz, 1H), 
5.54-5.76 (m, 3H), 4.68-4.77 (m, 1H), 4.56 (s, 2H),  4.33-4.44 (m, 2H), 4.24 (dd, JHH 
= 12.5, 6.6 Hz, 1H), 4.02-4.10 (m, 1H), 3.51 (dd, JHH = 9.5, 3.2 Hz, 1H), 3.38 (app t, 
JHH = 8.0 Hz, 1H), 3.13-3.33 (broad s, 4H), 1.75-1.85 (m, 1H), 1.68-1.71 (m, 1H);  
13
C NMR (125 MHz, CDCl3) " 137.7, 134.6, 134.6, 130.2, 128.9, 128.5, 128.0, 
127.9, 74.0, 73.4, 70.7, 69.8, 65.7, 58.7, 42.6;  
HRMS Exact Mass: calculate for C17H24O5 (M+NH4)
+
 326.1968; found 326.1942 
(FAB) 
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(1R, 6R, 8R)-2,9,10-Trioxa-1-phosphabicyclo[4.3.1]dec-4-ene, 8-ethenyl-3,3-
dimethyl-, 1-oxide,: 2.66 
O
P
O O
O
Me Me
 
A flask was charged with diol 2.49 (0.60 g, 4.69 mmol), NEt3
 
(1.444 g, 14.3 mmol), 
and DMAP (0.057 g, 0.47 mmol) in DCM (23 mL). The solution was cooled to 0 ºC, 
and freshly distilled POCl3 (0.789 g, 5.16 mmol)
 
was added dropwise. After 25 
minutes stirring in the ice bath, 20 mL of ether was added, and the salts filtered off. 
The concentrated reaction mixture was purified by flash chromatography (1:1 
Hexane/EtOAc) to supply 0.682 g (70% yield) of the (3R,5R)-phosphate 
monochloride as a clear oil. A solution of 2-methylbut-3-en-2-ol (0.310 g, 3.60 
mmol) in THF (18.0 mL) was cooled to -30 ºC. BuLi (2.47 M, 3.60 mmol) was 
slowly added, followed by one hour of stirring. A solution of phosphate monochloride  
(0.682 g, 3.27 mmol) in THF (6.0 mL) was slowly cannulated into the reaction vessel 
containing the alkoxide. The reaction was stirred at rt for 24 h and was quenched with 
1 mL of NH4Cl
 
(sat’d aq) and diluted with 20 ml distilled water. The separated 
aqueous layer was extracted EtOAc (3x), and the combined organic layers were 
washed with NaHCO3
 
(sat’d aq.), brine, and dried (Na2SO4). A flask containing triene 
phosphate was charged with CH2Cl2
 
(360 mL) that had been degassed 15 minutes 
with argon. Grubbs Second Generation catalyst was added (122 mg, 0.144 mmol) and 
the reaction mixture was refluxed for 3-3.5 h. Upon completion (monitored by TLC) 
the reaction was cooled to rt and concentrated under reduced pressure. Purification 
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via flash chromatography (1:1 Hexanes/EtOAc) supplied 377 mg (50% yield over 
two steps) of the 2.66.   
[!]D -93.2 (c = 0.72, CH2Cl2);  
IR (neat) 3197, 2933, 2383, 1384, 1299, 999 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.83-5.94 (m, 1H), 5.87 (dd, JHH = 12.2, 1.4 Hz, 1H), 
5.45 (d, JHH = 16.5 Hz, 1H), 5.42 (dd, JHH = 12.3, 4.7 Hz, 1H), 5.27 (d, JHH = 10.6 Hz, 
1H), 5.14 (ddd, J = 24.6, 5.9, 4.6 Hz, 1H), 4.99 (ddd, J = 11.9, 3.4, 1.5 Hz, 1H), 2.20 
(ddd, JHH = 18.2, 12.1, 6.2 Hz, 1H), 1.84 (s, 3H), 1.79 (app dd, JHH = 14.6, 1.2 Hz, 
1H), 1.52 (d, JHP = 2.6 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) " 137.9, 135.0 (d, JCP = 10.4 Hz), 125.6, 117.1 (d, JCP = 
1.1 Hz), 80.9 (d, JCP = 7.6 Hz), 75.9 (d, JCP = 6.5 Hz), 75.8 (d, JCP = 6.0 Hz), 34.6 (d, 
JCP = 5.8 Hz), 31.5 (d, JCP = 12.2 Hz), 28.7;  
31
P NMR (162 MHz, CDCl3) " -6.86;  
HRMS Exact Mass: calculate for C10H15O4P (M+H)
+
 231.0786; found 231.0793 
(ESI)  
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(3E)-Buten-1-ol, 4-[(1R, 6R, 8R)-3,3-dimethyl-1-oxido-2,9,10-trioxa-1-
phosphabicyclo[4.3.1]dec-4-en-8-yl]-: 2.67 
O
P
O O
O
Me Me
HO
 
A flask or pressure tube containing 2.66 (20 mg, 0.087 mmol) was charged with 
CH2Cl2 (2 mL) that had been degassed 15 minutes with argon. Homo-allyl alcohol 
(12.5 mg, 0.173 mmol) followed by Hoveyda-Grubbs II catalyst (2.3) (6.2 mg, 0.009 
mmol) was added and the reaction mixture was refluxed for 3-6 h. Upon completion 
(monitored by TLC) the reaction was cooled to rt and concentrated under reduced 
pressure. Purification via flash chromatography (9:1 EtOAc/MeOH) supplied 17 mg 
(71% yield) of 2.67 as an oil.  
[!]D -99.3 (c = 0.30, CH2Cl2);  
IR (neat) 3404, 2923, 1384, 1288, 1271, 1002 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.83 (dd, JHH = 15.1, 6.9 Hz, 1H), 5.77 (dd, JHH = 
12.3, 1.6 Hz, 1H), 5.56 (ddd, JHH = 15.1, 5.7, 0.6 Hz, 1H), 5.32 (dd, JHH = 12.3, 4.6 
Hz, 1H), 4.98-5.08 (m, 1H), 4.90 (q, J = 11.7, 5.7 Hz, 1H), 3.63 (t, JHH = 6.9 Hz, 2H), 
2.27 (q, JHH = 12.6, 6.2 Hz, 2H), 2.17 (ddd, JHH = 19.0, 12.0, 6.3 Hz, 1H), 1.75 (s, 
3H), 1.68 (ddd, JHH = 14.5, 3.2, 2.2 Hz, 1H), 1.44 (d, JHP = 2.5 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) " 137.9, 130.5, 129.8 (d, JCP = 10.1 Hz), 125.6, 80.9 (d, 
JCP = 7.7 Hz), 75.9 (d, JCP = 6.4 Hz), 75.8 (d, JCP = 5.9 Hz), 61.6, 35.4, 34.9 (d, JCP = 
5.8 Hz), 31.5 (d, JCP = 12.3 Hz), 28.7;  
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31
P NMR (162 MHz, CDCl3) ! -6.89;  
HRMS Exact Mass: calculate for C12H19O5P (M+H)
+
 275.1048; found 275.1059 
(ESI)  
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(1R, 6R, 8S)-2,9,10-Trioxa-1-phosphabicyclo[4.3.1]dec-4-ene-8-butanol, 3,3-
dimethyl-, 1-oxide: 2.68 
O
P
O O
O
Me Me
HO
 
CH2Cl2 (14 mL) was added to a flask containing the 2.67 (0.019 g, 0.069 mmol). 
Grubbs second generation catalyst (0.06 g, 0.007 mmol) was added along with Et3N 
(0.004 g, 0.03 mmol). The solution was then canulated into a H2 Parr bomb apparatus. 
The solution was purged with H2 and the bomb sealed. The mixture was heated at 37 
ºC and 300 psi H2
 
for 2 h. Concentration under reduced pressure and purification of 
the mixture via flash chromatography (9:1 EtOAc/MeOH) supplied 15 mg of the 2.68 
(76% yield) as a oil.  
[!]D -68.9 (c = 0.14, CH2Cl2); 
IR (neat) 3407, 2927, 2854, 1384, 1290, 1271, 1095, 1002 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 5.73 (dd, JHH = 10.3, 1.9 Hz, 1H), 5.28 (dd, JHH = 
12.3, 4.7 Hz, 1H), 4.96-5.02 (m, 1H), 4.38-4.45 (m, 1H), 3.57 (t, JHH = 6.3, 2H), 2.08 
(ddd, JHH = 18.0, 12.0, 6.0 Hz, 1H), 1.73 (s, 3H), 1.40-173 (m, 7H), 1.41 (d, JHP = 2.5 
Hz, 3H);  
13
C NMR (125 MHz, CDCl3) " 137.4, 125.5, 80.4 (d, JCP = 7.5 Hz), 75.9 (d, JCP = 3.8 
Hz), 75.8 (d, JCP = 3.8 Hz), 62.3, 35.1 (d, JCP = 8.8 Hz), 34.0 (d, JCP = 6.3 Hz), 31.9, 
31.2 (d, JCP = 12.5 Hz), 28.3, 20.7;  
31
P NMR (162 MHz, CDCl3) " -6.37;  
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HRMS Exact Mass: calculate for C12H21O5P (M+H)
+
 277.1205; found 277.1213 
(ESI) 
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(1R,6R,8S)-2,9,10-Trioxa-1-phosphabicyclo[4.3.1]dec-4-ene, 8-[4-[(4-
methoxyphenyl)methoxy]butyl]-3,3-dimethyl-, 1-oxide: 2.69 
O
P
O O
O
Me
Me
OPMB
 
The PMB-imidate was prepared via previous method (Organ, M. G.; Wang, J. J. Org. 
Chem. 2002, 67, 7847-7851). The crude PMB-imidate (86 mg, 0.306 mmol) was 
dissolved in CH2Cl2 (1.0 mL) at rt and 2.68 (28 mg, 0.102 mmol) and PPTS (3 mg, 
0.0119 mmol) were added. The mixture was stirred for 22 h during which time a 
white solid formed. After washing with saturated NaHCO3 and brine, the solution was 
dried over anhydrous Na2SO4 and subsequently filtered. Concentration under reduced 
pressure and purification of the mixture via flash chromatography (1:1 
EtOAc/MeOH) supplied 37 mg of the 2.69 (94% yield) as an oil.  
[!]D -65.7 (c = 0.525, CH2Cl2);  
IR (neat) 2931, 2858, 1612, 1512 1367, 1290, 1271, 1095, 1000 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 7.26 (app d, JHH = 6.50 Hz, 2H), " 6.87 (app d, JHH = 
8.6 Hz, 2H), " 5.81 (dd, JHH = 12.3, 1.7 Hz, 1H), 5.35 (dd, JHH = 12.3, 4.5 Hz, 1H), 
5.08 (app dt, J = 24.6, 5.6 Hz, 1H), 4.45-4.53 (m, 1H), 4.42 (s, 2H), 3.81 (s, 3H), 3.43 
(t, JHH = 6.2 Hz, 2H), 2.13 (ddd, JHH = 18.1, 11.9, 6.3 Hz, 1H), 1.81 (s, 3H), 1.45-179 
(m, 7H), 1.49 (d, JHP = 6.0 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) " 158.1, 136.6, 129.5, 128.3, 124.8, 112.8, 79.7 (d, JCP 
= 7.7 Hz), 75.2 (d, JCP = 3.1 Hz), 75.1 (d, JCP = 2.7 Hz), 71.6, 68.7, 54.3,  34.5 (d, JCP 
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= 9.3 Hz), 33.3 (d, JCP = 5.9 Hz), 30.5 (d, JCP = 12.1 Hz), 28.3, 27.6, 20.4;  
31
P NMR (162 MHz, CDCl3) ! -6.34;  
HRMS Exact Mass: calculate for C20H29O6P (M+H)
+
 397.1780; found 397.1782 
(ESI) 
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(4S,5R,7S)-11-(4-methoxybenzyloxy)-2,4-dimethylundec-2-ene-5,7-diol: 2.70 
OH OHOPMB
Me
Me  
A thoroughly dried flask was charged with a solution of CuCN•2LiCl in THF (0.342 
mL, 1.0 M solution) and lowered to –30 ºC. Me2Zn in THF (0.171 mL, 2.0 M 
solution) was slowly added. Upon addition, the mixture was stirred for 30 minutes at 
–30 ºC (mossy green color). A solution of 2.69 (27 mg, 0.069 mmol) in THF (0.069 
mL) was cannulated slowly into the cuprate solution (at –30 ºC). The reaction was 
stirred for 3 hrs and quenched with 10% HCl (5 mL, the reaction was stirred until 
copper solids dissolved). The two layers were separated, and the aqueous layer was 
washed with CH2Cl2
 
(4x). The combined organic layers were washed with H2O (1x) 
and concentrated under reduced pressure to provide the crude phosphonic acid (one 
product peak by 
31
P analysis) as an oil. The acid was taken up in methanol and 
TMSCHN2 was added at rt until the yellow solution persisted.  A drop of acetic acid 
was added and the solution was evaporated under reduced pressure.  The phosphate 
was taken up in toluene (0.685 mL) and cooled to 0 ºC. Red-Al (0.083 mL of 65% 
solution in toluene) was slowly added. Upon addition of Red-Al, the flask was 
warmed to rt and stirred for 3 hrs. The reaction was quenched with 3 mL of NH4Cl
 
(sat’d, aq.). The layers were separated and the aqueous layer was extracted with 
EtOAc (3x). The combined organic layers were washed with brine (1x), dried 
(Na2SO4), and concentrated under reduced pressure. Flash chromatography (1:1 
EtOAc/hexane) provided 15 mg of 2.70 (65% yield over three steps).  
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[!]D -13.7 (c = 0.510, CH2Cl2);  
IR (neat) 3392, 2927, 2856, 1612, 1512 1363, 1247, 1209, 1097, 1035 cm
-1
;   
1
H NMR (500 MHz, CDCl3) " 7.26 (app d, JHH = 8.4 Hz, 2H), " 6.87 (app d, JHH = 
8.5 Hz, 2H), " 4.97 (d, JHH = 9.8 Hz, 1H), 4.42 (s, 2H), 3.90-3.96 (m, 1H), 3.81 (s, 
3H), 3.58 (ddd, JHH = 7.9, 7.9, 3.0 Hz, 1H), 3.44 (t, JHH = 6.5 Hz, 2H), 2.80 (broad s, 
2H), 2.44-2.51 (m, 1H), 1.76 (s, 3H), 1.67-173 (m, 1H), 1.66 (s, 3H), 1.35-1.65 (m, 
9H), 0.92 (d, JHH = 6.7 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) " 159.1, 135.2, 130.7, 129.3, 126.7, 113.8, 73.4, 72.6, 
70.0, 69.1, 55.3, 39.0, 38.9, 37.2, 29.8, 26.1, 22.6, 18.4, 17.0;  
HRMS Exact Mass: calculate for C21H34O4 (M+H)
+
 351.2535; found 351.2538 (ESI) 
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4.3 Experimental Data: Chapter 3 
TBS-PMB Protected Phosphate: 3.26 
O
P
O O
O
 6% Hoveyda-
Grubbs Cat.
O
P
O O
O
Me
OPMB
Me
TBSO
Me
OPMB
Me
TBSO
DCE, 90 ºC
 
To a stirring solution of olefin 3.22 (3.22g, 8.51 mmol) and degassed DCE (85 mL) 
were added bicyclic phosphate 3.17 (870 mg, 4.26 mmol) and Hoveyda-Grubbs II 
catalyst (213 mg, 0.27 mmol).  The solution was equipped with a reflux condenser 
and placed into an oil bath at 90 ºC, at which time a stream of Ar was bubble through 
the solution for 1.5 h (until disappearance of phosphate 3.17 by TLC).  The solution 
was allowed to cool to room temperature before being concentrated under vacuum 
pressure. Purification via flash chromatography (2:1 EtOAc/Hexane) supplied 1.71 g 
(72% yield) of 3.26 as a viscous oil.  
[!]D -57.5 (c  =  0.80, CH2Cl2);  
FTIR (neat) 2954, 2927, 2883, 1514, 1463, 1249 cm
-1
;  
1
H NMR (500 MHz, CHCl3-d) " ppm 7.23 (d, J = 8.6 Hz, 2 H), 6.83 (d, J = 8.5 Hz, 2 
H), 6.04 (dddd, J = 11.8, 6.5, 2.9, 2.8 Hz, 1 H), 5.90 (dd, J = 15.5, 7.5 Hz, 1 H), 5.59 
(ddd, J = 11.8, 3.7, 2.6 Hz, 1 H), 5.53 (dd, J = 15.5, 6.5 Hz, 1 H), 5.11-5.20 (m, 1 H), 
4.97 (m, 1 H), 4.95 (dd, J = 12.9, 7.8 Hz, 1 H), 4.49 (d, J = 11.0 Hz, 1 H), 4.41 (d, J = 
11.0 Hz, 1 H), 4.37 (ddd, JHP = 27.7, JHH =  14.8, 6.7 Hz, 1 H), 3.80 (s, 3 H), 3.59-
3.67 (m, 1 H), 3.63 (dd, J = 8.1, 5.5 Hz, 1 H), 3.29 (dd, J = 7.7, 4.0 Hz, 1 H), 2.43-
2.50 (m, 1 H), 2.17 (ddd, J = 14.7, 12.1, 6.2 Hz, 1 H), 1.78-1.86 (m, 1 H), 1.63 (d, J = 
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13.8 Hz, 1 H), 1.01 (d, J = 6.8 Hz, 3 H), 0.93 (d, J = 6.9 Hz, 3 H), 0.90 (s, 9 H), 0.04 
(s, 6 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 159.1, 139.3, 131.2, 129.7, 129.2, 128.1, 
126.0 (JCP = 10.1 Hz), 113.7, 83.7, 76.8 (JCP = 6.4 Hz), 76.81, 74.2, 62.9 (JCP = 6.2 
Hz), 55.3, 38.6, 38.5, 35.3 (JCP = 5.5 Hz), 29.7, 26.0, 18.3, 14.5, 13.8, -5.3, -5.4; 
31
P NMR (162 MHz, CHCl3-d) ! ppm -3.57;  
HRMS Exact Mass: calculate for C28H49NO7PSi (M+NH4)
+
 570.3016; found 
570.3002 (ESI). 
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Partially Hydrogenated TBS-PMB Protected Phosphate: 3.27 
Et3N, DCM, rt,
24hO
P
O O
O
Me
OPMB
Me
TBSO
O
P
O O
O
Me
OPMB
Me
TBSO
o-NO2C6H4SO2NHNH2
 
The cross-metathesized phosphate intermediate (3.26) (1.53 g, 2.76 mmol) was taken 
up in CH2Cl2 (35 mL) followed by the addition of Et3N (12 mL, ~2 mL/gram of 
NBS-H), and NBS-H (6.00 g, 27.60 mmol).  After the reaction was stirred for 12 h, 
EtOAc (100 mL) was added, and the reaction extracted with NaHCO3 (sat’d aq, 2x).  
The aq layer was re-extracted with EtOAc (1x).  The combined organic layers were 
dried (anhydrous Na2SO4) and concentrated.  The material was then re-subjected to 
the same conditions before being purified.  Flash chromatography (2:1 Hex:EtOAc) 
afforded 3.27 (1.11 g, 72%) as a clear oil and 150 mg of starting material. 
[!]D 20.0 (c  =  0.46, CH2Cl2);  
FTIR (neat) 2954, 2929, 2883, 1514, 1461, 1249 1072 cm
-1
;  
1
H NMR (500 MHz, CHCl3-d) " ppm 7.27 (d, J = 7.6 Hz, 2 H), 6.88 (d, J = 8.5 Hz, 2 
H), 6.04 (dddd, J = 11.8, 6.5, 2.8, 2.6 Hz, 1 H), 5.59 (ddd, J = 11.8, 4.0, 2.5 Hz, 1 H), 
5.11 – 5.21 (m, 1 H), 5.01 (dddd, J = 11.8, 8.6, 5.2, 2.8 Hz, 1 H), 4.57 (d, J = 11.4 Hz, 
1 H), 4.44 – 4.51 (m, 1 H), 4.46 (d, J = 11.0 Hz, 1 H), 4.37 (ddd, JHP = 27.7, JHP = 
14.8, 6.6 Hz, 1 H), 3.81 (s, 3 H), 3.74 (dd, J = 9.8, 5.0 Hz, 1 H), 3.63 (dd, J = 9.8, 3.5 
Hz, 1 H), 3.26 (dd, J = 8.8, 2.5 Hz, 1 H), 2.09 (ddd, J = 14.5, 12.0, 6.3 Hz, 1 H), 1.71-
1.86 (m, 2 H), 1.55- 1.70 (m, 3 H), 1.34 – 1.54 (m, 2 H), 0.92 (s, 9 H), 0.90 (d, J = 4.1 
Hz, 3 H), 0.88 (d, J = 6.6 Hz, 3H), 0.06 (s, 3H), 0.06 (s, 3H); 
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13
C NMR (126 MHz, CHCl3-d) ! ppm 159.0, 131.5, 129.9, 129.4, 129.2, 127.9, 
113.7, 83.0, 77.3, 76.9, 74.1, 64.9, 62.9, 55.3, 38.5, 34.9, 34.6, 33.8, 26.0, 18.3, 14.73, 
13.4, -5.3, -5.4; 
31
P NMR (162 MHz, CHCl3-d) ! ppm -3.12;  
HRMS Exact Mass: calculate for C28H51NO7PSi (M+NH4)
+
 572.3172; found 
572.3163 (ESI). 
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(4S,6S,9R,10S,11R)-12-(tert-butyldimethylsilyloxy)-10-(4-methoxybenzyloxy)-
9,11-dimethyldodec-1-ene-4,6-diol: 3.31 
OO
Me
OPMB
Me
OTBS
P
O OMe
5% Pd(OAc)2:[HBu3P]BF4
 (1:1)
CO2H2, Et3N, DCE, 40 ºC
then TMSCHN2, MeOHO
P
O O
O
Me
OPMB
Me
TBSO
LiAlH4,
Et2O, 0 ºC
OHOH
Me
OPMB
Me
OTBS
 
Phosphate 3.27 (1.84 g, 3.30 mmol) was taken up in 90 mL of DCE and stirred at 
room temperature.  In a different reaction vessel 5 mol % Pd(OAc)2 (47 mg, 0.21 
mmol) and [HBu3P]BF4 (60 mg, 0.21 mmol) and were taken up in 7 mL of DCE.  At 
this time, Et3N (2.068 mL, 14.87 mmol) and CO2H2 (0.280 mL, 7.40 mmol) were 
added to the reaction vessel containing phosphate 3.27 and the 1:1 mixture of 
Pd(OAc)2 and [HBu3P]BF4 was also quickly cannulated into the reaction containing 
phosphate 3.27.  The reaction was heated to a temperature of 40 ºC.  The reaction was 
stirred at this temperature until the color of the reaction turned black (~1 h) as well as 
disappearance of starting material by TLC analysis.  The reaction was cooled to room 
temperature, diluted with 50 mL CH2Cl2 and 40 mL of 10 % aqueous HCl was added.  
The layers separated and the aqueous layer was re-extracted (2x) with CH2Cl2.  The 
organic layer was then concentrated to ~50 mL under reduced pressure. MeOH (2 
mL) followed by TMSCHN2 (2.0 mL, 2.0M in diethyl ether) were added to the 
stirring solution, which caused the reaction to bubble vigorously.  The reaction was 
allowed to stir for 5 min. and was monitored for disappearance of the phosphate acid.  
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Upon completion of the reaction a drop of glacial acetic acid was added and the 
mixture was extracted with CH2Cl2 and a saturated solution of NaHCO3.  The 
aqueous layer was re-extracted (2x) with CH2Cl2, dried (Na2SO4), filtered, and 
concentrated under reduced pressure.  Flash chromatography (2:1 Hexane:EtOAc) 
provided 1.67 g of 3.30 (~1:1 diastereomeric mixture at phosphate) in 87% yield as a 
clear oil.  
The 1:1 diastereomeric phosphate mixture (1.67 g, 2.91 mmol) was taken up 
in Et2O (103 mL) and cooled to 0 ºC.  LiAlH4 (0.222 g, 5.83 mmol) was slowly added 
in ~ 0.1 g increments.  Upon completion of the addition, the reaction was stirred at 0 
ºC for 1 h, and quenched via slow sequential addition of H2O (222 µl), 10% NaOH 
(222 µl), and H2O (666 µL), and removal from the bath.  After stirring for 1h, white 
salts had formed and were filtered through a pad of celite washing Et2O and was 
concentrated under reduced pressure.  The resulting clear oil was pushed through a 
short plug of silica (2:1 Hexane:EtOAc) to afford 1.09 g of 3.31 (76% yield) as a 
clear oil. 
[!]D 2.00 (c  =  0.35, CH2Cl2);  
FTIR (neat) 3344, 3074, 2954, 2929, 2856, 1247, 1082 cm
-1
;  
1
H NMR (500 MHz, CHCl3-d) " ppm 7.28 (d, J = 8.6 Hz, 2 H), 6.88 (d, J = 8.6 Hz, 2 
H), 5.78-5.88 (m, 1 H), 5.16-5.19 (m, 1 H), 5.13-5.15 (m, 1 H), 4.56 (d, J = 11.0 Hz, 
1 H), 4.49 (d, J = 11.0 Hz, 1 H), 3.94 (ddd, J = 12.5, 7.1, 5.4 Hz, 1 H), 3.86-3.92 (m, 
1 H), 3.81 (s, 3 H), 3.72 (dd, J = 9.6, 5.2 Hz, 1 H), 3.65 (dd, J = 9.7, 3.4 Hz, 1 H), 
3.29 (dd, J = 8.6, 2.8 Hz, 1 H), 2.23-2.33 (m, 3 H), 1.79-1.89 (m, 1 H), 1.57-1.66 (m, 
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5 H), 1.38-1.48 (m, 3 H), 0.92 (s, 9 H), 0.91 (d, J = 0.16 Hz, 3 H), 0.90 (d, J = 4.49 
Hz, 3 H), 0.06 (s, 3 H), 0.06 (s, 3 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 159.0, 134.6, 131.6, 129.2, 118.3, 113.7, 83.3, 
74.3, 69.5, 68.2, 65.0, 55.3, 42.0, 41.9, 38.6, 35.6, 35.2, 30.9, 26.0, 18.3, 14.8, 13.6, -
5.3, -5.4; 
HRMS Exact Mass: calculate for C28H50NaO5Si (M+Na)
+
 517.3325; found 517.3315 
(ESI). 
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((2R,3S,4R)-6-((4S,6S)-6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)-3-(4-
methoxybenzyloxy)-2,4-dimethylhexyloxy)(tert-butyl)dimethylsilane: 3.32 
OHOH
Me
OPMB
Me
OTBS
OO
Me
OPMB
Me
OTBS
MeMe
PPTS, 2,2-dimethoxypropane
DCM
 
The diol (1.07 g, 2.16 mmol) was dissolved in CH2Cl2 (4 mL) followed by the 
addition of 2,2-DMP (4 mL), and PPTS (54 mg, 0..216 mmol). Upon completion 
(~15 min, monitored by TLC) the reaction was diluted with CH2Cl2 and quenched 
with NaHCO3 (sat’d aq., 2 mL), dried (Na2SO4) and filtered.  Flash chromatograph 
(10:1 Hexane:EtOAc) provided acetonide 3.32 (1.10 g, 96%). 
 [!]D -4.33 (c  =  0.30, CH2Cl2);  
FTIR (neat) 3074, 2954, 2929, 2856, 1514, 1247, 1039 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) " ppm 7.27 (d, J = 8.5 Hz, 2 H), 6.87 (d, J = 8.7 Hz, 2 
H), 5.82 (dddd, J = 13.7, 10.6, 10.2, 7.1 Hz, 1 H), 5.08 (dd, J = 17.2, 1.8 Hz, 1 H), 
5.04-5.08 (m, 1 H), 4.55 (d, J = 10.9 Hz, 1 H), 4.48 (d, J = 10.9 Hz, 1 H), 3.82-3.90 
(m, 1 H), 3.81 (s, 3 H), 3.75 – 3.78 (m, 2 H), 3.65 (dd, J = 9.6, 3.4 Hz, 1 H), 3.26 (dd, 
J = 8.4, 2.6 Hz, 1 H), 2.27-2.36 (m, 1 H), 2.16 – 2.22 (m, 1 H), 1.79-1.87 (m, 1 H), 
1.52-1.61 (m, 4 H), 1.38-1.45 (m, 3 H), 1.36 (s, 3 H), 1.35 (s, 3 H), 0.92 (s, 9 H), 0.90 
(d, J = 3.6 Hz, 3 H), 0.89 (d, J = 5.4 Hz, 3 H), 0.06 (s, 3 H), 0.05 (s, 3 H); 
13
C NMR (126 MHz, CHCl3-d) " ppm 159.0, 134.5, 131.6, 129.2, 116.8, 113.7, 
100.2, 83.2, 74.4, 66.7, 66.2, 65.0, 55.3, 40.2, 38.6, 38.2, 35.0, 33.9, 30.4, 26.0, 24.8, 
24.8, 18.3, 14.7, 13.5, -5.3, -5.4; 
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HRMS Exact Mass: calculate for C31H54O5Si (M+H)
+
 535.3819; found 535.3817 
(ESI). 
 
 137 
1-((4R,6S)-6-((3R,4S,5R)-6-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-
3,5-dimethylhexyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-methylhex-5-en-2-one: 3.35 
Me
I
OO
Me
OPMB
Me
OTBS
MeMe
O
Me
OO
Me
OPMB
Me
OTBS
MeMe
OO
Me
OPMB
Me
OTBS
MeMe
OH
O3, pyridine
DCM, MeOH
Mg, Et2O
-78 ºC
OO
Me
OPMB
Me
OTBS
MeMe
OH
Me
Dess-
Martin
Periodinane
NaHCO3
DCM
 
The olefin (0.913 g, 1.71 mmol) was taken up in CH2Cl2:MeOH 1:1 (29 mL) 
followed by the addition of pyridine (1.352 g, 17.10 mmol) and SUDAN III 
(indicator, ~1 mg) at rt under argon.  The solution was cooled to -78
 
ºC, and a stream 
of O3 was lightly bubbled through the solution until a light yellow color persisted.  
The stream of O3 was removed when the SM was consumed (monitored by TLC).  
The flask was flushed with Ar, and Me2S (5.1 mL) was slowly added.  The reaction 
was slowly warmed to rt over a 4 h period.  After stirring for 1 h. at rt, Et2O (50 mL) 
was added and extracted with sat’d CuSO4 (2x 15 mL), and brine (1x), dried 
(anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  Flash 
chromatography (9:1 Hexane: EtOAc) afforded the aldehyde (0.657 g, 72 %) as an 
oil. 
To a solution of iodide (1.6 g, 8.0 mmol) in Et2O, with a cold finger condenser 
(dry ice, acetone), (8.9 mL, 0.9M solution) at rt was added freshly prepared 
magnesium chips (150 mg, 6.24 mmol).  At which time the reaction refluxed (metal 
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gray color) and was stirred under Ar until the solution had re-cooled to room 
temperature.  A separate reaction flask of aldehyde (641 mg, 1.20 mmol) in Et2O (6 
mL) was cooled to -78 ºC, then 6.64 mL of MgI solution was added dropwise.  The 
bath was removed after 5 min. of stirring and the reaction was warmed to rt. The 
reaction was quenched with aqueous 5 mL of NH4Cl (sat’d aq) after the 
disappearance of starting material.  The layers were separated and aqueous layer was 
extracted with Et2O (2x), and the combined organic layers washed with brine (1x), 
dried (anhydrous Na2SO4), and concentrated (rotary evaporator).  Flash 
chromatography (10:1 Hex:EtOAc) afforded a 1:1 mixture of 3.34 (ratio determined 
by 
1
H NMR analysis of crude reaction mixture, 700 mg, combine yield of 
diastereomers 96%). 
The alcohol (0.171 g, 0.281 mmol) was taken up in CH2Cl2 (9.3 mL) followed 
by the addition of NaHCO3 (0.236 g, 2.81 mmol) and Dess-Martin periodinane (0.261 
g, 0.618 mmol) at rt under argon.  Upon completion (monitored by TLC), Et2O (15 
mL) was added, and the solution extracted with NaHCO3 (sat’d aq., 2x).  The 
combined organic layers were rinsed with brine (1x), dried (anhydrous Na2SO4), 
filtered, and concentrated (rotary evaporator).  The mixture was pushed through a 
short plug of silica (10:1 Hex:EtOAc) to give the 3.34 (0.154 g, 90%) as a clear oil. 
[!]D 17.7 (c  =  1.65, CH2Cl2);  
FTIR (neat) 2954, 2933, 2856, 1718, 1458, 1247, 1037 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) " ppm 7.28 (d, J = 7.8 Hz, 2 H), 6.88 (d, J = 8.8 Hz, 2 
H), 4.75 (s, 1 H), 4.67 (s, 1 H), 4.58 (d, J = 10.7 Hz, 1 H), 4.49 (d, J = 10.7 Hz, 1 H), 
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4.30 (ddd, J = 14.4, 9.3, 5.4 Hz, 1 H), 3.82 (s, 3 H), 3.73 (dd, J = 9.9, 5.3 Hz, 2 H), 
3.64 (dd, J = 9.9, 3.3 Hz, 1 H), 3.28 (dd, J = 9.1, 2.88 Hz, 1 H), 2.68 (dd, J = 15.9, 8.3 
Hz, 1 H), 2.62 (dd, J = 7.3, 1.5 Hz, 1 H), 2.60 (d, J = 6.3 Hz, 1 H), 2.48 (dd, J = 15.9, 
4.8 Hz, 1 H), 2.29 (dd, J = 8.1, 7.3 Hz, 2 H), 1.78-1.87 (m, 1 H), 1.75 (s, 3 H), 1.48-
1.73 (m, 7 H), 1.36 (s, 3 H), 1.33 (s, 3 H), 0.93 (s, 9 H), 0.92 (d, J = 4.8 Hz, 3 H), 
0.90 (d, J = 4.6 Hz, 3 H), 0.07 (d, J = 2.0 Hz, 6 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 208.3, 159.0, 144.5, 131.6, 129.2, 113.6, 
110.0, 100.4, 83.4, 74.5, 66.9, 65.0, 63.2, 55.3, 48.7, 41.7, 38.6, 38.4, 35.2, 34.0, 31.1, 
30.6, 26.0, 24.7, 24.5, 22.7, 18.3, 14.7, 13.4, -5.3, -5.4; 
HRMS Exact Mass: calculate for C35H60NaO6Si (M+H)
+
 627.4057; found 627.4038 
(ESI). 
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(5S,7R,9S,12R,13S,14R)-15-(tert-butyldimethylsilyloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethylpentadec-1-ene-5,7,9-triol 3.37 
OO
Me
OPMB
Me
OTBS
MeMe
O
Me
OHOH
Me
OPMB
Me
OTBS
O
Me
OHOH
Me
OPMB
Me
OTBS
OH
Me
CeCl3•7H2O
H2O, CH3CN
Et2BOMe,
NaBH4,
4:1 THF:MeOH
-78 ºC
 
A solution of ketone 3.35 (0.050 g, 0.083 mmol) in CH3CN (1.38 mL) was added 
H2O (198 µl) followed by CeCl3•7H2O (93 mg, 0.250 mmol). The reaction was 
stirred until the disappearance of starting material (~5h).  The reaction was diluted 
with Et2O, quenched with NaHCO3 (sat’d aq.), and the aqueous layer was re-
extracted with Et2O (2x).  The organic layer was dried (Na2SO4), filtered and 
concentrated under reduced pressure.  Flash chromatography (3:1 Hexane:EtOAc) 
provided 40 mg of 3.36 in 87% yield as a clear oil. 
Reduction with Et2BOMe, NaBH4: To a solution of 3.36 (0.090 g, 0.159 mmol) in 
4:1 THF:MeOH (0.353 mL) was added Et2BOMe (1M in THF, 0.043 mL) at -78 ºC 
and stirred for 15 minutes. NaBH4 (0.014 g, 0.368 mmol) was added and stirred at -78 
ºC for 1 h.  Then the reaction flask was warmed to rt and stirred for an additional 
hour.  The reaction was quenched at -20 ºC with 10% aqueous NaOH, 35% H2O2, and 
stirred for 12 h at rt.  The layers were separated, and the aq. layer extracted with Et2O 
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(2x).   The combined organic layers were rinsed with brine (1x), dried (anhydrous 
Na2SO4), filtered, and concentrated (rotary evaporator).  The mixture was pushed 
through a silica column (2:1 Hex:EtOAc) to afford the title compound as a >20:1 
mixture (determined by 
1
H NMR of crude reaction) of 3.37 (0.054 g, 60%, 95% 
brsm) as a clear oil as well as 32 mg of starting ketone. 
Reduction with DIBAL-H: To a solution of the ketone (0.010 g, 0.0176 mmol) in 
toluene (0.200 mL) was slowly added DIBAL-H (1.0M in toluene, 0.040 mL) at -78 
ºC. After two hours of stirring at -78 
º
C, the reaction was quenched with NH4Cl 
(sat’d, aq.), and the reaction warmed to rt while stirring.  The layers were separated, 
and the aq. layer extracted with Et2O (2x).   The combined organic layers were rinsed 
with brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated (rotary 
evaporator).  The mixture was pushed through a short plug of silica (2:1 Hex:EtOAc) 
to afford the title compound as a 1:1 mixture (determined by 
1
H NMR of crude 
reaction) of 3.37 (0.0075 g, 75%) as a clear oil. 
Reduction with LiAlH4/LiI: To a solution of the ketone (0.020 g, 0.035 mmol) in 
Et2O (0.440 mL) was added LiI (0.047 g, 0.350 mmol) at 0 
º
C (solution turns reddish-
brown color).  Once the LiI is completely dissolved (< 5 min), the reaction was 
cooled to -78 
º
C and a solution of LiAl4H (2.0 M in Et2O, 0.175 mL) was slowly 
added.  After twenty minutes, the reaction was quenched with sodium-potassium 
tartrate (sat’d, aq.), and the reaction warmed to rt while stirring.  The layers were 
separated, and the aq. layer extracted with Et2O (2x).   The combined organic layers 
were rinsed with brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated 
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(rotary evaporator).  The mixture was pushed through a short plug of silica (2:1 
Hex:EtOAc) to afford the title compound as a 1.6:1 mixture (determined by 
1
H NMR 
of crude reaction) of 3.37 (0.018 g, 90%) as a clear oil. 
Reduction with Et3B, NaBH4: To a solution of the ketone (0.020 g, 0.035 mmol) in 
4:1 THF:MeOH (0.353 mL) was added Et3B (1.0M in THF 0.056 mL) at rt stirred for 
15 minutes.  The reaction was then cooled to -78 ºC and NaBH4 (0.003 g, 0.071 
mmol) was added and stirred at that temperature for 3h. The reaction was quenched at 
-78 ºC with 10% aqueous NaOH, 35% H2O2, and the reaction was stirred for 12 h at 
rt.  The layers were separated, and the aq. layer extracted with Et2O (2x).   The 
combined organic layers were rinsed with brine (1x), dried (anhydrous Na2SO4), 
filtered, and concentrated (rotary evaporator).  The mixture was pushed through a 
short plug of silica (2:1 Hex:EtOAc) to afford the title compound as a 5.3:1 mixture 
(determined by 
1
H NMR of crude reaction) of 3.37 (0.014 g, 70%) as a clear oil. 
Reduction with ZnCl2, NaBH4: To a solution of the ketone (0.010 g, 0.0175 mmol) 
in CH2Cl2 (0.175 mL) was added ZnCl2 (1M in THF, 0.0175 mL) at rt and stirred for 
15 minutes.  NaBH4 (0.0015 mg, 0.0012 mmol) was then added and the reaction was 
stirred for 12 h.  The reaction was quenched with 10% aqueous NaOH, 35% H2O2, 
and the reaction was stirred for 12 h at rt.  The layers were separated, and the aq. 
layer extracted with Et2O (2x).   The combined organic layers were rinsed with brine 
(1x), dried (anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  The 
mixture was pushed through a short plug of silica (2:1 Hex:EtOAc) to afford the title 
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compound as a 3.3:1 mixture (determined by 
1
H NMR of crude reaction) of 3.37 
(0.006 g, 64%) as a clear oil. 
 [!]D 7.26 (c  =  1.35, CH2Cl2);  
FTIR (neat) 3371, 2933, 2883, 2856, 1612, 1514, 1461 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) " ppm 7.27 (d, J = 8.6 Hz, 2 H), 6.89 (d, J = 8.6 Hz, 2 
H), 4.74 (d, J = 1.3 Hz, 1 H), 4.73 (s, 1 H), 4.56 (d, J = 10.9 Hz, 1 H), 4.49 (d, J = 
10.9 Hz, 1 H), 4.18-4.26 (m, 1 H), 3.85-3.97 (m, 2 H), 3.80 (s, 3 H), 3.73 (dd, J = 9.6, 
5.3 Hz, 1 H), 3.63 (dd, J = 9.6, 3.3 Hz, 1 H), 3.30 (dd, J = 8.8, 2.5 Hz, 1 H), 2.14 
(dddd, 2 H), 1.78-1.86 (m, 1 H), 1.75 (s, 3 H), 1.58-1.73 (m, 8 H), 1.46-1.57 (m, 4 H), 
1.27 (m, 3 H), 0.92 (s, 9 H), 0.91 (d, J = 2.3 Hz, 3 H), 0.89 (d, J = 2.3 Hz, 3 H), 0.06 
(s, 3 H), 0.05 (s, 3 H); 
13
C NMR (126 MHz, CHCl3-d) " ppm 159.0, 145.7, 131.61, 129.2, 113.7, 110.3, 
83.3, 77.3, 74.3, 73.2, 70.9, 69.8, 65.0, 55.3, 42.5, 38.6, 35.9, 35.7, 35.3, 33.8, 31.1, 
26.0, 22.4, 18.3, 14.7, 13.4, -5.3, -5.4; 
HRMS Exact Mass: calculate for C32H58NaO6Si (M+Na)
+
 589.3900; found 589.3890 
(ESI). 
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PMB protected hydroxyl bicyclic phosphate: 3.41 
O
P
O
O
O
O CCl3
NH
PPTS, DCM
OH
O
P
O
O
O
OPMB
 
To a solution of NaH (38 mg, 0.955 mmol) in Et2O (5 mL) was slowly cannulated a 
solution of PMBOH (5.28 g , 38.2 mmol) in Et2O (19 mL) at rt.  After stirring for 40 
min. the solution was cooled to 0 ºC and Cl3CCN (5.52 g, 38.2 mmol) was slowly 
added via dropwise addition.  After 5-10 min., the solution was removed from the 
bath and stirred for an additional hour.  The reaction was quenched with 10 mL of 
NaHCO3 (sat’d aq), and the layers separated.  The aqueous layer was further 
extracted with Et2O (3x), the combined organic layers were dried (anhydrous 
Na2SO4), filtered, and concentrated (rotary evaporator).  The crude mixture was then 
cannulated with CH2Cl2 (96 mL) to a flask containing the phosphate (2.1 g, 9.55 
mmol), followed by the addition of PPTS (239 mg, 0.96 mmol).  After stirring for 16 
h the reaction was quenched with 50 mL of NH4Cl (sat’d aq), and the layers 
separated.  The aq. layer was extracted with CH2Cl2 (3x), and the combined organic 
layers washed with brine (1x), dried (anhydrous Na2SO4), and concentrated (rotary 
evaporator). Flash chromatography (EtOAc) provided 2.89 g (89% yield) of 3.41 as a 
viscous, light yellow oil.   
[!]D
20
 = +63.8 (c = 3.1, CH2Cl2);  
FTIR (neat) 2934, 1730, 1612, 1514, 1299, 1091 cm
-1
;  
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1
H NMR (500 MHz, CDCl3) ! 7.23, (d, J  =  8.5 Hz, 2H), 6.88 (d, J  =  8.6 Hz, 2H), 
5.98-6.05 (m, 1H), 5.56 (ddd, 11.9, 3.8, 2.6 Hz, 1H), 5.16 (d, J  =  24.4 Hz, 1H), 4.95-
5.04 (m, 1H), 4.76-4.84 (m, 1H), 4.42 (s, 2H), 4.30-4.46 (m, 1H), 3.82 (s, 3H), 3.52-
3.65 (m, 2H), 2.13-2.24 (m, 1H), 1.83-2.00 (m, 2H), 1.74 (d, J  =  14.4 Hz, 1H);  
13
C NMR (125 MHz, CDCl3) ! 159.1, 130.1, 129.8, 129.2, 127.7, 113.7, 77.2 (d, JCP  
=  6.5 Hz), 74.0 (d, JCP  =  6.7 Hz), 72.7, 64.7, 62.9, 55.2, 35.8 (d, JCP  =  9.5 Hz), 
34.8 (d, JCP  =  6.0 Hz);  
31
P NMR (162 MHz, CDCl3) ! -2.29;  
HRMS calculated for C16H21O6P (M+Na)
+
 369.0973; found 369.0984 (FAB).   
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Monocyclic PMB-Protected Phosphate Ester: 3.42 
PMBO
O
Me
O
P
O OMe
i. CuCN•2LiCl
Me2Zn
ii.  TMSCHN2
MeOHO
P
O
O
O
OPMB
 
Within a drybox, CuCN (3.28 g, 36.6 mmol, dried overnight in a vacuum oven at 60 
o
C/0.3 mmHg and stored in a drybox), and LiCl (3.10 g, 73.3 mmol, dried overnight 
in a vacuum oven at 60 ºC/0.3 mmHg and stored in a drybox) were added to a round 
bottom flask and sealed with a septa.  The flask was removed from the drybox and 
placed under a balloon of argon.  THF (37 mL) was added and the mixture was stirred 
for 20 minutes at rt, then cooled to -30 ºC.  A solution of Me2Zn (33.3 mL, 1.2 M in 
toluene) was then added fast drop wise and the solution stirred for 30 minutes at -30 
ºC (solution turns deep green).  After 30 minutes, the phosphate (2.5 g, 7.33 mmol) in 
THF (7.3 mL) was cannulated fast dropwise (0.5 mL rinse), and the solution 
immediately removed from the bath and stirred at rt for 2 h.  Upon completion 
(monitored by TLC, baseline spot in EtOAc), the reaction was cooled to 0 ºC and 
slowly quenched with 10% HCl (4 mL) followed by water (8 mL), and stirred at rt for 
10 min (pepper colored salts form).  The solution was filtered through a pad of celite 
and rinsed thoroughly with EtOAc.  To the resulting bilayer solution was added 10% 
HCl (5 mL), and the layers separated.  The aq layer was extracted with EtOAc (2x), 
and the combined organic layers were concentrated via a rotary evaporator.  The 
resulting oil was taken up in MeOH (~20 mL), followed by the dropwise addition of 
TMSCHN2 (2 M in Et2O, ~10 mL), resulting in a deep yellow solution.  Excess 
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TMSCHN2 was quenched via slow dropwise addition of glacial acetic acid (3-4 
drops), and the solution dried (anhydrous Na2SO4), filtered, and concentrated (rotary 
evaporator). Flash chromatography (2:1 EtOAc) provided 2.37 g (87% yield) of 3.42 
as a clear oil, and as a ~1:1 mixture of diastereomers at phosphorus.   
1
H NMR (400 MHz, CDCl3) ! 7.24 (d, JHH  =  8.6 Hz, 2H), 6.87 (d, JHH  =  8.6 Hz, 
2H), 5.80 (dddd, J  =  17.4, 10.4, 7.6, 1.7, 1H), 5.06-5.13 (m, 2H), 4.67-4.80 (m, 1H), 
4.30-4.48 (m, 3H), 3.81 (s, 3H), 3.77 (d, 7.24 (d, JHP  =  5.4 Hz, 1.5H), 3.74 (d, JHP  =  
5.4 Hz, 1.5H), 3.54-3.68 (m, 2H), 2.37-2.55 (m, 1H), 2.06-2.22 (m, 2H), 1.67-1.98 
(m, 2H), 1.09 (d, JHH  =  6.9 Hz, 1.5H), 1.05 (d, JHH  =  6.9 Hz, 1.5H);  
13
C NMR (100 MHz, CDCl3) ! 159.1, 138.2, 137.7, 130.0, 129.9, 129.2, 116.6, 
116.3, 113.7, 79.8 (d, JCP  =  6.4 Hz), 78.8 (d, JP  =  7.0 Hz), 76.3 (d, JCP  =  7.2 Hz), 
74.3 (d, JCP  =  6.2 Hz), 72.7, 65.6, 65.2, 55.1, 54.2 (d, JCP  =  6.1 Hz), 53.7 (d, JCP  =  
5.7 Hz), 42.3 (d, JCP  =  7.9 Hz), 41.6 (d, JCP  =  5.2 Hz), 35.4 (d, JCP  =  6.1 Hz), 34.1, 
32.8 (d, JCP  =  7.2 Hz), 32.0 (d, JCP  =  7.9 Hz), 15.7, 15.3,  
31
P NMR (162 MHz, CDCl3) ! -4.17, -4.50.  
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(3R,5S,6R)-1-(4-methoxybenzyloxy)-6-methyloct-7-ene-3,5-diol: 3.43 
PMBO
O
Me
O
P
O OMe
LiAlH4, Ether
0 ºC
PMBO
OH
Me
OH
 
The 1:1 diastereomeric phosphate mixture (2.27 g, 6.19 mmol) was taken up in Et2O 
(103 mL) and cooled to 0 ºC.  LiAlH4 (0.464 g, 12.2 mmol) was slowly added in ~ 
0.1 g increments.  Upon complete addition, the reaction was stirred at 0 ºC for 2.5 h, 
and quenched via slow sequential addition of H2O (464 mL), 10% NaOH (464 mL), 
and H2O (1.4 mL), and removal from the bath.  After stirring for 30 minutes, 15 mL 
of 10% HCl was added and the layers separated.  The aq layer was extracted with 
Et2O (3x), and the combined organic layers rinsed with brine (1x), dried (anhydrous 
Na2SO4), filtered, and concentrated (rotary evaporator).  The resulting clear oil was 
pushed through a short plug of silica (1:1 EtOAc:Hex) to afford 1.76 g of 3.43 (96% 
yield) as a clear oil.   
[!]D
20
  =  – 6.8 (c  =  6.4, CH2Cl2);  
FTIR (neat) 3407, 2916, 1612, 1514, 1247, 1091, 1035 cm
-1
;  
1
H NMR (500 MHz, CDCl3) " 7.23 (d, J  =  8.6 Hz, 2H), 6.85 (d, J  =  8.6 Hz, 2H), 
5.71-5.80 (m, 1H), 5.08 (s, 1H), 5.04 (d, J  =  2.2, 1H), 4.43 (s, 2H), 4.06-4.13 (m, 
1H), 3.72 (s, 3H), 3.71-3.77 (m, 1H), 3.55-3.68 (m, 2H), 3.53 (bs, 2H), 2.15-2.24 (m, 
1H), 1.78-1.89 (m, 1H), 1.64-1.73 (m, 1H), 1.51-1.59 (m, 2H), 0.99 (d, J  =  6.9, 3H);  
13
C NMR (125 MHz, CDCl3) " 159.1, 140.4, 129.9, 129.2, 115.5, 113.7, 72.7, 71.35, 
68.5, 68.4, 55.1, 44.0, 39.9, 36.3, 15.8; 
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 (4S,6R)-4-((R)-but-3-en-2-yl)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-
dioxane: 3.44a 
PMBO
O
Me
O
Me Me
PMBO
OH
Me
OH 1:1 DCM; 2,2-DMP
PPTS
 
The diol (0.079 g, 0.269 mmol) was dissolved in DCM (1 mL) followed by the 
addition of 2,2-DMP (1 mL), and  PPTS (3.3 mg, 0.013 mmol). Upon completion 
(~15 min, monitored by TLC) the reaction was quenched with NaHCO3 (sat’d aq., 20 
mL), and anhydrous Na2SO4 was added, filtered through a short plug of silica 
(EtOAc), and concentrated (rotary evaporator), to provide acetonide 3.44a (0.088 g, 
98%) that was used without further purification.   
[!]D
20
 = -17.3 (c = 2.8, CH2Cl2);  
FTIR (neat) 2983, 1612, 1514, 1379, 1247 cm
-1
;  
1
H NMR (400 MHz, CDCl3) " ppm 7.28 (d, J = 8.4 Hz, 2H), 6.90 (d, J = 8.6 Hz, 
2H), 5.85 (ddd, J = 17.6, 10.6, 7.2 Hz, 1H), 5.06 (d, J = 6.7 Hz, 1H), 5.02 (d, J = 0.8 
Hz, 1H), 4.44 (s, 2H), 3.91-3.99 (m, 1H), 3.83 (s, 3H), 3.67 (ddd, J = 12.6, 6.3, 3.2 
Hz, 1H), 3.50-3.58 (m, 2H), 2.21-2.29 (m, 1H), 1.79 (d, J = 4.3 Hz, 1H), 1.76 (d, J = 
6.4 Hz, 1H), 1.71 (ddd, J = 15.5, 9.6, 6.0 Hz, 1H), 1.43-1.55 (m, 2H), 1.35 (s, 6H), 
1.01 (d, J = 6.8 Hz, 3H);  
13
C NMR (100 MHz, CDCl3) " ppm 159.1, 140.8, 130.5, 129.3, 114.4, 113.7, 100.3, 
72.7, 69.9, 66.3, 63.3, 63.9, 55.3, 42.0, 36.0, 35.9, 24.6, 24.3, 15.2;  
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HRMS calculated for C20H30O4 (M+Na)
+
 357.2042; found 357.2046 (FAB).  
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(3R,4S,6R)-8-(4-methoxybenzyloxy)-3-methyl-6-(triisopropylsilyloxy)oct-1-en-4-
ol: SI1 
PMBO
OH
Me
OH
PMBO
TIPSO
Me
OHTIPSCl, Im.
DMAP, DCM
 
The diol (1.76 g, 5.98 mmol) was dissolved in CH2Cl2 (40 mL) followed by the 
addition of imidazole (2.44 g, 35.88 mmol), and DMAP (73 mg, 0.598 mmol).  
TIPSCl (3.80 mL, 17.94 mmol) was then added dropwise over several minutes.  The 
reaction was stirred at rt overnight.  The reaction was diluted with Et2O (100 mL) 
followed by 10% HCl (30 mL), and the layers separated.  The aq layer was extracted 
with Et2O (1x), and the combined organic layers rinsed with brine (1x), dried 
(anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  Flash 
chromatography (9:1 Hex:Et2O to remove excess silane, then 5:1 Hex:EtOAc) 
yielded monosilylated SI1 (2.31g, 86%) as a clear oil.  
1
H NMR (500 MHz, CDCl3) ! ppm 7.24 (d, J  =  8.5 Hz, 2H), 6.88 (d, J  =  8.6 Hz, 
2H), 5.73-5.84 (m, 1H), 5.04 (s, 1H), 5.01 (d, J  =  2.3 Hz, 1H), 4.43 (d, J  =  11.6 Hz, 
1H), 4.37 (d, J  =  11.6 Hz, 1H), 4.27-4.32 (m, 1H), 3.79-3.85 (m, 1H), 3.80 (s, 3H), 
3.56 (bs, 1H), 3.41-3.56 (m, 2H), 2.13-2.22 (m, 1H), 1.91-2.08 (m, 2H), 1.70 (ddd, J  
=  14.8, 10.6, 4.3 Hz, 1H), 1.53 (ddd, J  =  14.6, 4.0, 1.8 Hz, 1H), 1.04-1.09 (m, 21H), 
1.00 (d, J  =  6.9 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) ! ppm 159.1, 140.6, 136.3, 129.2, 114.8, 113.7, 72.6, 
71.5, 69.9, 66.3, 55.2, 44.1, 37.7, 35.8, 18.1, 18.0, 15.3, 12.4;  
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HRMS calculated for C26H46O4Si (M+Na)
+
 473.3063; found 473.3029 (FAB).  
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(5S,7R)-5-((R)-but-3-en-2-yl)-9,9-diisopropyl-7-(2-(4-methoxybenzyloxy)ethyl)-
10-methyl-2,4,8-trioxa-9-silaundecane: 3.44b 
PMBO
TIPSO
Me
OH MOMCl, iPr2NEt
DCE, 50 ºC
PMBO
TIPSO
Me
OMOM
 
The secondary alcohol (0.700 g, 1.55 mmol) was dissolved in DCE (5.2 mL) 
followed by the addition of Et2iPrN (2.00 g, 15.6 mmol) and MOMCl (0.624 g, 7.75 
mmol) at rt under argon.  The flask was fitted with a reflux condenser under argon, 
and the reaction was heated to 50 ºC for 3-4 h.  Upon completion (monitored by 
TLC), the reaction was cooled to rt and Et2O (20 mL) was added followed by slow 
addition of 10% HCl (2 mL).  The layers are separated, and the aq. layer extracted 
with Et2O (2x).   The combined organic layers were rinsed with brine (1x), dried 
(anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  The mixture was 
pushed through a short plug of silica (3:1 Hex:EtOAc) to afford 3.44b (0.699 g, 91%) 
as a clear oil.   
[!]D
20
  =  + 3.0 (c  =  3.74, CH2Cl2);  
FTIR (neat) 3072, 2943, 1612, 1514, 1247, 1097, 1039 cm
-1
;  
1
H NMR (500 MHz, CDCl3) " ppm 7.26 (d, J  =  8.6 Hz, 2H), 6.88 (d, J  =  8.6 Hz, 
2H), 5.74-5.84 (m, 1H), 5.06 (dd, J  =  2.0, 1.1 Hz, 1H), 5.03 (dd, J  =  1.7, 1.3 Hz, 
1H), 4.69 (d, J  =  6.9 Hz, 1H), 4.65 (d, J  =  6.9, 1H), 4.44 (d, J  =  11.6 Hz, 1H), 
4.40 (d, J  =  11.6, 1H), 4.05-4.11 (m, 1H), 3.80 (s, 3H), 3.65-3.69 (m, 1H), 3.53-3.57 
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(m, 2H), 3.37 (s, 3H), 2.46-2.56 (m, 1H), 1.81-1.89 (m, 2H), 1.64 (ddd, J  =  14.1, 
6.9, 4.4 Hz, 1H), 1.56 (ddd, J  =  14.6, 7.0, 5.0 Hz, 1H), 1.04-1.07 (m, 24H);  
13
C NMR (125 MHz, CDCl3) ! ppm 159.0, 140.1, 130.7, 129.1, 114.9, 113.6, 96.5, 
79.5, 72.6, 68.0, 66.4, 55.6, 55.2, 41.2, 39.1, 37.7, 18.2, 14.4, 12.8;  
HRMS calculated for C28H50O5Si (M+Na)
+
 517.3325; found 517.3300 (FAB).  
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(2S,3S,5R)-7-(4-methoxybenzyloxy)-3-(methoxymethoxy)-2-methyl-5-
(triisopropylsilyloxy)heptanal: 3.45b 
PMBO H
TIPSO
Me
OP1
PMBO
TIPSO
Me
OP1
P1 = MOM
O
O3, Py., SUDAN III
1:1 MeOH:DCM
-78 ºC to rt
 
The olefin (0.450 g, 0.910 mmol) was taken up in CH2Cl2:MeOH 1:1 (15 mL) 
followed by the addition of pyridine (0.720 g, 9.10 mmol) and SUDAN III (indicator, 
~1 mg) at rt under argon.  The solution was cooled to -78 ºC, and a stream of O3 was 
lightly bubbled through the solution until a light yellow color persisted.  The stream 
of O3 was removed and the reaction was stirred until the SM was consumed 
(monitored by TLC).  The flask was flushed with Ar, and Me2S (3.3 mL) was slowly 
added.  The reaction was slowly warmed to over to rt over a 4 h period.  After stirring 
for 1 h. at rt, Et2O (40 mL) was added and extracted with sat’d CuSO4 (2x 10 mL), 
and brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated (rotary 
evaporator).  Flash chromatography (7:2:1 Hex:Et2O:EtOAc) afforded 3.45b (0.339 
g, 75 %) as an off-white oil. 
1
H NMR (500 MHz, CDCl3) ! ppm 9.71 (d, J  =  1.3 Hz, 1H), 7.23 (d, J  =  8.6 Hz, 
2H), 6.87 (d, J  =  8.6 Hz, 2H), 4.71 (d, J  =  7.0 Hz, 1H), 4.63 (d, J  =  7.0 Hz, 1H), 
4.43 (d, J  =  11.6 Hz, 1H), 4.38 (d, J  =  11.6, 1H), 4.09-4.15 (m, 2H), 3.79 (s, 3H), 
3.49 (t, J  =  6.6 Hz, 2H), 3.34 (s, 3H), 2.72-2.79 (m, 1H), 1.85-1.94 (m, 1H), 1.76-
1.84 (m, 2H), 1.47 (ddd, J  =  14.1, 7.7, 3.5 Hz, 1H), 1.11 (d, J  =  7.0, 3H), 1.03-1.07 
(m, 21H);  
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13
C NMR (125 MHz, CDCl3) ! ppm 203.3, 159.0, 130.5, 129.1, 113.6, 96.8, 76.3, 
72.6, 67.8, 66.2, 55.7, 55.1, 50.9, 40.3, 37.9, 18.1, 12.8, 9.2. 
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(R,E)-1-iodo-2-methylhept-1-en-4-ol: 3.47 
I
Me
Me
OH
Me
OHH Cp2ZrHCl, AlMe3
H2O; then I2
 
Cp2ZrHCl (3.93 g, 13.40 mmol) was taken up in CH2Cl2 (223 mL) followed by the 
addition of Me3Al (2.0 M solution in toluene, 41.5 mL, 83.02 mmol) at rt under 
argon.  The solution was cooled to 0 ºC, and H2O (0.482 mL, 26.78 mmol) was added 
over 10 min. After an additional 20 minutes of stirring, the alkyne (3.0 g, 26.78 
mmol) was cannulated in CH2Cl2 (14 mL) and the reaction warmed to rt and stirred 
for 12 h.  The reaction was cooled to -30 ºC, and quenched via cannulation of I2 (13.6 
g, 53.56 mmol) in THF (100 mL).  The reaction was warmed to rt and stirred for an 
additional 20 min., followed by the slow addition of sat’d K2CO3 (2 mL) and 30 
minutes of stirring (white salts form).  Anhydrous Na2SO4 is added and the reaction 
filtered through a pad of Celite, and concentrated (rotary evaporator).  Flash 
chromatography (4:1 Hex:EtOAc) afforded 3.47 (4.2 g, 61 %) as a light yellow oil.   
[!]D
20
  =  –13.6 (c 2.7, CH2Cl2);  
FTIR (neat) 3382, 3056, 2996, 1614, 1273 cm
-1
,  
1
H NMR (400 MHz, CDCl3) " 6.10 (s, 1H), 3.71-3.78 (m, 1H), 2.37 (dd, J  =  13.7, 
4.1 Hz, 1H), 2.30 (dd, J  =  13.7, 8.5 Hz, 1H), 1.88 (s, 3H), 1.55 (bs, 1H), 1.33-1.51 
(m, 4H), 0.94 (t, J  =  7.0, 3H);  
13
C NMR (100 MHz, CDCl3) " 145.1, 77.2, 68.7, 47.7, 39.1, 24.1, 18.8, 14.0. 
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(R,E)-1-iodo-4-(methoxymethoxy)-2-methylhept-1-ene: 3.48 
MOMCl, iPr2NEt
DCE, 50 ºC I
Me
Me
OMOM
I
Me
Me
OH
 
The alcohol (1.56 g, 6.2 mmol) was dissolved in DCE (31 mL) followed by the 
addition of iPr2NEt (8.0 g, 61.9 mmol) and MOMCl (2.49 g, 31.0 mmol) at rt under 
argon.  The flask was fitted with a reflux condenser under argon, and the reaction was 
heated to 50 ºC for 3-4 h.  Upon completion (monitored by TLC), the reaction was 
cooled to rt and Et2O (20 mL) was added followed by slow addition of 10% HCl (10 
mL).  The layers are separated, and the aq. layer extracted with Et2O (2x).   The 
combined organic layers were rinsed with brine (1x), dried (anhydrous Na2SO4), 
filtered, and concentrated (rotary evaporator).  The mixture was pushed through a 
short plug of silica (4:1 Hex:EtOAc) to 3.48 (1.76 g, 95%) as a clear oil.   
[!]D
20
  =  + 1.2 (c 12.8, CH2Cl2);  
FTIR (neat) 3058, 2956, 2931, 1377, 1274, 1149 cm
-1
;  
1
H NMR (400 MHz, CDCl3) " 5.97 (s, 1H), 4.63 (d, J  =  7.1 Hz, 1H), 4.59 (d, J  =  
7.1 Hz, 1H), 3.65-3.72 (m, 1H), 3.33 (s, 3H), 2.43 (dd, J  =  13.8, 7.3 Hz, 1H), 2.32 
(dd, J  =  13.7, 5.3 Hz, 1H), 1.85 (s, 3H), 1.26-1.49 (m, 4H), 0.92 (t, J  =  7.0 Hz, 3H),  
13
C NMR (100 MHz, CDCl3) " 144.9, 95.3, 77.1, 74.7, 55.6, 44.8, 36.7, 24.4, 18.5, 
14.1. 
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(2R,3R,7R,E)-2-((4S,6R)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-
dioxan-4-yl)-7-(methoxymethoxy)-5-methyldec-4-en-3-ol (syn-3.49a and anti-
3.49a) 
PMBO
O
Me
O OH Me OMOM
Me
Me Me
PMBO H
O
Me
O
Me Me
O
I
Me
Me
OMOM
vinylate
addition
+
PMBO
O
Me
O OH Me OMOM
Me
Me Me
1,3-syn
1,3-anti  
Procedure for vinyl lithiate addition:  To a solution of the vinyl iodide (0.036 mg, 
0.119 mmol) in Et2O (0.265 mL) at – 78 ºC was tBuLi (1.7 M in pentane, 0.140 mL, 
0.231 mmol), and the reaction was immediately warmed to 0 ºC for 25 min.  The 
reaction was recooled to - 78 ºC, and the aldehyde (0.020 g, 0.059 mmol) was slowly 
added via syringe in Et2O (0.180 mL, 20 mL rinse).  After 1 h, the reaction was 
quenched at - 78 ºC with NH4Cl (sat’d, aq), warmed to rt, and the layers separated.  
The aq. layer was extracted with Et2O (2x), and the combined organic layers washed 
with brine (1x), dried (anhydrous Na2SO4), and concentrated (rotary evaporator). 
Flash chromatography (3:1 Hex:EtOAc) afforded a 2:1 mixture of 1,3 anti:syn (ratio 
determined by 
1
H NMR analysis of crude reaction mixture, 21 mg, combine yield of 
diastereomers 68%).   
Procedure for vinyl Grignard addition: To a solution of the vinyl iodide (0.080 mg, 
0.269 mmol) in Et2O (0.331 mL) at - 78 ºC was added tBuLi (1.65 M in pentane, 
0.154 mL, 0.253 mmol), and the reaction (pale yellow color) stirred for 15 minutes.  
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A MgBr2•Et2O solution (0.3 M in THF, 0.993 mL, 0.298 mmol) was added and the 
reaction was warmed to 0 ºC and stirred for 15 minutes (white precipitates form).  
After 15 minutes, the aldehyde (0.050 mg, 0.149 mmol) is cannulated in Et2O (0.82 
mL, 0.100 mL rinse) and the reaction stirred at temperature for 3 h.  The reaction was 
quenched with 4 mL of NH4Cl (sat’d aq), and the layers separated.  The aq. layer was 
extracted with Et2O (2x), and the combined organic layers washed with brine (1x), 
dried (anhydrous Na2SO4), and concentrated (rotary evaporator).  Flash 
chromatography (3:1 Hex:EtOAc) afforded a 4:1 mixture of 1,3 anti:syn (ratio 
determined by 
1
H NMR analysis of crude reaction mixture, 54 mg, combine yield of 
diastereomers 73%).  
Procedure for vinyl magnesiate addition: To a solution of iPrMgCl (2.0 M in THF, 
0.316 mL, 0.600 mmol) at 0 ºC was added sBuLi (1.4 M in cyclohexane, 0.920 mL, 
1.20 mmol) and the reaction (light yellow color) stirred for 10 minutes.  The vinyl 
iodide (0.178 mg, 0.600 mmol) in THF (1.0 mL) was cannulated slowly, and the 
reaction stirred for 30 min at which point it was cooled - 78 ºC.  The aldehyde (0.100 
g, 0.300 mmol), which was stirred for 20 minutes with MgBr2•Et2O solution (0.3 M 
in THF, 2 mL, 0.60 mmol, light heating was used to insure the mixture remained 
homogenous), was then cannulated to the vinyl magnesiate and stirred for 2 h at - 78 
ºC. The reaction was quenched with 5 mL of NH4Cl (sat’d aq), and the layers 
separated.  The aqueous layer was extracted with Et2O (2x), and the combined 
organic layers washed with brine (1x), dried (anhydrous Na2SO4), and concentrated 
(rotary evaporator).  Flash chromatography (3:1 Hex:EtOAc) afforded a 8:1 mixture 
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of 1,3 anti:syn (ratio determined by 
1
H NMR analysis of crude reaction mixture, 103 
mg, combine yield of diastereomers 68%). 
[!]D
20
 = -4.0 , (c , 0.3 CH2Cl2);  
FTIR (neat)  3448, 2954, 1610, 1512, 1247, 1097 cm
-1
;  
1
H NMR (400 MHz, CDCl3) " ppm 7.25 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.5, 2H), 
5.34 (J = 8.9, 2H), 4.65 (d, J = 6.8 Hz, 1H), 4.60 (d, J = 6.9 Hz, 1H), 4.43-4.46 (m, 
1H), 4.41 (s, 2H), 3.98-4.03 (m, 1H), 3.84-3.89 (m, 1H), 3.82 (s, 3H), 3.69-3.75 (m, 
1H), 3.48-3.57 (m, 2H), 3.38 (s, 3H), 2.32 (dd, J = 13.7, 6.3 Hz, 1H), 2.17 (dd, J = 
13.7, 6.1 Hz, 1H), 1.81-1.86 (m, 1H), 1.74-1.81 (m, 1H), 1.72 (s, 3H), 1.56-1.71 (m, 
2H), 1.43-1.51 (m, 3H), 1.41 (s, 3H), 1.35-1.41 (m, 1H), 1.34 (s, 3H), 0.93-0.96 (m, 
3H), 0.83 (d, J = 7.0 Hz, 3H);  
13
C NMR (100 MHz, CDCl3) " ppm 159.2, 135.1, 130.5, 129.3, 127.9, 113.8, 100.7, 
95.4, 75.5, 72.8, 70.9, 70.1, 66.2, 63.8, 55.5, 55.3, 45.3, 44.1, 37.6, 36.7, 35.8, 24.7, 
24.5, 18.7, 17.2, 14.2, 11.8.  
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(5R,9R,10R,11S,13R,E)-15,15-diisopropyl-13-(2-(4-methoxybenzyloxy)ethyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-
en-9-ol (1,3-syn-3.49b and 1,3-anti-3.49b) 
vinylate
addition 1,3-syn
1,3-anti
PMBO H
TIPSO
Me
OP1 O
P1 = MOM
I
Me
Me
OMOM
PMBO
TIPSO
Me
OP1 OH Me OMOM
Me
+
PMBO
TIPSO
Me
OP1 OH OMOM
Me
 
Procedure for asymmetric zincate addition: The vinyl iodide (0.691 g, 2.32 mmol) 
was dissolved in Et2O (3.8 mL) and cooled to -78 ºC followed by the fast dropwise 
addition of tBuLi (1.7 M in pentane, 2.67 mL, 4.54 mmol).  The solution was stirred 
for 40 min. at -78 ºC, followed by the addition of ZnBr2 (0.87 M in Et2O, 2.87 mL, 
2.50 mmol) and transfer to a 0 ºC bath.  After 40 minutes, a solution of (1R,2S)-
LiNME [prepared from (R,S)-NME (0.416 g, 2.32 mmol) in 11.6 mL toluene at 0 ºC 
was added nBuLi (2.5 M in hexane, 0.928 mL, 2.32 mmol) and stirred for 20 
minutes] was slowly cannulated to the flask containing the zincate and stirred for 1 h 
at 0 ºC.  After 1 h, the aldehyde (0.460 g, 0.926 mmol) was cannulated as a solution 
in toluene (2.81 mL) and stirred for 1.5 h at 0 ºC.  The reaction was quenched with 20 
mL of NH4Cl (sat’d aq), and the layers separated.  The aqueous layer was extracted 
with Et2O (3x), and the combined organic layers washed with brine (1x), dried 
(anhydrous Na2SO4), and concentrated (rotary evaporator). Flash chromatography 
(2:1 Hex:EtOAc) afforded syn-3.49b as the major diastereomer (11:1 dr , 368 mg, 65 
%) as a clear oil.   
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[!]D
20
  =  +1.1, (c , 5.6 CH2Cl2);  
FTIR (neat)  3469, 3103, 2939, 1612, 1514, 1463, 1097, 1040 cm
-1
,  
1
H NMR (400 MHz, CDCl3) " ppm 7.25 (d, J  =  8.6 Hz, 2H), 6.87 (d, J  =  8.6, 2H), 
5.24 (J  =  8.6, 1H), 4.55-4.71 (m, 5H), 4.42 (s, 2H), 4.10-4.17 (m, 2H), 4.03-4.07 (m, 
1H), 3.81 (s, 3H), 3.67-3.74 (m, 1H), 3.54 (t, J  =  6.4, 2H), 3.37 (s, 3H), 3.36 (s, 3H), 
2.31 (dd, J  =  13.5, 6.0 Hz, 1H), 2.15 (dd, J  =  13.3, 7.3 Hz, 1H), 1.84-1.98 (m, 3H), 
1.69 (s, 3H), 1.64-1.73 (m, 2H), 1.31-1.51 (m, 4H), 1.01-1.18 (m, 21H), 0.87-0.94 (m, 
3H), 0.79 (d, J  =  6.9 Hz, 3H);  
13
C NMR (100 MHz, CDCl3) " ppm 159.1, 135.8, 130.7, 130.0, 129.2, 113.7, 96.6, 
95.4, 75.4, 72.6, 70.2, 68.6, 66.7, 55.7, 55.5, 55.2, 45.2, 43.1, 38.7, 38.1, 36.6, 18.4, 
18.3, 17.1, 14.2, 12.9, 10.9;  
HRMS calculated for C37H68O8 (M+Na)
+
 691.4581; found 691.4598 (FAB). 
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(5R,10S,11S,13R,E)-15,15-diisopropyl-13-(2-(4-methoxybenzyloxy)ethyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-
en-9-one: 3.50 
PMBO
TIPSO
Me
OP1 OH Me OMOM
Me
DMP, Py.
PMBO
TIPSO
Me
OP1 O Me OMOM
Me
 
The alcohol (0.050 g, 0.074 mmol) was taken up in DCM (2.5 mL) followed by the 
addition of pyridine (0.046 g, 0.590 mmol) and Dess-Martin periodinane (0.063 g, 
0.149 mmol) at rt under argon.  Upon completion (monitored by TLC), Et2O (15 mL) 
was added, and the solution extracted with NaHCO3 (sat’d aq., 2x).  The combined 
organic layers were rinsed with brine (1x), dried (anhydrous Na2SO4), filtered, and 
concentrated (rotary evaporator).  The mixture was pushed through a short plug of 
silica (1:1 Hex:EtOAc) to give 3.50 (0.049 g, 98%) as a clear oil.   
[!]D
20
 = +24.1 (c = 2.1, CH2Cl2);  
FTIR (neat) 1680, 1612, 1512, 1099, 1037 cm
-1
;  
1
H NMR (400 MHz, CDCl3) " ppm 7.24 (d, J = 8.5 Hz, 2H), 6.86 (d, J = 8.5 Hz, 
2H), 6.19 (s, 1H), 4.68 (d, J = 7.0 Hz, 1H), 4.66 (d, J = 7.0, 1H), 4.63 (s, 2H), 4.39 (d, 
J = 1.8 Hz, 2H), 4.02-4.13 (m, 2H), 3.80 (s, 3H), 3.72-3.79 (m, 1H), 3.46-3.53 (m, 
2H), 3.35 (s, 6H), 2.98 (dq, J = 6.9, 1.7 Hz, 1H), 2.39 (dd, J = 13.2, 6.4 Hz, 1H), 2.23 
(dd, J = 13.2, 6.4 Hz, 1H), 2.14 (s, 3H), 1.76-1.94 (m, 2H), 1.59-1.68 (m, 1H), 1.31-
1.49 (m, 4H), 0.97-1.10 (m, 24H), 0.92 (t, J = 6.9, 3H);  
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13
C NMR (100 MHz, CDCl3) ! ppm 201.6, 159.0, 156.0, 130.7, 129.2, 125.3, 113.7, 
97.0, 95.4, 75.4, 72.6, 67.8, 66.5, 55.8, 55.5, 55.2, 51.8, 46.9, 39.2, 38.1, 36.8, 19.9, 
18.5, 18.2, 14.1, 12.9, 10.4;  
HRMS calculated for C37H66O8 (M+Na)
+
 689.4425; found 689.4425 (FAB). 
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(5R,9R,10R,11S,13R,E)-15,15-diisopropyl-13-(2-(4-methoxybenzyloxy)ethyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-
en-9-ol: 3.49b 
PMBO
TIPSO
Me
OP1 OH Me OMOM
MePMBO
TIPSO
Me
OP1 O Me OMOM
Me
Reduction
 
Reduction with DIBAL-H: To a solution of the ketone (0.050 g, 0.0746 mmol) in 
toluene (0.746 mL) was slowly added DIBAL-H (1.0M in toluene, 0.149 mL) at -78 
ºC. After two hours of stirring at -78 ºC, the reaction was quenched with NH4Cl 
(sat’d, aq.), and the reaction warmed to rt while stirring.  The layers were separated, 
and the aq. layer extracted with Et2O (2x).   The combined organic layers were rinsed 
with brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated (rotary 
evaporator).  The mixture was pushed through a short plug of silica (2:1 Hex:EtOAc) 
to afford the title compound as a 5:1 mixture (determined by 
1
H NMR of crude 
reaction) of 1,3 anti:syn (0.040 g, 80%) as a clear oil. 
Reduction with LiAlH4/LiI: To a solution of the ketone (0.030 g, 0.045 mmol) in 
Et2O (0.563 mL) was added LiI (0.06 g, 0.45 mmol) at 0 ºC (solution turns reddish-
brown color).  Once the LiI is completely dissolved (< 5 min), the reaction was 
cooled to -78 ºC and a solution of LiAl4H (1.0 M in Et2O, 0.450 mL) was slowly 
added.  After twenty minutes, the reaction was quenched with sodium-potassium 
tartrate (sat’d, aq.), and the reaction warmed to rt while stirring.  The layers were 
separated, and the aq. layer extracted with Et2O (2x).   The combined organic layers 
were rinsed with brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated 
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(rotary evaporator).  The mixture was pushed through a short plug of silica (2:1 
Hex:EtOAc) to afford the title compound as a 4.3:1 mixture (determined by 
1
H NMR 
of crude reaction) of 1,3 syn:anti 3.49b (0.028 g, 90%) as a clear oil. 
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(3R,5S,6S,7R,11R,E)-5,7,11-tris(methoxymethoxy)-6,9-dimethyl-3-
(triisopropylsilyloxy)tetradec-8-en-1-ol: 3.52 
P1 = MOM
HO
TIPSO
Me
OP1 OP1 Me OMOM
MePMBO
TIPSO
Me
OP1 OH Me OMOM
Me 2. DDQ, pH 7 buffer
1. MOMCl, iPr2NEt
DCE, 50 ºC
 
The secondary alcohol (0.05 g, 0.074 mmol) was dissolved in DCE (300 mL) 
followed by the addition of iPr2NEt (0.096 g, 0.740 mmol) and MOMCl (0.030 g, 
0.372 mmol) at rt under argon.  The flask was fitted with a reflux condenser under 
argon, and the reaction was heated to 50 ºC for 3-4 h.  Upon completion (monitored 
by TLC), the reaction was cooled to rt and Et2O (2 mL) was added followed by slow 
addition of 10% HCl (1 mL).  The layers were separated, and the aq. layer extracted 
with Et2O (2x).   The combined organic layers were rinsed with brine (1x), dried 
(anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  The mixture was 
pushed through a short plug of silica (1:1 Hex:EtOAc) to the MOM-protected ether 
(0.044 g, 82%) as a clear oil.  The MOM- protected PMB ether (0.05 g, 0.070 mmol) 
was taken up in CH2Cl2 (1.4 mL) followed by the addition of pH buffer solution (0.07 
mL) and DDQ (0.032 g, 0.139 mmol) at rt.  Upon completion (~1 h, monitored by 
TLC), Et2O (2 mL) was added followed by NaHCO3 (sat’d aq, 1 mL).  The layers 
were separated, and the aq. layer extracted with Et2O (2x).   The combined organic 
layers were rinsed with brine (1x), dried (anhydrous Na2SO4), filtered, and 
concentrated (rotary evaporator).  Flash chromatography (2:1 Hex:EtOAc) afforded 
3.52 (0.038 g, 92%) as a clear oil.   
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[!]D
20
  =  –26.0 (c = 0.77, CH2Cl2);  
FTIR (neat) 3507, 2941, 2359, 2341, 1097, 1037 cm
-1
;  
1
H NMR (400 MHz, CDCl3) " ppm 5.02 (d, J  =  9.4, 1H), 4.61-4.68 (m, 6H), 4.38 
(d, J  = 6.5 Hz, 1H), 4.21-4.24 (m, 1H), 4.13 (dd, J  =  9.2, 9.1, 1H), 4.00-4.03 (m, 
1H), 3.85-3.90 (m, 1H), 3.75-3.81 (m, 1H), 3.68-3.73 (m, 1H), 3.39-3.51 (m, 9H),  
2.52 (bs, 1H), 2.34 (dd, J  =  13.3, 5.8 Hz, 1H), 2.17 (dd, J  =  13.3, 5.4 Hz, 1H), 2.05-
2.11 (m, 1H), 1.92-1.98 (m, 1H), 1.84-1.90 (m, 1H), 1.75-1.79 (m, 2H), 1.70 (d, J  =  
1.5 Hz, 3H), 1.42-1.48 (m, 3H), 1.33-1.37 (m, 1H), 1.07-1.10 (m, 21H), 0.90 (t, J  =  
6.9, 3H), 0.83 (d, J  =  8.1 Hz, 3H);  
13
C NMR (100 MHz, CDCl3) " ppm 138.1, 126.9, 96.7, 95.4, 93.2, 77.1, 75.5, 73.2, 
70.0, 59.6, 56.0, 55.7, 55.5, 45.1, 41.4, 39.1, 36.7, 36.5, 18.4, 18.2, 17.1, 14.1, 12.7, 
10.5;  
HRMS calculated for C31H64O8Si (M+Na)
+
 615.4268; found 615.4222 (FAB). 
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(5R,9R,10S,11S,13R,E)-15,15-diisopropyl-9,11-bis(methoxymethoxy)-7,10,16-
trimethyl-13-(pent-4-enyl)-5-propyl-2,4,14-trioxa-15-silaheptadec-7-ene: 3.54 
P1 = MOM
TIPSO
Me
OP1 OP1 Me OMOM
MeHO
TIPSO
Me
OP1 OP1 Me OMOM
Me 2. AllylMgBr, CuI
1. TsCl 1:1
Py:DCM
 
The primary alcohol (0.045 g, 0.076 mmol) was taken up in CH2Cl2 (0.365 mL) and 
pyridine (0.365 mL), and TsCl was added (0.029 g, 0.152 mmol).  The reaction was 
stirred until starting material was no longer being consumed (monitored by TLC). 
The reaction was quenched (aq NH4Cl), the layers separated, and the aq. layer 
extracted with Et2O (2x).   The combined organic layers were rinsed with brine (1x), 
dried (anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  The 
mixture was pushed through a short plug of silica (3:1 Hex:EtOAc) to afford the 
tosylate (0.030 g, 53 %) as a clear oil, which was immediately used.  The tosylate 
(0.030 g, 0.025 mmol) was taken up in THF (0.500 mL) and CuI (0.013 g, 0.06 
mmol) was added.  The solution was cooled to – 50 ºC and allylMgBr (1.0 M in Et2O, 
0.240 mL) was added.  The reaction was warmed to rt and stirred for 3 h, at which 
time it was quenched with NH4Cl (sat’d, aq), layers separated, and the aqueous layer 
extracted with Et2O (2 x). The combined organic layers were rinsed with brine (1x), 
dried (anhydrous Na2SO4), filtered, and concentrated (rotary evaporator). Flash 
chromatography (2:1 Hex:EtOAc) afforded 3.54 (0.024 g, 80%, ~1:1 ratio with SM) 
as a clear oil.   
[!]D
20
  =   – 18.4  (c  =  0.3, CH2Cl2);  
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FTIR (neat) 3082, 2939, 2866, 1464, 1151, 1097, 1040 cm
-1
;   
1
H NMR (400 MHz, CDCl3) ! ppm 5.76-5.8 (m, 1H), 4.98-5.04 (m, 2H), 4.93-4.97 
(m, 1H), 4.73 (d, J  =  6.7 Hz, 1H), 4.64-4.69 (m, 3H), 4.62 (d, J  =  6.8 Hz, 1H), 4.38 
(d, J  =  6.7 Hz, 1H), 4.15-4.19 (m, 1H), 4.12 (dd, J  =  9.4, 9.3 Hz, 1H), 4.02-4.07 
(m, 1H), 3.68-3.73 (m, 1H), 3.38 (s, 3H), 3.37 (s, 3H), 3.36 (s, 3H), 2.35 (dd, J  =  
13.4, 5.6 Hz, 1H), 2.17 (dd, J  =  13.3, 7.3 Hz, 1H), 2.12-2.17 (m, 1H), 2.03-2.08 (m, 
2H), 1.71 (d, J  =  0.90 Hz, 3H), 1.42-1.65 (m, 14H), 1.04-1.09 (m, 21H), 0.88-1.92 
(m, 3H), 0.82 (d, J  =  7.0 Hz, 3H),  
13
C NMR (125 MHz, CDCl3) ! ppm 139.1, 138.3, 127.4, 114.7, 97.8, 95.7, 93.1, 
77.3, 75.8, 73.1, 69.9, 56.2, 56.0, 55.8, 45.3, 41.9, 38.4, 36.8, 36.5, 34.3, 24.4, 18.7, 
18.6, 18.5, 17.4, 14.4, 13.2, 10.6.  
HRMS calculated for C34H68O8Si (M+Na)
+
 639.4632; found 639.4641 (FAB). 
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Partially Hydrogenated PMB-Protected derived Bicyclic Phosphate: 3.56 
PMBO
1. H-G 2nd Gen.
DCE, 90 ºC
2. Et3N, DCM
o-NO2C6H4SO2NHNH2
O
P
O
O
O
O
P
O
O
O
OPMB
 
The bicyclic phosphate (1.36 g, 6.67 mmol) was taken up in DCE (degassed 10 min. 
with Ar, 133.4 mL) followed by the addition of the PMB-ether protected terminal 
olefin (1.92 g, 10.0 mmol), and Hoveyda-Grubbs 2
nd
 generation catalyst (0.208, 0.333 
mmol) under argon at rt. The flask was fitted with a reflux condenser under argon, 
and lowered into a preheated 90 ºC bath for 2 h.  Upon completion (monitored by 
31
P 
NMR analysis of aliquots of the reaction), the reaction was concentrated (rotary 
evaporator).  Flash chromatography (1:2 Hex:EtOAc) afforded the cross-metathesis 
product (2.01 g, 82%, >20:1 E:Z) as a light brown oil.  The cross-metathesized 
phosphate intermediate (1.5 g, 4.10 mmol) was taken up in CH2Cl2 (82 mL) followed 
by the addition of Et3N (18 mL, ~2 mL per gram of NBS-H), and NBS-H (8.90 g, 
41.0 mmol).  After the reaction was stirred for 12 h, EtOAc (150 mL) was added, and 
the reaction extracted with NaHCO3 (sat’d aq, 2x).  The aq layer was reextracted with 
EtOAc (1x).  The combined organic layers were dried (anhydrous Na2SO4) and 
concentrated.  Flash chromatography (1:2 Hex:EtOAc) afforded 3.56 (1.13 g, 75%) as 
a clear oil and 300 mg of starting material.   
[!]D
20
  =   +50.3 (c  =  5.4, CH2Cl2);  
FTIR (neat) 2936, 1612, 1512, 1300, 1247, cm
-1
;  
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1
H NMR (500 MHz, CDCl3) ! ppm 7.28, (d, J  =  8.6, 2H), 6.98 (d, J  =  8.7, 2H), 
6.03 (dddd, J  =  11.9, 6.7, 3.0, 2.1 Hz, 1H), 5.59 (ddd, 11.8, 3.8, 2.5 Hz, 1H), 5.18 (d, 
J  =  24.3 Hz, 1H), 4.98-5.05 (m, 1H), 4.55-4.61 (m, 1H), 4.45 (s, 2H), 4.37 (ddd, J  =  
27.6, 14.7, 6.7 Hz, 1H), 3.82 (s, 3H), 3.45 (t, J  =  6.5 Hz, 2H), 2.18 (ddd, J  =  14.6, 
11.9, 6.3 Hz, 1H), 1.68-1.81 (m, 2H), 1.35-1.80 (m, 7H);  
13
C NMR (125 MHz, CDCl3) ! ppm 158.9, 130.5, 129.7, 129.0, 127.7, 113.5, 77.13 
(d, JCP  =  6.6 Hz), 76.6 (d, JCP  =  6.7 Hz), 72.3, 69.6, 62.7 (d, JCP  =  6.4 Hz), 55.1, 
35.4 (d, JCP  =  9.4 Hz), 34.6 (d, JCP  =  5.9 Hz), 29.3, 25.6, 24.2;  
31
P NMR (162 MHz, CDCl3) ! -2.96;  
HRMS calculated for C19H27O6P (M+Na)
+
 405.1443; found 405.1427 (FAB).   
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(5S,7R)-5-((R)-but-3-en-2-yl)-9,9-diisopropyl-7-(5-(4-methoxybenzyloxy)pentyl)-
10-methyl-2,4,8-trioxa-9-silaundecane: 3.60 
OH
Me
OH
O
P
O
O
O
OPMB
1. TIPSCl, Im.
DMAP, DCM
2. MOMCl, iPr2NEt
DCE, 50 ºC
1.i. CuCN•2LiCl
Me2Zn ii.  TMSCHN2
MeOH
2. LiAlH4, Ether
0 ºC
OPMB
TIPSO
Me
OMOM
OPMB
 
Following cuprate addition protocol, CuCN (2.11 g, 23.56 mmol) and LiCl (2.0 g, 
47.12 mmol) were stirred in THF (24 mL) for 20 min at rt, then cooled to -30 ºC.  A 
solution of Me2Zn (1.2 M in toluene, 19.6 mL, 23.6 mmol) was added (stirred for 30 
minutes), followed by phosphate addition (2.08 g, 5.62 mmol) in THF (6 mL, 0.4 mL 
rinse), and the solution immediately removed from the bath and stirred at rt for 2 h.  
Reaction workup, methylation, and flash chromatography (1:1 Hex:EtOAc) provided 
the monocyclic phosphate (2.05 g, 91 % yield) as a clear oil, and as a ~1:1 mixture of 
diastereomers at phosphorus.  Following phosphate cleavage protocol, to the 1:1 
diastereomeric phosphates (2.05 g, 5.13 mmol) in Et2O (86 mL) was added LiAlH4 
(0.486 g, 12.8 mmol) at 0 ºC. Reaction workup and flash chromatography (1:1 
Hex:EtOAc) provided the diol (1.59 g, 92% yield) as a clear oil.  Following 
monosilylation protocol, the diol (1.39 g, 4.13 mmol) in CH2Cl2 (28 mL) was added 
imidazole (1.69 g, 24.8 mmol) and DMAP (50 mg, 0.413 mmol), followed by TIPSCl 
(2.39 g, 12.4 mmol). Reaction workup and flash chromatography (9:1 Hex:Et2O, then 
5:1 Hex:EtOAc) provided monosilylated product (1.36 g, 80%) as a clear oil.  
Following MOM protection protocol, to the secondary alcohol (0.830g, 1.68 mmol) 
in DCE (4.2 mL) and Et2iPrN (2.17 g, 16.8 mmol) was added MOMCl (0.678 g, 8.42 
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mmol). After heating at 50 ºC for 3-4 h, reaction workup and flash chromatography 
(2:1 Hex:EtOAc) provided 3.60 (0.860 mg, 95%) as a clear oil.   
[!]D
20
  =   – 4.2  (c  =  3.3, CH2Cl2);  
FTIR (neat) 3072, 2939, 1514, 1464, 1245, 1097, 1040 cm
-1
;  
1
H NMR (500 MHz, CDCl3) " ppm 7.26 (d, J  =  8.6 Hz, 2H), 6.90 (d, J  =  8.6 Hz, 
2H), 5.77-5.86 (m, 1H), 5.09 (dd, J  =  4.1, 1.4 Hz, 1H), 5.05 (d, J  =  1.1 Hz, 1H), 
4.71 (d, J  =  6.8 Hz, 1H), 4.68 (d, J  =  6.8, 1H), 4.45 (s, 2H), 3.92-3.99 (m, 1H), 3.82 
(s, 3H), 3.68-3.73 (m, 1H), 3.49 (t, J  =  6.5 Hz, 2H), 3.39 (s, 3H), 2.51-2.57 (m, 1H), 
1.34-1.64 (m, 10H), 1.02-1.16 (m, 24H);  
13
C NMR (125 MHz, CDCl3) " ppm 159.1, 140.2, 130.7, 129.1, 114.8, 113.7, 96.7, 
79.7, 72.5, 70.1, 70.1, 55.6, 55.1, 41.4, 38.5, 37.9, 29.7, 26.5, 24.5, 18.2, 18.2, 14.3, 
12.9;  
HRMS calculated for C31H56O5Si (M+Na)
+
 559.3795; found 559.3749 (FAB). 
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(5R,9R,10S,11S,13R,E)-15,15-diisopropyl-13-(5-(4-methoxybenzyloxy)pentyl)-9-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-
en-11-ol: 3.62 
I
Me
Me
OMOM
TIPSO
Me
OP1 O
PMBO
P1 = MOM
TIPSO
Me
OP1 OH Me
nPr
OP1
H
PMBO
H
tBuLi, - 78 ºC
+
 
To a solution of vinyl iodide (0.140 mg, 0.469 mmol) in Et2O (1.42 mL) at -78 ºC 
was added tBuLi (1.7 M in pentane, 0.529 mL, 0.901 mmol), and the reaction was 
immediately warmed to 0 ºC for 25 min.  The reaction was recooled to -78 ºC, and the 
aldehyde (0.101 g, 0.188 mmol) was slowly added via syringe in Et2O (0.312 mL, 30 
mL rinse).  After 1 h, the reaction was quenched at -78 ºC with NH4Cl (sat’d, aq), 
warmed to rt, and the layers separated.  The aqueous layer was extracted with Et2O 
(2x), and the combined organic layers washed with brine (1x), dried (anhydrous 
Na2SO4), and concentrated (rotary evaporator). Flash chromatography (3:1 
Hex:EtOAc) afforded a 1:1 mixture of 3.62 (ratio determined by 
1
H NMR analysis of 
crude reaction mixture, 94 mg, combine yield of diastereomers 70 %).  Separation of 
diastereomers was achieved using a Horizon Biotage flash chromatography system 
(Biotage Si 12M column, 5-10 % EtOAc gradient in hexanes).  Compound data for 
1,3-syn 3.62.   
1
H NMR (400 MHz, CDCl3) ! ppm 7.26 (d, J  =  8.5 Hz, 2H), 6.88 (d, J  =  8.6, 2H), 
5.28 (J  =  8.7, 2H), 4.63-4.73 (m, 4H), 4.43 (s, 2H), 4.18 (dd, J  =  9.2, 9.0 Hz, 1H), 
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4.05-4.10 (m, 1H), 3.98-4.03 (m, 1H), 3.85 (s, 3H), 3.70-3.75 (m, 1H), 3.45 (t, J  =  
6.5, 2H), 3.35-3.43 (m, 6H), 2.34 (dd, J  =  13.2, 5.8 Hz, 1H), 2.19 (dd, J  =  13.3, 7.4 
Hz, 1H), 1.73 (s, 3H), 1.31-1.69 (m, 14 H), 1.04-1.12 (m, 21 H), 0.89-0.98 (m, 3H), 
0.80 (d, J  =  6.9 Hz, 3H);  
13
C NMR (125 MHz, CDCl3) ! ppm 159.1, 135.8, 130.7, 129.9, 129.2, 113.7, 96.7, 
95.4, 77.8, 75.4, 72.5, 70.6, 70.3, 70.1, 55.7, 55.5, 45.2, 43.1, 38.3, 38.3, 36.6, 29.8, 
26.6, 24.9, 18.4, 17.1, 14.1, 13.0, 12.9, 10.9;  
HRMS calculated for C40H74O8Si (M+Na)
+
 733.5051; found 733.5031 (FAB). 
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(5R,10S,11S,13R,E)-15,15-diisopropyl-13-(5-(4-methoxybenzyloxy)pentyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-
en-9-one: SI2 
P1 = MOM
TIPSO
Me
OP1 OH Me
nPr
OP1
H
PMBO
DMP, Pyr.
P1 = MOM
TIPSO
Me
OP1 O Me
nPr
OP1
H
PMBO
 
To a solution of allylic alcohol (0.057 mg, 0.080 mmol) in CH2Cl2 (2.7 mL) at rt was 
added pyridine (53 µL, 0.656 mmol) followed by DMP (0.075 mg, 0.176 mmol).  The 
reaction was allowed to stir until the disappearance of starting material (via TLC, 
~1h).  The reaction was then diluted with Et2O and washed with NaHCO3 (2X) and 
the layers separated.  The aq. layer was extracted with Et2O (2x), and the combined 
organic layers washed with brine (1x), dried (anhydrous Na2SO4), and concentrated 
(rotary evaporator). Flash chromatography (5:1 Hex:EtOAc) afforded 51 mg of the 
desired ketone in 90% yield as a clear oil.   
1
H NMR (400 MHz, CDCl3) ! ppm 7.27 (d, J  =  8.4 Hz, 2H), 6.89 (d, J  =  8.6, 2H), 
6.21 (s, 1H), 4.70 (q, J  =  12.2, 6.9 Hz, 2H), 4.64 (s, 2H), 4.44 (s, 2H), 4.06-4.12 (m, 
1H), 3.92-4.00 (m, 1H), 3.82 (s, 3H), 3.74-3.80 (m, 1H), 3.45 (t, J  =  6.6, 2H), 3.37 
(d, J  =  2.3, 6H), 2.96-3.05 (m, 1H), 2.42 (dd, J  =  13.4, 6.4 Hz, 1H), 2.25 (dd, J  =  
15.3, 8.6 Hz, 1H), 2.15 (s, 3H), 1.31-1.69 (m, 14 H), 1.09 (d, J  =  6.9 Hz, 3H), 1.04-
1.09 (m, 21 H), 0.89-0.98 (m, 3H);  
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13
C NMR (125 MHz, CDCl3) ! ppm 201.7, 159.1, 156.0, 130.7, 129.2, 125.4, 113.7, 
97.2, 95.4, 77.3, 75.4, 72.5, 70.1, 69.8, 60.4, 55.8, 55.6, 55.2, 52.0, 46.9, 38.7, 38.3, 
36.7, 29.8, 26.6, 24.8, 19.9, 18.5, 18.3, 18.3, 14.2, 14.1, 13.0;
 
HRMS calculated for C40H72O8Si (M+NH4)
+
 726.5340; found 726.5358 (FAB). 
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(5R,9R,10S,11S,13R,E)-15,15-diisopropyl-9,11-bis(methoxymethoxy)-7,10,16-
trimethyl-13-(pent-4-enyl)-5-propyl-2,4,14-trioxa-15-silaheptadec-7-ene: 3.54 
PMBO
TIPSO
Me
OP1 OR Me
nPr
OP1
H
1. DDQ, pH7 buffer
5
TIPSO
Me
OP1 OP1 Me
nPr
OP1
H
R = H
R = P1 = MOM
MOMCl, iPr2NEt
DCE, 50 ºC
2. Im, Ph3P, I2 DCM, 0 ºC
3. tBuOK, THF, rt
 
Reduction with LiAlH4/LiI: To a solution of the ketone (0.030 g, 0.045 mmol) in 
Et2O (0.563 mL) was added LiI (0.06 g, 0.45 mmol) at 0 ºC (solution turns reddish-
brown color).  Once the LiI is completely dissolved (< 5 min), the reaction was 
cooled to -78 ºC and a solution of LiAl4H (1.0 M in Et2O, 0.450 mL) was slowly 
added.  After twenty minutes, the reaction was quenched with sodium-potassium 
tartrate (sat’d, aq.), and the reaction warmed to rt while stirring.  The layers were 
separated, and the aq. layer extracted with Et2O (2x).   The combined organic layers 
were rinsed with brine (1x), dried (anhydrous Na2SO4), filtered, and concentrated 
(rotary evaporator).  The mixture was pushed through a short plug of silica (2:1 
Hex:EtOAc) to afford the title compound as a 4.5:1 mixture (determined by 
1
H NMR 
of crude reaction) of alcohol (0.028 g, 90%) as a clear oil.  Following the same 
procedure for MOM protection, the alcohol (0.032 g, 0.045 mmol) was dissolved in 
DCE (0.225 mL) followed by the addition of iPr2NEt (0.061 g, 0.468 mmol) and 
MOMCl (0.019 g, 0.234 mmol) at rt under argon. Reaction workup and flash 
chromatography (4:1 Hex:EtOAc) afforded the MOM-protected ether (0.031 g, 95%).  
Following the same procedure of PMB removal, tri-MOM protected PMB ether 
(0.031 g, 0.041 mmol) was taken up in CH2Cl2 (0.820 mL) followed by the addition 
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of pH 7 phosphate buffer solution (0.043 mL) and DDQ (0.019 g, 0.082 mmol) at rt.  
Reaction workup and flash chromatography (2:1 Hex:EtOAc) afforded the primary 
alcohol (0.024 g, 92%) as a clear oil.  The primary alcohol was taken up in CH2Cl2 
(0.139 mL), followed by the addition of imidazole (0.003 mg, 0.0417 mmol), Ph3P 
(0.011 mg, 0.042 mmol).  The reaction was cooled to 0 
o
C and I2 (0.007 mg, 0.0278 
mmol) was added.  Upon completion (reaction monitored by TLC, ~30 minutes), the 
reaction was concentrated and subjected to flash chromatography (3:1 Hex:EtOAc) to 
afford the primary iodide (8.8 mg, 84 %).  The iodide was subsequently taken up in 
THF (0.140 mL) and a solution of tBuOK (1.0 M in THF, 0.018 mL) at rt.  Upon 
completion (reaction monitored by TLC, ~30 min.), the reaction was concentrated 
and subjected to flash chromatography (3:1 Hex:EtOAc) to afford 3.54 (0.007 mg, 
94%).    
[!]D
20
 = – 18.4  (c = 0.3, CH2Cl2);  
FTIR (neat) 3082, 2939, 2866, 1464, 1151, 1097, 1040 cm
-1
;   
1
H NMR (400 MHz, CDCl3) " ppm 5.76-5.8 (m, 1H), 4.98-5.04 (m, 2H), 4.93-4.97 
(m, 1H), 4.73 (d, J  =  6.7 Hz, 1H), 4.64-4.69 (m, 3H), 4.62 (d, J  =  6.8 Hz, 1H), 4.38 
(d, J  =  6.7 Hz, 1H), 4.15-4.19 (m, 1H), 4.12 (dd, J  =  9.4, 9.3 Hz, 1H), 4.02-4.07 
(m, 1H), 3.68-3.73 (m, 1H), 3.38 (s, 3H), 3.37 (s, 3H), 3.36 (s, 3H), 2.35 (dd, J  =  
13.4, 5.6 Hz, 1H), 2.17 (dd, J  =  13.3, 7.3 Hz, 1H), 2.12-2.17 (m, 1H), 2.03-2.08 (m, 
2H), 1.71 (d, J  =  0.90 Hz, 3H), 1.42-1.65 (m, 14H), 1.04-1.09 (m, 21H), 0.88-1.92 
(m, 3H), 0.82 (d, J  =  7.0 Hz, 3H),  
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13
C NMR (125 MHz, CDCl3) ! ppm 139.1, 138.3, 127.4, 114.7, 97.8, 95.7, 93.1, 
77.3, 75.8, 73.1, 69.9, 56.2, 56.0, 55.8, 45.3, 41.9, 38.4, 36.8, 36.5, 34.3, 24.4, 18.7, 
18.6, 18.5, 17.4, 14.4, 13.2, 10.6.  
HRMS calculated for C34H68O8Si (M+Na)
+
 639.4632; found 639.4641 (FAB). 
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Stereochemical Analysis of the C23 Carbinol Position. 
The stereochemical assignment for the C23 carbinol center was based on vicinal 
1
H 
coupling constant analysis of 1,3-syn and 1,3-anti isomers SI3 and SI4 respectively, 
with the structurally similar C15-C30 fragment reported by Leighton and coworkers 
(SI5, Figure SI-1).  Key markers include the C22 methyl substituent, C23 proton, and 
C24 vinylic proton.  Proton-proton interactions and coupling patterns were confirmed 
by 2D-COSY analysis.  Good correlation was found between syn- SI3 and Leighton’s 
SI5, with both C22-Me and C24-H chemical shifts being in close agreement.  Most 
notably however are the identical shifts (4.26 to 4.27 ppm) and coupling constants  
(8.7 to 8.6 Hz) for the C23-H of SI3 and SI5.  
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Figure SI-2: C23 stereochemical assignment. 
 These coupling constants are in accord with the analysis of Weldman, Boger, 
and others, who have proposed both rigid twisted-boat (not shown) and chair 
confirmation H-bonding models (SI6) to elucidate the C10-C11 relative 
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stereochemistry in cytostatin (Figure SI-2).
1
 SI6 shows that the largely anti-periplanar 
relationship between H10 and H11 results in larger coupling constants of 8-10 Hz.  
Analogously, fragment SI6 similarly could be imagined as existing in a chair 
conformation (SI7) favoring the all-equatorial arrangement of C21-R, C22-Me, and 
C23-vinyl groups.  The preferred conformation of the C23-vinyl group would further 
explain the identical coupling constants observed between the H23-H22 and H23-H24 
protons of SI3. 
O
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Figure SI-2: H-Bonding Chair Model 
While the coupling constant of the syn-relation of C23-H could not be 
extrapolated from SI8, TIPS protection (84 %) cleanly afforded an autonomous C23-
H signal for 
1
H analysis.  The silylated C23 carbinol position with 1,3-anti 3.44 has 
an 8.6 Hz coupling with the adjacent vinylic proton, and an anticipated smaller 
coupling of 2.2 Hz with the syn-C22 proton.  This correlates well with Leighton and 
coworkers reported TBS protected 1,3-syn SI9, in which the C22-H had the same 
chemical shift as the C22-H of 3.21 (4.81 ppm), but with a larger 5.0 Hz coupling 
constant with the adjacent C22 proton.   
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Scheme SI-1:  
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Finally, removal of the ketal, followed by acetonide formation provided a 
mixture of starting material and regioisomeric acetonide SI11 (Scheme SI-2).  In 
accordance with Rychnovsky-Evans acetonide analysis,
 2
 
13
C analysis of the 1,3-anti 
isomer SI11 contained acetonide peaks at 25.44 ppm and 24.10 ppm, indicative of the 
newly formed 1,3-anti acetonide.  The difference in chemical shifts of 25.44 ppm and 
24.10 ppm (D  =  1.34 ppm) for SI10 compared with that of 24.67 ppm and 24.54 
ppm (D = 0.33 ppm) for 3.46 is consistent with previous reports for larger methyl 
acetonide shifts with 1,3-anti acetonides for polyketide fragments, in which a methyl 
group is contained within the acetonide ring. 
Scheme SI-2 
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Stereochemical Analysis of the C11 Carbinol Position. 
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Finally, isolation of the major diastereomer of the reduction, followed by 
acetonide formation provided a mixture of 3.37 and regioisomeric acetonide (Scheme 
SI-1).  In accordance with Rychnovsky-Evans acetonide analysis,
2 13
C analysis of the 
SI12 contained acetonide peaks at 30.24 ppm, 19.68 ppm, and 98.68, indicative of the 
newly formed 1,3-syn acetonide.   
Scheme SI-3 
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 187 
(4S,6R)-4-((R)-but-3-en-2-yl)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-
1,3-dioxane: 3.65 
PMBO
O O
Me
MeMe
PMBO
OH OH
Me
2,2-DMP, PPTS
CH2Cl2
 
Diol 3.59 (391 mg, 1.09 mmol) was taken up in CH2Cl2 (4 mL) at room temperature.  
2,2-Dimethoxypropane (4 mL) and pyridinium ptoluenesulfonate (28 mg, 0.10 mmol) 
were added respectively and clear solution was stirred until completion.  Reaction 
was quenched with NaHCO3 and diluted with Et2O.  Aqueous layer was extracted 
three times with Et2O (5 mL portions) and organics were washed once with brine (5 
mL).  The collected organic layer was dried with Na2SO4 and concentrated in vacuo. 
3.65 was isolated using flash chromatography (19:1, Hexanes:Ethyl Acetate) as a 
clear oil in 98% yield (408 mg, 1.08 mmol).  
[!]D -36.3 (c = 0.4, CH2Cl2);  
FTIR (neat) 2983, 2935, 2856, 1612, 1512, 819 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.25 (d, J =8.4, 2H), 6.87 (d, J =8.6, 2H), 5.83 
(ddd, J =17.4, 10.5, 7.3, 1H), 5.03 (ddd, J =17.5, 11.0, 2.6, 2H), 4.43 (s, 2H), 3.80 (s, 
3H), 3.66-3.74 (m, 1H), 3.63 (ddd, J =9.7, 6.3, 1H), 3.45 (t, J =6.6, 2H), 2.18-2.26 
(m, 1H), 1.64-1.71 (m, 1H), 1.53-1.63 (m, 2H), 1.55-1.35 (m, 7H), 1.32 (s, 6H), 1.30-
1.24 (m, 2H), 0.98 (d, J =6.9, 3H);  
13
C NMR (CDCl3, 500 MHz) " ppm 159.1, 140.9, 130.7, 129.3, 114.4, 113.7, 100.3, 
72.5, 70.1, 70.0, 66.8, 55.3, 42.1, 36.3, 35.9, 29.7, 26.2, 25.3, 24.7, 24.4, 15.3.   
HRMS calculated for C23H36O4 (M+Na) 319.0198; found 320.1426 (ESI). 
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(R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-
yl)propan-1-ol: 3.66 
1. OsO4, NMO
then NaIO4
2. NaBH4, EtOH
PMBO
O O
Me
MeMe
PMBO
O O
Me
OH
MeMe
 
Olefin was taken up in tBuOH:THF:H2O (10:2:1, 3.5 mL) at room temperature. N-
methyl morpholine oxide (112 mg, 0.96 mmol) and OsO4 (0.19 mL, 0.03 mmol,  4% 
aq. in H2O) and stirred for approximately 12 h until olefin was completely consumed. 
The mixture was then diluted with phosphate buffer pH 7 (2x’s the volume of 
tBuOH) and sodium periodinate was added (911 mg, 4.26 mmol).  The reaction was 
stirred vigorously for approximately 2 h when diol was completely consumed. The 
milky white solution was partitioned with 1:1 Et2O:H2O and aqueous layer was 
extracted three times with Et2O (5 mL portions). Collected organics were washed 
once with brine (5 mL portion) was then dried with Na2SO4. After concentrating in 
vacuo, product was isolated using flash chromatography (5:1, Hexanes:Ethyl 
Acetate). The title compound was a gold oil.  
The resultant aldehyde was taken up in ethanol (3.5 mL) and cooled to 0 °C. 
Sodium borohydride (65 mg, 1.71 mmol) was added and the reaction was slowly 
brought back to room temperature. Upon completion (~45 min), the solution was 
partitioned with 2:1, Et2O:H2O. The aqueous layer was extracted three times with 
Et2O (5 mL portions) and collected organics were washed once with brine (5 mL). 
After drying the organics with MgSO4, 3.66 (290 mg, 0.77 mmol) was isolated using 
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flash chromatography (1:2, Hexanes:Ethyl Acetate) as clear oil in 81% yield over two 
steps. 
[!]D -0.26 (c 0.18, CH2Cl2);  
FTIR (neat 3442, 2933, 2856, 1612, 1512, 819 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.25 (d, J = 8.5, 2H), 6.87 (d, J = 8.6, 2H), 4.43 
(s, 2H), 3.81 (s, 3H), 3.79-3.73 (m, 1H), 3.68 (ddd, J = 9.2, 6.3, 1H), 3.58 (d, J = 5.1, 
2H), 3.43 (t, J = 6.6, 2H), 3.08 (s, 1H), 1.80-1.20 (m, 11H), 1.38 (s, 3H), 1.33 (s, 3H), 
0.82 (d, J = 7.0, 3H);  
13
C NMR (CDCl3, 500 MHz) " ppm 159.1, 130.8, 129.2, 113.7, 100.5, 73.1, 72.5, 
70.1, 68.3, 66.6, 55.3, 40.6, 37.9, 35.8, 29.7, 26.2, 25.2, 24.6, 24.6, 12.7.   
HRMS calculated for C22H36O5 (M+Na) 403.2460; found 403.2413 (ESI). 
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tert-butyl((R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-
dioxan-4-yl)propoxy)dimethylsilane: SI13 
PMBO
O O
Me
OH
MeMe
PMBO
O O
Me
OTBS
MeMe
TBSCl, Imidazole
DMAP, CH2Cl2
 
Alcohol 3.66 ( 290 mg, 0.77 mmol) was taken up in CH2Cl2 (5.1 mL) at room 
temperature.  Imidazole (79 mg, 1.16 mmol), DMAP (10 mg, 0.08 mmol) and TBSCl 
(138 mg, 0.92 mmol) were added respectively and reaction was run until completion 
(about 90 min). Reaction was quenched with NH4Cl and diluted with Et2O. Aqueous 
layer was extracted Et2O three times (5 mL) and organics were washed once with 
brine (5 mL). Collected organics were dried with Na2SO4 and concentrated in vacuo. 
SI13 was isolated using flash chromatography (20:1, hexanes:ethyl acetate) as a gold 
colored oil in 95% yield (358 mg, 0.72 mmol).  
[!]D -16.6 (c 0.35, CH2Cl2);  
FTIR neat 2933, 2856, 2881, 1247, 835 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.26 (d, J = 8.4, 2H), 6.88 (d, J = 8.6, 2H), 4.24 
(s, 2H), 3.80 (s, 3H), 3.66-3.74 (m, 2H), 3.56 (d, J = 4.4, 2H), 3.44 (t, J = 6.6, 2H), 
1.37-1.67 (m, 11H), 1.31 (s, 6H), 0.89 (s, 9H), 0.85 (d, J = 6.8, 3H), 0.02 (s, 6H);  
13
C NMR (CDCl3, 500 MHz) " ppm 159.0, 130.7, 129.2, 113.7, 100.1, 72.5, 70.1, 
67.0, 66.8, 64.1, 55.2, 40.5, 36.6, 35.9, 29.7, 26.1, 25.9, 25.3, 24.6, 24.5, 18.2, 12.2, -
5.5, -5.5.   
HRMS calculated for C28H50O5Si (M+Na) 517.3325; found 517.3334 (ESI). 
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5-((4R,6S)-6-((R)-1-(tert-butyldimethylsilyloxy)propan-2-yl)-2,2-dimethyl-1,3-
dioxan-4-yl)pentan-1-ol: 3.67 
HO
O O
Me
OTBS
MeMe
PMBO
O O
Me
OTBS
MeMe
DDQ
phosphate
buffer
pH = 7  
PMB Ether (614 mg, 1.25 mmol) was taken up in CH2Cl2 (11.9 mL) and pH 7 
phosphate butter (0.6 mL) at room temperature.  DDQ (340 mg, 1.50 mmol) was 
added and solution immediately turned a green color.  After reaction was complete 
(~1 hrs, solution color light orange), saturated, aqueous NaHCO3 (1 mL) was added.  
Aqueous layer was extracted three times with Et2O (5 mL portions) and organics 
were washed once with brine (5 mL).  After drying with Na2SO4, 3.67 was isolated 
using flash chromatography (10:1 Hexanes:Ethyl Acetate) as a clear oil (390 mg, 1.04 
mmol) in 82% yield.   
[!]D -0.11 (c 0.4, CH2Cl2);  
FTIR (neat) 3357, 2933, 2858, 1379, 1251, 1224, 835, 775 cm
-1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 3.72 (dd, J = 14.5, 2H) 3.67-3.60 (m, 2H), 3.58-
3.52 (d, J = 4.8, 2H), 1.70-1.38 (m, 10H), 1.33 (s, 6H), 1.28-1.22 (m, 2H), 0.90-0.88 
(s, 9H), 0.85-0.83 (d, J = 6.9, 3H), 0.05-0.02 (s, 6H);  
13
C NMR (CDCl3, 500 MHz) " ppm 100.2, 67.1, 66.8, 64.1, 63.0, 40.5, 36.6, 35.9, 
32.7, 25.9, 25.7, 25.3, 24.6, 24.5, 18.2, 12.2, -5.5, -5.5;  
HRMS calculated for C20H42O4Si (M+Na) 397.2750, found 397.2773 (ESI). 
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(R)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)propan-1-ol: SI14 
HO
O O
Me
OTBS
MeMe
1. I2, PPh3
then tBuOK
2. TBAF
O O
Me
OH
MeMe
 
Alcohol (300 mg, 0.80 mmol) was taken up in THF (8 mL) at room temperature.  
Triphenylphosphine (252 mg, 0.96 mmol) and imidazole (120 mg, 1.76 mmol) were 
added respectively and cooled to 0 ºC.  I2 (242 mg, 0.96 mmol) was added and stirred 
for approximately 30 minutes (followed by TLC). Diluted with hexanes and filtered 
through a pad of silica, while washing with hexanes, and concentrated in vacuo. 
Crude product was taken onto next step.  
Iodo compound was taken up in THF (10 mL) at room temperature and a 
solution of tBuOK in THF (2.14 mL, 1.0 M in THF) was added. Reaction was stirred 
for about 30 minutes and was then quenched with H2O. The aqueous layer was 
extracted three times with ethyl acetate (5 mL portions) and collected organics were 
washed once with brine (5 mL). Ethyl acetate layer was dried with Na2SO4 and 
concentrated in vacuo.  3.68 (209 mg, 0.59 mmol) was isolated by flash 
chromatography (20:1, hexanes:EtOAc) as a clear oil in 73% yield.  
The resultant silyl ether (203 mg, 0.57 mmol) was then taken up in THF (2.8 
mL) and cooled to 0 ºC. A solution of TBAF in THF (0.85 mL, 1.0 M in THF) was 
added dropwise. The reaction stirred at 0 ºC until completion (approximately 45 
minutes). Reaction was quenched with NH4Cl and the aqueous layer was extracted 
three times with Et2O (5 mL portions). Collected organics were washed once with 
brine (5 mL) and dried with Na2SO4. After concentrating in vacuo, SI14 was isolated 
 193 
by flash chromatography (10:1, hexanes:EtOAc) as a clear oil (132 mg, 0.55 mmol, 
95% yield).  
[!]D -78.6 (c 0.5, CH2Cl2);  
FTIR (neat) 3446, 2983, 2935, 2879, 1379, 1224, 908 cm
-1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 5.86-5.75 (m, 1H), 5.07-4.93 (m, 2H), 3.82-3.76 
(m, 1H), 3.73-3.66 (ddd, J = 9.2, 6.2, 1H), 3.61-3.55 (m, 2H), 3.12-3.05 (s, 1H), 2.06 
(dd, J = 14.1, 7.1, 2H), 1.40-180 (m, 8H), 1.38 (s, 3H), 1.33 (s, 3H), 0.83-0.80 (d, J = 
7.0, 3H);  
13
C NMR (CDCl3, 500 MHz) " ppm 138.7, 114.7, 100.5, 73.0, 68.2, 66.6, 40.6, 37.8, 
35.3, 33.6, 24.7, 24.6, 12.6.   
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(2R,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyl-
7-(triethylsilyloxy)dec-4-en-3-ol: 3.71 
O
Me
O O Me
nPr
OTES
Me Me
O
Me
O OH Me
nPr
OTES
Me Me
H
I
O
Me
O
Me Me
OH
Swern Ox.
tBuLi, Et2O,vinyl iodide, 
-78 ºC to 0 ºC 30 min;
then aldehyde, -78 ºC, 79 %
 
A solution of oxalyl chloride (0.06 mL, 0.70 mmol) in CH2Cl2 (2.1 mL) was cooled 
to -78 ºC and dimethyl sulfoxide (0.102 mL, 1.45 mmol) was added slowly by 
syringe (gas evolution).  After stirring for 10 minutes a solution of alcohol SI14 (130 
mg, 0.537 mmol) in CH2Cl2 (1.34 mL) was added by cannula and rinsed twice with 
0.2 mL of CH2Cl2.  The cloudly mixture was stirred at -78 ºC was 15 minutes at 
which time triethylamine (0.225 mL, 1.61 mmol) was added dropwise.  The reaction 
mixture was then stirred for 1 h at -78 ºC.  The reaction was quenched cold with 
NaHCO3 (2 mL) and was allowed to warm to room temperature.  The reaction was 
diluted with CH2Cl2, and the layers were separated.  The aqueous layer was re-
extracted with CH2Cl2 (3x).  The organic layer was dried (Na2SO4), filtered through a 
silica plug and rinse (3 x 10 mL) with a 1:1 EtOAc:CH2Cl2. The filtrate was then 
concentrated under reduced pressure to give aldehyde 3.69 as a yellow oil.  The crude 
aldehyde was taken immediately to the next reaction with further purification.   
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To a solution of the vinyl iodide (456 mg, 1.25 mmol) in Et2O (4.16 mL) at  
–78 ºC was tBuLi (1.7 M in pentane, 1.47 mL, 2.50 mmol), and the reaction was 
immediately warmed to 0 ºC for 25 min.  The reaction was recooled to - 78 ºC, and 
the aldehyde was slowly added via syringe in Et2O (1.0 mL, 0.25 mL rinse).  After 1 
h, the reaction was quenched at - 78 ºC with NH4Cl (sat’d, aq), warmed to rt, and the 
layers separated.  The aq. layer was extracted with Et2O (2x), and the combined 
organic layers washed with brine (1x), dried (anhydrous Na2SO4), and concentrated 
(rotary evaporator). Flash chromatography (10:1 Hex:EtOAc) afforded a 1:1 mixture 
of 1,3 anti:syn 3.71 (ratio determined by 
1
H NMR analysis of crude reaction mixture, 
195 mg, 0.42 mmol, combine yield of diastereomers 79% over two steps).
 
1
H NMR (CDCl3, 500 MHz) ! ppm 5.82 (dddd, J = 16.9, 10.1, 6.7, 6.7 Hz, 1 H), 5.16 
(d, J = 9.1 Hz, 1 H), 5.01 (ddd, J = 17.1, 3.4, 1.5 Hz, 1 H), 4.95 (d, J = 10.2 Hz, 1 H), 
4.27 (t, J = 8.7 Hz, 1 H), 3.99 (s, 1H), 3.84-3.74 (m, 3H), 2.27 (dd, J =14.1, 4.3, 1H), 
2.16 (dd, J =8.7, 3.0, 1H), 2.06 (q, J = 7.0, 2H), 1.70 (s, 3H), 1.41 (s, 3H), 1.35 (s, 
3H), 1.72-1.20 (m, 11H), 0.96 (t, J = 8.2 Hz, 9H), 0.88 (t, J = 7.3 Hz, 3H), 0.71 (d, J 
= 6.9 Hz, 3H), 0.59 (q, J = 8.2 Hz, 6H);  
13
C NMR (CDCl3, 500 MHz) ! ppm 138.6, 136.0, 128.8, 114.6, 100.6, 72.9, 72.4, 
70.7, 66.6, 48.5, 44.1, 38.7, 38.0, 35.2, 33.6, 31.6, 24.7, 24.6, 24.5, 18.4, 17.3, 14.2, 
11.6, 7.0, 5.0; 
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(5S,7R,9S,12R,13S,14R)-15-(tert-butyldimethylsilyloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethylpentadec-1-ene-5,7,9-triyl triacetate: 3.75 
OHOH
Me
OPMB
Me
OTBS
OH
Me
OAcOAc
Me
OPMB
Me
OTBS
OAc
Me
Ac2O, Pyr.
CH2Cl, DMAP
 
A solution of triol 3.37 (60 mg, 0.107 mmol) in CH2Cl2 (1.5 mL) was added DMAP 
(2 mg, 0.016 mmol), pyridine (0.345 mL, 4.28 mmol), and acetic anhydride (0.203 
mL, 2.15 mmol). The reaction was stirred until disappearance of starting material at rt 
(~2h).  The reaction was diluted with EtOAc, quenched with NH4Cl (sat’d aq.), and 
the aqueous layer was re-extracted with EtOAc (3x).  The organic layer was then 
washed with brine (1x), dried (Na2SO4), filtered and concentrated under reduced 
pressure.  Flash chromatography (5:1 Hexane:EtOAc) provided of 3.75 (70 mg, 0.102 
mmol) in 95% yield as a clear oil. 
 [!]D 12.4 (c  =  0.50, CH2Cl2);  
FTIR (neat) 2956, 2929, 2883, 2856, 1739, 1514, 1461, 1247 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.26 (d, J = 8.7 Hz, 2 H), 6.87 (d, J = 8.7 Hz, 2 
H), 4.97 (dddd, J = 9.5, 6.2, 6.2, 3.1 Hz, 1 H), 4.89 (m, 2 H), 4.71 (s, 1H), 4.66 (s, 
1H), 4.53 (d, J = 10.9 Hz, 1 H), 4.46 (d, J = 10.9 Hz, 1 H), 3.80 (s, 3 H), 3.71 (dd, J = 
9.7, 5.3 Hz, 1 H), 3.63 (dd, J = 9.7, 3.3 Hz, 1 H), 3.25 (dd, J = 8.7, 2.4 Hz, 1 H), 1.99-
2.07 (m, 2 H), 2.05 (s, 3H), 2.03 (s, 3H), 1.99 (s, 3H), 1.92 (dddd, J = 18.7, 10.2, 4.4, 
4.4 Hz, 1 H), 1.68-1.84 (m, 6H), 1.71 (s, 3 H), 1.54-1.64 (m, 3 H), 1.38-1.46 (m, 1 H), 
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1.22-1.34 (m, 1 H), 0.92 (s, 9 H), 0.90 (d, J = 2.3 Hz, 3 H), 0.88 (d, J = 2.3 Hz, 3 H), 
0.06 (s, 3 H), 0.05 (s, 3 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 170.8, 170.7, 170.6, 159.1, 144.9, 131.7, 
129.3, 113.9, 110.5, 83.3, 74.6, 70.9, 70.3, 67.5, 65.1, 55.4, 39.2, 38.7, 38.6, 35.4, 
33.5, 33.1, 32.3, 30.5, 29.9, 26.1, 22.6, 21.3, 21.3, 21.2, 18.5, 14.8, 13.6, -5.2, -5.2; 
HRMS Exact Mass: calculate for C38H64NaO9Si (M+Na)
+
 715.4217; found 715.4213 
(ESI). 
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(5S,7R,9S,12R,13S,14R)-15-hydroxy-13-(4-methoxybenzyloxy)-2,12,14-
trimethylpentadec-1-ene-5,7,9-triyl triacetate: 3.76 
OAcOAc
Me
OPMB
Me
OTBS
OAc
Me
OAcOAc
Me
OPMB
Me
OH
OAc
Me
THF, rt
TBAF
 
A solution of 3.75 (65 mg, 0.094 mmol) in THF (1 mL) was added TBAF (0.283 mL, 
1.0M in THF).  The reaction was stirred until disappearance of starting material at rt 
(~3h).  The reaction was diluted with EtOAc, quenched with NH4Cl (sat’d aq.), and 
the aqueous layer was re-extracted with EtOAc (2x).  The organic layer was dried 
(Na2SO4), filtered and concentrated under reduced pressure.  Flash chromatography 
(2:1 Hexane:EtOAc) provided of 3.76 (50 mg, 0.087 mmol) in 93% yield as a clear 
oil. 
 [!]D 13.1 (c  =  2.35, CH2Cl2);  
FTIR (neat) 3502, 3072, 2964, 2935, 2875, 1737, 1514, 1454, 1245 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.28 (d, J = 8.5 Hz, 2 H), 6.88 (d, J = 8.6 Hz, 2 
H), 4.98 (dddd, J = 9.6, 6.3, 6.3, 3.3 Hz, 1 H), 4.91 (m, 2 H), 4.73 (s, 1H), 4.67 (s, 
1H), 4.58 (d, J = 10.6 Hz, 1 H), 4.51 (d, J = 10.6 Hz, 1 H), 3.81 (s, 3 H), 3.64 (m, 2 
H), 3.25 (dd, J = 7.6, 3.3 Hz, 1 H), 2.71 (s, 1 H), 1.99-2.07 (m, 2 H), 2.06 (s, 3 H), 
2.04 (s, 3 H), 2.02 (s, 3 H), 1.86-1.95 (m, 2 H) 1.68-1.84 (m, 6 H), 1.72 (s, 3 H), 1.56-
1.64 (m, 2 H), 1.44-1.54 (m, 1 H), 1.22-1.34 (m, 1 H), 0.96 (d, J = 6.9 Hz, 3 H), 0.94 
(d, J = 7.1 Hz, 3 H); 
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13
C NMR (126 MHz, CHCl3-d) ! ppm 170.7, 170.6, 170.5, 159.3, 144.7, 130.4, 
129.4, 113.9, 110.4, 87.6, 74.8, 70.6, 70.0, 67.3, 66.5, 55.3, 39.0, 38.4, 37.7, 36.1, 
33.3, 32.8, 32.2, 30.0, 22.4, 21.2, 21.1, 21.1, 15.4, 14.3; 
HRMS Exact Mass: calculate for C32H50NaO9 (M+Na)
+
 601.3353; found 601.3354 
(ESI). 
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(2S,3S,4R,7S,9R,11S)-7,9,11-triacetoxy-3-(4-methoxybenzyloxy)-2,4,14-
trimethylpentadec-14-enoic acid: 3.77 
OAcOAc
Me
OPMB
Me
OH
OAc
Me
OAcOAc
Me
OPMB
Me
O
OAc
Me
2. NaH2PO4, NaHClO2
2-methyl-2-butene
1. Swern Ox.
OH
 
A solution of oxalyl chloride (0.017 mL, 0.190 mmol) in CH2Cl2 (0.562 mL) was 
cooled to -78 ºC and dimethyl sulfoxide (0.032 mL, 0.447 mmol) was added slowly 
by syringe (gas evolution).  After stirring for 10 minutes a solution of alcohol 3.76 
(42 mg, 0.075 mmol) in CH2Cl2 (0.680 mL) was added by cannula and rinsed twice 
with 0.05 mL of CH2Cl2.  The cloudy mixture was stirred at -78 ºC was 15 minutes at 
which time triethylamine (0.075 mL, 0.535 mmol) was added dropwise.  The reaction 
mixture was then stirred for 2 h at -78 ºC.  The reaction was quenched cold with 
NaHCO3 (1 mL) and was allowed to warm to room temperature.  The reaction was 
diluted with CH2Cl2, and the layers were separated.  The aqueous layer was re-
extracted with CH2Cl2 (3x).  The organic layer was dried (Na2SO4), filtered and 
concentrated under reduced pressure to give aldehyde SI15 as a yellow oil.  The 
crude aldehyde was taken immediately to the next reaction with further purification.   
 To a solution of crude aldehyde SI15 was added tbutanol (1.5 mL) and 2-
methyl-2-butene (0.5 mL).  A solution of sodium chlorite (135 mg, 1.500 mmol) and 
sodium dihydrogen phosphate (125 mg, 1.042 mmol) in H2O (0.743 mL) was 
prepared and added to the reaction mixture by syringe.  The yellow solution was 
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stirred vigorously for 2 h at room temperature.  The reaction was then diluted with 
Et2O (5 mL) and pour into H2O (3 mL), the layers were separated and the aqueous 
phase was extracted with Et2O (3x).  The combine organic layers were dried with 
(Na2SO4), filtered and concentrated under reduced pressure.  Flash chromatography 
(1:1 Hexane:EtOAc) provided 3.77 (34 mg, 0.059)  in 81% yield (over two steps) as a 
clear oil. 
 [!]D 8.13 (c  =  0.16, CH2Cl2);  
FTIR (neat) 3251, 3076, 2964, 2923, 2854, 1737, 1714, 1512, 1454, 1245 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.24 (d, J = 8.5 Hz, 2 H), 6.85 (d, J = 8.6 Hz, 2 
H), 4.85-5.10 (m, 3 H), 4.73 (s, 1H), 4.67 (s, 1H), 4.56 (d, J = 10.7 Hz, 1 H), 4.50 (d, 
J = 10.6 Hz, 1 H), 3.79 (s, 3 H), 3.57 (dd, J = 7.2, 3.5 Hz, 1 H), 2.78 (dddd, J = 14.33, 
7.1, 7.1, 7.1 Hz, 1 H), 1.99-2.07 (m, 2 H), 2.06 (s, 3 H), 2.04 (s, 3 H), 2.02 (s, 3 H), 
1.86-1.95 (m, 1 H) 1.64-1.84 (m, 5 H), 1.72 (s, 3 H), 1.40-1.64 (m, 3 H), 1.20-1.39 
(m, 2 H), 1.17 (d, J = 7.1 Hz, 3 H), 0.93 (d, J = 6.7 Hz, 3 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 177.3, 170.8, 170.7, 170.5, 159.4, 144.7, 
130.0, 129.5, 113.9, 110.3, 84.2, 74.4, 70.8, 69.9, 67.3, 55.3, 42.3, 39.0, 38.1, 35.6, 
33.3, 32.5, 32.3, 28.9, 22.4, 21.2, 21.1, 21.1, 14.7, 14.4; 
HRMS Exact Mass: calculate for C32H48NaO10 (M+Na)
+
 615.3145; found 615.3131 
(ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-
enyl)-1,3-dioxan-4-yl)-5-methyl-7-(triethylsilyloxy)dec-4-en-3-yloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl 
triacetate: 3.78 
O
Me
O OH Me
nPr
OTES
Me Me
OAcOAc
Me
PMBO
Me
O
OAc
Me
OH
2,4,6-trichloro-
benzoyl chloride,
O
Me
O Me
nPr
OTES
Me Me
OAcOAc
Me
PMBO
Me
O
OAc
Me
O
DMAP, Et3N, 
Toluene, 73%
 
A solution of alcohol 3.71 (17 mg, 0.035 mmol), carboxylic acid 3.77 (23 mg, 0.039 
mmol), and 4-dimethylaminopyridine (215 mg, 1.766 mmol) in toluene (6.93 mL) at -
78 ºC was added triethylamine (0.111 mL, 0.798 mmol) dropwise followed by the 
slow addition of 2,4,6-trichlorobenzoyl chloride (0.124 mL, 0.7911 mmol).  This 
caused the white solution to thicken and the mixture was stirred for 21h at -78 ºC 
ensuring that the bath temperature did not rise above -65 ºC.  The reaction flask was 
then moved to a dry ice/acetonitrile bath and stirred for 2.5h maintaining the 
temperature between -30 ºC to -42 ºC.  At the end of the 2.5h the solution was slowly 
allowed to warm to rt in the bath over 1h.  The flask was then placed in an ice bath 
for 2h while being stirred.  The reaction was quenched by the addition of NaHCO3 (3 
mL).  The layers were separated and the aqueous layer was back extracted with Et2O 
(6 mL).  The combined organic layers were dried with Na2SO4, filtered, and 
concentrated under reduce pressure.  Purification by flash chromatography (5:1 
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hexane:EtOAc) provided ester 3.78 (27.3 mg, 0.025 mmol) in 73% yield as a 
colorless oil.    
[!]D 3.63 (c  =  0.275, CH2Cl2);  
FTIR (neat) 3076, 2954, 2935, 2875, 1739, 1515, 1442, 1244 cm
-1
;  
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.19 (d, J = 8.7 Hz, 2 H), 6.83 (d, J = 8.7 Hz, 2 
H), 5.82 (dddd, J = 17.0, 10.2, 6.8, 6.8 Hz, 1 H), 5.68 (dd, J = 9.9, 5.7 Hz, 1 H), 5.17 
(d, J = 9.8 Hz, 1 H), 5.02 (ddd, J = 17.1, 3.2, 1.6 Hz, 1 H), 4.93-5.00 (m, 3 H), 4.85-
4.94 (m, 2 H), 4.74 (s, 1 H), 4.67 (s, 1 H), 4.51 (d, J = 10.8 Hz, 1 H), 4.34 (d, J = 10.8 
Hz, 1 H), 3.79 (s, 3 H), 3.70-3.80 (m, 2 H), 3.60-3.69 (m, 3 H), 2.69 (dt, J = 14.2, 7.1 
Hz, 1 H), 1.89-2.20 (m, 8 H), 2.06 (s, 3 H), 2.04 (s, 3 H), 2.00 (s, 3 H), 1.76 (s, 3 H), 
1.73 (s, 3 H), 1.34 (s, 3 H), 1.29 (s, 3 H), 1.20-1.80 (m, 20 H), 1.08 (d, J = 7.1 Hz, 3 
H), 0.96 (t, J = 7.9 Hz, 9 H), 0.84-0.93 (m, 9 H) 0.58 (q, J = 7.9 Hz, 6 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 175.3, 170.6, 170.6, 170.5, 158.9, 144.7, 
139.6, 138.8, 131.2, 129.0, 122.7, 114.6, 113.6, 110.3, 100.1, 83.1, 73.9, 71.4, 70.7, 
70.2, 70.0, 67.3, 67.1, 66.5, 55.2, 53.5, 48.8, 43.5, 42.1, 39.1, 38.5, 38.5, 35.4, 34.7, 
33.7, 33.3, 32.1, 30.3, 29.9, 29.7, 24.9, 24.9, 24.8, 22.4, 21.2, 21.1, 21.1, 18.3, 17.6, 
15.3, 14.8, 13.2, 9.8, 7.0, 5.0; 
HRMS Exact Mass: calculate for C60H100NaO13Si (M+Na)
+
 1079.6831; found 
1079.7115 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-
dioxan-4-yl)-7-hydroxy-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: SI16 
O
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nPr
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Me
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Me
O
OAc
Me
O
TBAF
Me Me
O
Me
O Me
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The ester (27.3 mg, 0.025 mmol) was then taken up in THF (0.100 mL) and 
cooled to 0 ºC. A solution of TBAF in THF (0.038 mL, 1.0 M in THF) was added 
dropwise. The reaction stirred at 0ºC until completion (approximately 45 minutes). 
Reaction was quenched with NH4Cl and the aqueous layer was extracted three times 
with Et2O (5 mL portions).  Collected organics were washed once with brine (5 mL), 
dried with Na2SO4, filter, and concentrated under reduced pressure. Purification by 
flash chromatography (2:1, hexanes:EtOAc) afforded SI16 (22.7 mg, 0.024 mmol) as 
a clear oil in 93% yield.  
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.22 (d, J = 8.7 Hz, 2 H), 6.84 (d, J = 8.7 Hz, 2 
H), 5.81 (dddd, J = 17.0, 10.2, 6.7, 6.7 Hz, 1 H), 5.64 (dd, J = 9.9, 5.2 Hz, 1 H), 5.20 
(d, J = 9.6 Hz, 1 H), 5.01 (ddd, J = 17.1, 3.4, 1.6 Hz, 1 H), 4.93-5.00 (m, 2 H), 4.85-
4.93 (m, 2 H), 4.72 (s, 1 H), 4.67 (s, 1H), 4.53 (d, J = 10.7 Hz, 1H), 4.38 (d, J = 10.7 
Hz, 1 H), 3.79 (s, 3 H), 3.69-3.76 (m, 1 H), 3.59-3.66 (m, 1 H), 3.60-3.54 (m, 1 H), 
3.53 (dd, J = 8.4, 3.0 Hz, 1 H), 2.70 (dt, J = 15.2, 7.2 Hz, 1 H), 1.87-2.15 (m, 8 H), 
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2.06 (s, 3 H), 2.04 (s, 3 H), 2.00 (s, 3 H), 1.20-1.80 (m, 23 H), 1.76 (s, 3 H), 1.73 (s, 3 
H), 1.33 (s, 3 H), 1.28 (s, 3 H), 1.10 (d, J = 7.1 Hz, 3H), 0.84-0.93 (m, 9 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 175.3, 170.7, 170.6, 170.5, 158.9, 144.7, 
139.6, 138.7, 131.2, 128.8, 123.1, 114.6, 113.5, 110.3, 100.2, 83.7, 73.8, 71.8, 70.7, 
70.0, 68.4, 67.3, 66.4, 55.2, 53.5, 48.1, 43.4, 42.1, 39.2, 39.1, 38.5, 36.3, 35.4, 35.1, 
33.7, 33.3, 32.8, 32.2, 29.8, 29.7, 24.8, 24.6, 22.4, 21.2, 21.1, 21.0, 18.9, 17.5, 14.8, 
14.2, 13.6, 9.9; 
HRMS Exact Mass: calculate for C54H86NaO13 (M+Na)
+
  965.5966; found 965.5897 
(ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-7-acetoxy-2-((4S,6R)-2,2-dimethyl-6-
(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyldec-4-en-3-yloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl 
triacetate: 3.79 
O
Me
O Me
nPr
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Me
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A solution of triol SI16 (10 mg, 0.0106 mmol) in CH2Cl2 (0.5 mL) was added DMAP 
(1 crystal), pyridine (0.034 mL, 0.424 mmol), and acetic anhydride (0.020 mL, 0.212 
mmol). The reaction was stirred until disappearance of starting material at rt (~2h).  
The reaction was diluted with EtOAc, quenched with NH4Cl (sat’d aq.), and the 
aqueous layer was re-extracted with EtOAc (3x).  The organic layer was then washed 
with brine (1x), dried (Na2SO4), filtered and concentrated under reduced pressure.  
Flash chromatography (1.5:1 Hexane:EtOAc) provided 3.79 (10 mg, 0.0102 mmol) in 
96% yield as a clear oil. 
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.18 (d, J = 8.6 Hz, 2 H), 6.83 (d, J = 8.6 Hz, 2 
H), 5.80 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1 H), 5.67 (dd, J = 9.9, 5.6 Hz, 1 H), 5.16 
(d, J = 9.7 Hz, 1 H), 5.00 (ddd, J = 17.1, 3.4, 1.6 Hz, 1 H), 4.92-5.00 (m, 3 H), 4.84-
4.92 (m, 2 H), 4.73 (s, 1 H), 4.66 (s, 1 H), 4.50 (d, J = 10.9 Hz, 1 H), 4.35 (d, J = 10.9 
Hz, 1 H), 3.79 (s, 3 H), 3.68-3.75 (m, 1 H), 3.55-3.62 (m, 2 H), 2.68 (dt, J = 16.0, 6.9, 
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1 H), 1.87-2.15 (m, 8 H), 2.06 (s, 3 H), 2.04 (s, 3 H), 2.02 (s, 3 H), 2.00 (s, 3 H), 1.20-
1.80 (m, 20 H), 1.77 (s, 3 H), 1.73 (s, 3 H), 1.33 (s, 3 H), 1.27 (s, 3 H), 1.06 (d, J = 
7.1 Hz, 3 H), 0.84-0.93 (m, 9 H); 
13
C NMR (126 MHz, CHCl3-d) ! ppm 175.1, 170.6, 170.6, 170.6, 170.5, 158.9, 
144.7, 138.7, 138.6, 131.3, 128.8, 122.5, 114.6, 113.5, 110.3, 100.2, 83.2, 73.8, 72.1, 
71.2, 70.7, 70.0, 67.3, 66.4, 55.2, 53.5, 44.2, 42.1, 39.2, 39.1, 35.9, 35.4, 33.7, 33.3, 
32.2, 31.9, 31.6, 29.9, 24.8, 24.8, 22.7, 21.3, 21.2, 21.1, 21.0, 18.4, 17.8, 14.7, 14.2, 
14.2, 14.0, 13.2, 9.7; 
HRMS Exact Mass: calculate for C56H88NaO14 (M+Na)
+
  1007.6072; found 
1007.6210 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,Z)-4-acetoxy-10,12-dihydroxy-
6,9-dimethylheptadeca-6,16-dien-8-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: SI17 
OH
Me
OH Me
nPr
OAc
OAcOAc
Me
PMBO
Me
O
OAc
Me
O
MeOH, 83%
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A solution of tetraacetate 3.79 (20 mg, 0.0203 mmol) in MeOH (2 mL) was added 
PPTS (0.800 mg, 0.0305 mmol). The reaction was stirred until disappearance of 
starting material at rt (~4h).  The reaction was diluted with EtOAc, quenched with 
NaHCO3 (sat’d aq.), and the aqueous layer was re-extracted with EtOAc (3x).  The 
organic layer was then washed with brine (1x), dried (Na2SO4), filtered and 
concentrated under reduced pressure.  Flash chromatography (1.5:1 Hexane:EtOAc) 
provided SI17 (15.7 mg, 0.017 mmol) in 83% yield as a clear oil. 
1
H NMR (400 MHz, CHCl3-d) ! ppm 7.21 (d, J = 8.3 Hz, 2 H), 6.85 (d, J = 8.4 Hz, 2 
H), 5.82 (dddd, J = 15.8, 12.1, 5.4, 5.4 Hz, 1 H), 5.69 (dd, J = 9.7, 6.0 Hz, 1 H), 5.18 
(d, J = 9.8 Hz, 1 H), 4.85-5.05 (m, 6 H), 4.73 (s, 1 H), 4.67 (s, 1 H), 4.51 (d, J = 10.9 
Hz, 1 H), 4.34 (d, J = 11.0 Hz, 1 H), 3.86-3.92 (m, 1 H), 3.80 (s, 3 H), 3.71 (m, 1 H), 
3.58 (dd, J = 8.4, 2.0 Hz, 1 H), 2.73 (dddd, J = 14.2, 6.8, 6.8, 6.8 Hz, 1 H), 1.19-2.50 
(m, 28 H), 2.07 (s, 3 H), 2.03 (s, 3 H), 2.02 (s, 3 H), 1.82 (s, 3 H), 1.72 (s, 3 H), 1.09 
(d, J = 7.0 Hz, 3 H), 0.89 (t, J = 7.3 Hz, 3 H), 0.81-0.86 (m, 9 H); 
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13
C NMR (126 MHz, CHCl3-d) ! ppm 175.1, 170.7, 170.6, 170.6, 170.5, 158.9, 
144.7, 138.7, 138.6, 131.1, 128.4, 123.4, 114.7, 113.7, 110.3, 83.5, 73.8, 73.5, 72.5, 
70.7, 70.1, 68.8, 67.3, 60.4, 55.2, 44.3, 43.4, 43.0, 39.5, 39.1, 38.5, 37.1, 36.3, 34.9, 
33.7, 33.3, 32.2, 31.6, 29.8, 25.1, 22.7, 21.3, 21.2, 21.1, 21.1, 18.4, 17.8, 14.2, 14.0, 
13.6, 10.8;  
HRMS Exact Mass: calculate for C53H84NaO14 (M+Na)
+
 967.5759; found 967.5789 
(ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,Z)-4-acetoxy-10,12-dihydroxy-
6,9-dimethylheptadeca-6,16-dien-8-yloxy)-13-hydroxy-2,12,14-trimethyl-15-
oxopentadec-1-ene-5,7,9-triyl triacetate: 3.80 
OH
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Me
O
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The ester SI17 (0.016 mg, 0.0169 mmol) was taken up in CH2Cl2 (1.0 mL) followed 
by the addition of pH buffer solution (1.0 mL) and DDQ (8 mg, 0.0338 mmol) at rt.  
Upon completion (~0.5 h, monitored by TLC), CH2Cl2 (2 mL) was added followed by 
NaHCO3 (sat’d aq, 1 mL).  The layers were separated, and the aq. layer extracted 
with CH2Cl2 (3x).   The combined organic layers were rinsed with brine (1x), dried 
(anhydrous Na2SO4), filtered, and concentrated (rotary evaporator).  Flash 
chromatography (2:1 Hex:EtOAc) afforded 3.80 (12.9 mg, 0.0157 mmol, 93%) as a 
clear oil. 
1
H NMR (400 MHz, CHCl3-d) ! ppm 5.79 (dddd, J = 17.0, 10.2, 6.7, 6.7 Hz, 1 H), 
5.19 (dd, J = 9.7, 9.5 Hz, 1 H), 4.87-5.07 (m, 6 H), 4.73 (s, 1 H), 4.66 (s, 1 H), 4.09-
4.15 (m, 2 H), 3.89-3.96 (m, 1 H), 3.71 (dd, J = 9.9, 1.2 Hz, 1 H), 2.54 (dddd, J = 
14.1, 7.0, 7.0, 7.0 Hz, 1 H), 1.19-2.17 (m, 28 H), 2.07 (s, 3 H), 2.03 (s, 3 H), 2.02 (s, 3 
H), 1.82 (s, 3 H), 1.72 (s, 3 H), 1.08 (d, J = 7.0 Hz, 3 H), 0.89 (t, J = 7.3 Hz, 3 H), 
0.81-0.86 (m, 9 H); 
 211 
13
C NMR (126 MHz, CHCl3-d) ! ppm 174.0, 172.4, 170.8, 170.8, 170.6, 144.6, 
138.7, 138.0, 125.3, 114.6, 110.4, 72.6, 72.6, 72.4, 71.9, 70.7, 68.1, 67.1, 66.9, 45.3, 
44.2, 42.7, 39.0, 37.6, 37.3, 36.9, 36.0, 33.7, 33.6, 33.3, 32.3, 31.5, 29.0, 25.3, 22.4, 
21.4, 21.3, 21.2, 21.1, 18.5, 17.8, 13.9, 13.6, 12.5, 9.5; 
HRMS Exact Mass: calculate for C45H76NaO13 (M+Na)
+
 847.5184; found 847.5183 
(ESI). 
 212 
(3S,4S,5R,8S,10R,12S,20R,22S,23S,24R,E)-24-((R,E)-4-acetoxy-2-methylhept-1-
enyl)-4,20,22-trihydroxy-3,5,15,23-tetramethyl-2-oxooxacyclotetracos-15-ene-
8,10,12-triyl triacetate, Dolabelide C: 3.12 
OH
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OH Me
nPr
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OAcOAc
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O
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O
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60% E:Z = 1:1
 
To a refluxing solution of ester 3.80 (5.4 mg, 0.0065 mmol) in degassed CH2Cl2 (13.5 
mL) was added Grubbs II catalyst (0.620 mg, 0.73 µmol).  The reaction was refluxed 
6 h with the addition of Grubbs II catalyst (0.310 mg, 0.37 µmol) at 2 h intervals.   
The solution was allowed to cool to room temperature before being concentrated 
under vacuum pressure. Purification via flash chromatography (8:1 CH2Cl2/acetone) 
supplied 3.12, (3.1 mg, 0.0039 mmol) as a 1:1 E/Z mixture, as a viscous oil in 60% 
yield.  Repeat purification in by flash chromatography (8:1 CH2Cl2/acetone) afforded 
a 3.12 as a 4:1 E/Z mixture. 
1
H NMR (500 MHz, pyridine-d5) ! 6.30-6.40 (br s, 1H), 5.90-6.10 (br m, 2H), 5.70 
(t, J = 9.3 Hz, 1H), 5.40 (d, J = 9.5 Hz, 1H), 5.31-5.38 (m, 2H), 5.23-5.30 (m, 2H), 
5.10-5.16 (m, 1H), 4.82-4.88 (m, 1H), 4.32-4.37 (m, 1H), 4.03 (br d, J =9.1 Hz, 1H), 
2.85-2.93 (m, 1H), 2.48-2.52 (m, 1H), 2.32 (dd, J = 14.0, 7.9 Hz, 1H), 2.28 (dd, J = 
13.9, 5.4 Hz, 1H), 2.15-2.21 (m, 1H), 2.00-2.11 (m, 6H), 2.08 (s, 3H), 2.06 (s, 3H), 
2.05 (s, 3H), 2.05 (s, 3H), 1.98 (s, 3H), 1.92-1.96 (m, 2H), 1.80-1.90 (m, 4H), 1.58-
1.79 (m, 7H), 1.59 (s, 3H), 1.49-1.53 (m, 3H), 1.28-1.32 (m, 2H), 1.19 (d, J = 7.3 Hz, 
3H), 1.16 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H), 0.84 (t, J = 7.3 Hz, 3H); 
 213 
13
C NMR (126 MHz, pyridine-d5) ! ppm 173.9, 170.6, 170.5, 170.4, 170.3, 136.7, 
132.6, 127.3, 127.2, 74.3, 73.5, 71.8, 69.9, 69.9, 68.0, 67.9, 67.3, 46.4, 44.5, 43.7, 
38.8, 38.5, 38.0, 37.2, 36.3, 35.2, 34.1, 31.8, 31.6, 29.3, 28.0, 27.0, 21.1, 21.0, 20.9, 
20.9, 18.8, 17.6, 15.2, 14.0, 13.8, 12.6, 11.0; 
HRMS Exact Mass: calculate for C43H72NaO13 (M+Na)
+
 819.4871; found 819.4858 
(ESI). 
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Appendix A 
NMR Spectra: Chapters 2 and 3
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Allyl Alcohol derived Bicyclo[4.3.1]phosphate Triester: 2.55 
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TBS-Protected Allyl Alcohol derived Bicyclo[4.3.1]phosphate Triester: 2.56 
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Boc-Protected Allyl Amine derived Bicyclo[4.3.1]phosphate Triester: 2.57 
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Allyl Phosphate derived Bicyclo[4.3.1]phosphate Triester: 2.58 
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Methyl Vinyl Ketone derived Bicyclo[4.3.1]phosphate Triester: 2.54 
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Methyl acrylate derived Bicyclo[4.3.1]phosphate Triester: 2.60 
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t-Butyl acrylate derived Bicyclo[4.3.1]phosphate Triester: 2.61 
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Acrolein derived Bicyclo[4.3.1]phosphate Triester: 2.62 
O
P
O O
O
O
H
 
 
 231 
O
P
O O
O
O
H
 
 232 
(R)-1-(Benzyloxy)buten-2-ol derived Bicyclo[4.3.1]phosphate Triester: 2.63 
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 233 
(2Z,4R,6R,7E,9R)-10-(benzyloxy)deca-2,7-diene-1,4,6,9-tetraol: 2.64 
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Second Generation Bicyclic Phosphate: 2.66 
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Allyl Alcohol Derive Second Generation Bicyclic Phosphate: 2.67 
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Partially Hydrogenation Alcohol derive Second Generation Phosphate: 2.68 
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PMB-Protected Hydrogenated Second Generation Phosphate: 2.69 
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 242 
(4S,5R,7S)-11-(4-methoxybenzyloxy)-2,4-dimethylundec-2-ene-5,7-diol: 2.70 
OH OHOPMB
 
 
TBS-PMB Protected Phosphate: 3.26 
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Partially Hydrogenated TBS-PMB Protected Phosphate: 3.27 
O
PO O
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246 
(4S,6S,9R,10S,11R)-12-(tert-butyldimethylsilyloxy)-10-(4-methoxybenzyloxy)-
9,11-dimethyldodec-1-ene-4,6-diol: 3.31 
OH OH
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((2R,3S,4R)-6-((4S,6S)-6-allyl-2,2-dimethyl-1,3-dioxan-4-yl)-3-(4-
methoxybenzyloxy)-2,4-dimethylhexyloxy)(tert-butyl)dimethylsilane: 3.32 
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1-((4R,6S)-6-((3R,4S,5R)-6-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-
3,5-dimethylhexyl)-2,2-dimethyl-1,3-dioxan-4-yl)-5-methylhex-5-en-2-one: 3.35 
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(5S,7R,9S,12R,13S,14R)-15-(tert-butyldimethylsilyloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethylpentadec-1-ene-5,7,9-triol 3.37 
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PMB protected hydroxyl bicyclic phosphate: 3.41 
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Monocyclic Phosphate Ester: 3.42 
PMBO
O O
P
O OMe
 
 
 
254 
 
 
 
255 
(3R,5S,6R)-1-(4-methoxybenzyloxy)-6-methyloct-7-ene-3,5-diol: 3.43 
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OH OH
 
 
 
256 
(3R,4S,6R)-8-(4-methoxybenzyloxy)-3-methyl-6-(triisopropylsilyloxy)oct-1-en-4-ol: SI1 
PMBO
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(5S,7R)-5-((R)-but-3-en-2-yl)-9,9-diisopropyl-7-(2-(4-methoxybenzyloxy)ethyl)-10-
methyl-2,4,8-trioxa-9-silaundecane: 3.44b 
PMBO
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(2S,3S,5R)-7-(4-methoxybenzyloxy)-3-(methoxymethoxy)-2-methyl-5-
(triisopropylsilyloxy)heptanal: 3.45b 
PMBO H
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(R,E)-1-iodo-2-methylhept-1-en-4-ol: 3.47 
I
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(R,E)-1-iodo-4-(methoxymethoxy)-2-methylhept-1-ene: 3.48 
I
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261 
(5R,9R,10R,11S,13R,E)-15,15-diisopropyl-13-(2-(4-methoxybenzyloxy)ethyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-en-9-ol: 
1,3-syn-3.49b 
P1 = MOM
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(3R,5S,6S,7R,11R,E)-5,7,11-tris(methoxymethoxy)-6,9-dimethyl-3-
(triisopropylsilyloxy)tetradec-8-en-1-ol: 3.52 
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(4S,6R)-4-((R)-but-3-en-2-yl)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-
dioxane: 3.44a 
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(2R,3R,7R,E)-2-((4S,6R)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-
7-(methoxymethoxy)-5-methyldec-4-en-3-ol: anti-3.49a 
PMBO
O O OH OMOM
 
 
 
265 
(5R,9S,E)-11,11-diisopropyl-9-((S)-1-((4S,6R)-6-(2-(4-methoxybenzyloxy)ethyl)-
2,2-dimethyl-1,3-dioxan-4-yl)ethyl)-7,12-dimethyl-5-propyl-2,4,10-trioxa-11-
silatridec-7-ene  
PMBO
O O OTIPS OMOM
 
 
 
266 
(5R,10S,11S,13R,E)-15,15-diisopropyl-13-(2-(4-methoxybenzyloxy)ethyl)-11-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-en-9-one: 
3.50 
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Partially Hydrogenated PMB-Protected derived Bicyclic Phosphate: 3.56 
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269 
(5S,7R)-5-((R)-but-3-en-2-yl)-9,9-diisopropyl-7-(5-(4-methoxybenzyloxy)pentyl)-
10-methyl-2,4,8-trioxa-9-silaundecane: 3.60 
TIPSO OMOM
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(5R,9R,10S,11S,13R,E)-15,15-diisopropyl-13-(5-(4-methoxybenzyloxy)pentyl)-9-
(methoxymethoxy)-7,10,16-trimethyl-5-propyl-2,4,14-trioxa-15-silaheptadec-7-en-11-ol: 
3.62 
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(5R,9R,10S,11S,13R,E)-15,15-diisopropyl-9,11-bis(methoxymethoxy)-7,10,16-trimethyl-
13-(pent-4-enyl)-5-propyl-2,4,14-trioxa-15-silaheptadec-7-ene: 3.54 
 
 
 272 
(4S,6R)-4-((R)-but-3-en-2-yl)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-
1,3-dioxane: 3.65 
 
 
 
 
 
 
 
 
 
 
PMBO
O
O
Me
Me
Me
 
 
 
 
 
 273 
(R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-
yl)propan-1-ol: 3.66 
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tert-butyl((R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-
dioxan-4-yl)propoxy)dimethylsilane: SI13 
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5-((4R,6S)-6-((R)-1-(tert-butyldimethylsilyloxy)propan-2-yl)-2,2-dimethyl-1,3-
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(R)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)propan-1-ol: SI14 
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(2R,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyl-
7-(triethylsilyloxy)dec-4-en-3-ol: 3.71 
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(5S,7R,9S,12R,13S,14R)-15-(tert-butyldimethylsilyloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethylpentadec-1-ene-5,7,9-triyl triacetate: 3.75 
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 279 
(5S,7R,9S,12R,13S,14R)-15-hydroxy-13-(4-methoxybenzyloxy)-2,12,14-
trimethylpentadec-1-ene-5,7,9-triyl triacetate: 3.76 
 
O
A
c
O
A
c
M
e
O
P
M
B
M
e
O
H
O
A
c
M
e
 280 
(2S,3S,4R,7S,9R,11S)-7,9,11-triacetoxy-3-(4-methoxybenzyloxy)-2,4,14-
trimethylpentadec-14-enoic acid: 3.77 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-
enyl)-1,3-dioxan-4-yl)-5-methyl-7-(triethylsilyloxy)dec-4-en-3-yloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl 
triacetate: 3.78 
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 282 
(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-
dioxan-4-yl)-7-hydroxy-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: SI16 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,Z)-7-acetoxy-2-((4S,6R)-2,2-dimethyl-6-
(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyldec-4-en-3-yloxy)-13-(4-
methoxybenzyloxy)-2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl 
triacetate: 3.79 
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,Z)-4-acetoxy-10,12-dihydroxy-
6,9-dimethylheptadeca-6,16-dien-8-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: SI17 
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,Z)-4-acetoxy-10,12-dihydroxy-
6,9-dimethylheptadeca-6,16-dien-8-yloxy)-13-hydroxy-2,12,14-trimethyl-15-
oxopentadec-1-ene-5,7,9-triyl triacetate: 3.80 
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(3S,4S,5R,8S,10R,12S,20R,22S,23S,24R,E)-24-((R,E)-4-acetoxy-2-methylhept-1-
enyl)-4,20,22-trihydroxy-3,5,15,23-tetramethyl-2-oxooxacyclotetracos-15-ene-
8,10,12-triyl triacetate, Dolabelide C: 3.12 
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